Plant quality traits

ABSTRACT

The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties, including increased soluble solids, lycopene, and improved plant volume or yield, as compared to wild-type or control plants. The invention also pertains to expression systems that may be used to regulate these transcription factor polynucleotides, providing constitutive, transient, inducible and tissue-specific regulation.

RELATIONSHIP TO COPENDING APPLICATIONS

This application claims the benefit of Application No. 60/961,403, filedJul. 20, 2007(pending). This application is a continuation-in-part ofapplication Ser. No. 10/286,264, filed Nov. 1, 2002(pending), which is adivisional of application Ser. No. 09/533,030, filed Mar. 22, 2000(abandoned), which claims the benefit of Application No. 60/125,814,filed Mar. 23, 1999. This application is a continuation-in-part ofapplication Ser. No. 10/675,852, filed Sep. 30, 2003(pending). Thisapplication is a continuation-in-part of application Ser. No.11/479,226, filed Jun. 30, 2006(pending), which is acontinuation-in-part of application Ser. No. 09/713,994, filed Nov. 16,2000 (abandoned), which claims the benefit of Application No.60/166,228, filed Nov. 17, 1999, which also claims the benefit ofApplication No. 60/197,899, filed Apr. 17, 2000, which also claims thebenefit of Application No. 60/227,439, filed Aug. 22, 2000. Thisapplication is a continuation-in-part of application Ser. No.10/669,824, filed Sep. 23, 2003, which is a continuation-in-part of,Ser. No. 09/823,676, filed Mar. 30, 2001 (issued as U.S. Pat. No.6,717,034). This application is a continuation-in-part of applicationSer. No. 11/725,235, filed Mar. 16, 2007(pending), which is a divisionalof application Ser. No. 10/225,068, filed Aug. 9, 2002 (issued as U.S.Pat. No. 7,193,129), which claims the benefit of Application No.60/310,847, filed Aug. 9, 2001, and also claims the benefit ofApplication No. 60/336,049, filed Nov. 19, 2001, and also claims thebenefit of Application No. 60/338,692, filed Dec. 11, 2001; applicationSer. No. 10/225,068 is also a continuation-in-part of application Ser.No. 09/837,944, filed Apr. 18, 2001 (abandoned), and is also acontinuation-in-part of application Ser. No. 10/171,468, filed Jun. 14,2002 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 11/728,567, filed Mar. 26, 2007, which is adivisional of application Ser. No. 10/225,066, filed Aug. 9, 2002(issued as U.S. Pat. No. 7,238,860), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, and also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, and alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001.Application Ser. No. 10/225,066 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isa continuation-in-part of application Ser. No. 10/171,468, filed Jun.14, 2002 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 11/375,241, filed Mar. 16, 2006(pending), whichclaims the benefit of Application No. 60/713,952, filed Aug. 31, 2005.Application Ser. No. 11/375,241 is also a continuation-in-part ofapplication Ser. No. 10/225,067, filed Aug. 9, 2002 (issued as U.S. Pat.No. 7,135,616), which claims the benefit of Application No. 60/310,847,filed Aug. 9, 2001, which also claims the benefit of Application No.60/336,049, filed Nov. 19, 2001, and also claims the benefit ofApplication No. 60/338,692, filed Dec. 11, 2001. Application Ser. No.10/225,067 is also a continuation-in-part of application Ser. No.09/837,944, filed Apr. 18, 2001 (abandoned), and is also acontinuation-in-part of application Ser. No. 10/171,468, filed Jun. 14,2002 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 11/069,255, filed Feb. 28, 2005(pending), which isa continuation-in-part of application Ser. No. 10/112,887, filed Mar.18, 2002 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 10/374,780, filed Feb. 25, 2003(pending), which isa continuation-in-part of application Ser. No. 09/934,455, filed Aug.22, 2001 (abandoned), which is a continuation-in-part of applicationSer. No. 09/713,994, Nov. 16, 2000 (abandoned), which is also acontinuation-in-part of application Ser. No. 09/837,944, filed Apr. 18,2001 (abandoned), which also claims priority to Application No.60/227,439, filed Aug. 22, 2000. Application Ser. No. 10/374,780 is alsoa continuation-in-part of application Ser. No. 10/225,068, filed Aug. 9,2002 (issued as U.S. Pat. No. 7,193,129), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, and also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, and alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001.Application Ser. No. 10/225,068 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isalso a continuation-in-part of application Ser. No. 10/171,468, filedJun. 14, 2002 (abandoned). Application Ser. No. 10/374,780 is also acontinuation-in-part of application Ser. No. 10/225,066, filed Aug. 9,2002 (issued as U.S. Pat. No. 7,238,860), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, which also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, which alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001;application Ser. No. 10/225,066 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isalso a continuation-in-part of application Ser. No. 10/171,468, filedJun. 14, 2002 (abandoned). Application Ser. No. 10/374,780 is also acontinuation-in-part of application Ser. No. 10/225,067, filed Aug. 9,2002 (issued as U.S. Pat. No. 7,135,616), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, and also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, and alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001;application Ser. No. 10/225,067 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isalso a continuation-in-part of application Ser. No. 10/171,468, filedJun. 14, 2002 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 10/546,266, filed Aug. 19, 2005(pending), which isa '371 National Stage filing of International Application No.PCT/US2004005654, filed Feb. 25, 2004 (converted), which is acontinuation-in-part of application Ser. No. 10/374,780, filed Feb. 25,2003(pending), and is also a continuation-in-part of application Ser.No. 10/675,852, filed Sep. 30, 2003(pending). This application is also acontinuation-in-part of application Ser. No. 11/986,992, filed Nov. 26,2007(pending), which is a division of application Ser. No. 10/412,699,filed Apr. 10, 2003 (issued as U.S. Pat. No. 7,345,217), which is acontinuation-in-part of application Ser. No. 10/295,403, filed Nov. 15,2002 (abandoned), which is a divisional of application Ser. No.09/394,519, filed Sep. 13, 1999 (abandoned), which claims the benefit ofApplication No. 60/101,349, filed Sep. 22, 1998, which also claims thebenefit of Application No. 60/103,312, filed Oct. 6, 1998, which alsoclaims the benefit of Application No. 60/108,734, filed Nov. 17, 1998,which also claims the benefit of Application No. 60/113,409, filed Dec.22, 1998. Application Ser. No. 10/412,699 is also a continuation-in-partof application Ser. No. 09/489,376, filed Jan. 21, 2000 (abandoned),which claimed priority to Application No. 60/116,841, filed Jan. 22,1999. Application Ser. No. 10/412,699 is also a continuation-in-part ofapplication Ser. No. 10/302,267, filed Nov. 22, 2002 (issued as U.S.Pat. No. 7,223,904), which is a divisional of application Ser. No.09/506,720, filed Feb. 17, 2000 (abandoned), which claims the benefit ofApplication No. 60/120,880, filed Feb. 18, 1999, which also claims thebenefit of Application No. 60/121,037, filed Feb. 22, 1999, which alsoclaims the benefit of Application No. 60/124,278, filed Mar. 11, 1999,which also claims the benefit of Application No. 60/129,450, filed Apr.15, 1999, which also claims the benefit of Application No. 60/135,134,filed May 20, 1999, which also claims the benefit of Application No.60/144,153, filed Jul. 15, 1999, which also claims the benefit ofApplication No. 60/161,143, filed Oct. 22, 1999, which also claims thebenefit of Application No. 60/162,656, filed Nov. 1, 1999. ApplicationSer. No. 10/412,699 is also a continuation-in-part of application Ser.No. 10/278,173, filed Oct. 21, 2002 (abandoned), which is a divisionalof application Ser. No. 09/533,392, filed Mar. 22, 2000 (abandoned),which claims the benefit of Application No. 60/125,814, filed Mar. 23,1999. Application Ser. No. 10/412,699 is also a continuation-in-part ofapplication Ser. No. 09/533,029, filed Mar. 22, 2000 (issued as U.S.Pat. No. 6,664,446), which claims the benefit of Application No.60/125,814, filed Mar. 23, 1999. Application Ser. No. 10/412,699 is alsoa continuation-in-part of application Ser. No. 10/278,536, filed Oct.22, 2002 (abandoned), which is a divisional of application Ser. No.09/532,591, filed Mar. 22, 2000 (abandoned), which claims priority toApplication No. 60/125,814, filed Mar. 23, 1999. Application Ser. No.10/412,699 is also a continuation-in-part of application Ser. No.09/713,994, filed Nov. 16, 2000 (abandoned), which claims the benefit ofApplication No. 60/166,228, filed Nov. 17, 1999, which also claims thebenefit of Application No. 60/197,899, filed Apr. 17, 2000, which alsoclaims the benefit of Application No. 60/227,439, filed Aug. 22, 2000.Application Ser. No. 10/412,699 is also a continuation-in-part ofapplication Ser. No. 09/819,142, filed Mar. 27, 2001. Application Ser.No. 10/412,699 is also a continuation-in-part of application Ser. No.09/934,455, filed Aug. 22, 2001 (abandoned), which is acontinuation-in-part of application Ser. No. 09/713,994, filed Nov. 16,2000 (abandoned), which is also a continuation-in-part of applicationSer. No. 09/837,944, filed Apr. 18, 2001 (abandoned), which also claimthe benefit of Application No. 60/227,439, filed Aug. 22, 2000.Application Ser. No. 10/412,699 is also a continuation-in-part ofapplication Ser. No. 10/225,068, filed Aug. 9, 2002 (issued as U.S. Pat.No. 7,193,129), which claims the benefit of Application No. 60/310,847,filed Aug. 9, 2001, which also claims the benefit of Application No.60/336,049, filed Nov. 19, 2001, which also claims the benefit ofApplication No. 60/338,692, filed Dec. 11, 2001; and, application Ser.No. 10/225,068 is also a continuation-in-part of application Ser. No.09/837,944, filed Apr. 18, 2001 (abandoned), and is also acontinuation-in-part of application Ser. No. 10/171,468, filed Jun. 14,2002 (abandoned). Application Ser. No. 10/412,699 is also acontinuation-in-part of application Ser. No. 10/225,066, filed Aug. 9,2002 (issued as U.S. Pat. No. 7,238,860), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, which also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, which alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001;and, application Ser. No. 10/225,066 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isalso a continuation-in-part of application Ser. No. 10/171,468, filedJun. 14, 2002 (abandoned). Application Ser. No. 10/412,699 is also acontinuation-in-part of application Ser. No. 10/225,067, filed Aug. 9,2002 (issued as U.S. Pat. No. 7,135,616), which claims the benefit ofApplication No. 60/310,847, filed Aug. 9, 2001, which also claims thebenefit of Application No. 60/336,049, filed Nov. 19, 2001, which alsoclaims the benefit of Application No. 60/338,692, filed Dec. 11, 2001;and, application Ser. No. 10/225,067 is also a continuation-in-part ofapplication Ser. No. 09/837,944, filed Apr. 18, 2001 (abandoned), and isalso a continuation-in-part of application Ser. No. 10/171,468, filedJun. 14, 2002 (abandoned). Application Ser. No. 10/412,699 is also acontinuation-in-part of application Ser. No. 10/374,780, filed Feb. 25,2003(pending). This application is a continuation-in-part of applicationSer. No. 10/559,441, filed Dec. 2, 2005(pending), which is a '371National Stage filing of International Application No.PCT/US2004/017768, filed Jun. 4, 2004 (converted), which is acontinuation-in-part of application Ser. No. 10/456,882, filed Jun. 6,2003 (abandoned). This application is a continuation-in-part ofapplication Ser. No. 11/642,814, filed Dec. 20, 2006(pending), which isa divisional of application Ser. No. 10/666,642, filed Sep. 18, 2003(issued as U.S. Pat. No. 7,196,245), which claims the benefit ofApplication No. 60/411,837, filed Sep. 18, 2002, and also claims thebenefit of Application No. 60/434,166, filed Dec. 17, 2002, and alsoclaims the benefit of Application No. 60/465,809, filed Apr. 24, 2003.This application is a continuation-in-part of application Ser. No.10/714,887, filed Nov. 13, 2003(pending), which is acontinuation-in-part of application Ser. No. 10/456,882, filed Jun. 6,2003 (abandoned); and application Ser. No. 10/714,887 is also acontinuation-in-part of application Ser. No. 10/666,642, filed Sep. 18,2003 (issued as U.S. Pat. No. 7,196,245), which claims the benefit ofApplication No. 60/411,837, filed Sep. 18, 2002, which also claims thebenefit of Application No. 60/434,166, filed Dec. 17, 2002, which alsoclaims the benefit of Application No. 60/465,809, filed Apr. 24, 2003.This application is a continuation-in-part of application Ser. No.11/435,388, filed May 15, 2006(pending), which is a continuation-in-partof International Application No. PCT/US04/37584, filed Nov. 12, 2004(converted), which is a continuation-in-part of application Ser. No.10/714,887, filed Nov. 13, 2003(pending), and also claims the benefit ofApplication No. 60/527,658, filed Dec. 5, 2003, and also claims thebenefit of Application No. 60/542,928, filed Feb. 5, 2004. Thisapplication is a continuation-in-part of application Ser. No.11/632,390, filed Jan. 11, 2007(pending), which is a '371 National Stagefiling of International Application No. PCT/US2005/025010, filed Jul.14, 2005 (converted), which claims the benefit of Application No.60/588,405, filed Jul. 14, 2004. This application is acontinuation-in-part of application Ser. No. 12/064,961, filed Feb. 26,2008(pending), which is a continuation-in-part of PCT applicationPCT/US06/34615, filed Aug. 31, 2006 (expired), which claims the benefitof Application No. 60/713,952, filed Aug. 31, 2005. This application isa continuation-in-part of International Application no.PCT/US2006/34615, filed Aug. 31, 2006(pending), which claims the benefitof Application No. 60/713,952, filed Aug. 31, 2005. This application isa continuation-in-part of application Ser. No. 10/903,236, filed Jul.30, 2004(pending), which is a continuation-in-part of application Ser.No. 10/456,882, filed Jun. 6, 2003 (abandoned), and is also acontinuation-in-part of application Ser. No. 10/666,642, filed Sep. 18,2003 (issued as U.S. Pat. No. 7,196,245), which claims the benefit ofApplication No. 60/411,837, filed Sep. 18, 2002, and also claims thebenefit of Application No. 60/465,809, filed Apr. 24, 2003. Thisapplication is a continuation-in-part of application Ser. No.11/699,973, filed Jan. 29, 2007(pending), which is acontinuation-in-part of International Application No. PCT/US2005-027151,filed Jul. 29, 2005 (converted), which is a continuation-in-part ofapplication Ser. No. 10/903,236, filed Jul. 30, 2004(pending). Thisapplication is a continuation-in-part of application Ser. No.10/870,198, filed Jun. 16, 2004(pending), which claims the benefit ofApplication No. 60/565,948, filed Apr. 26, 2004, which also claims thebenefit of Application No. 60/527,658, filed Dec. 5, 2003, which alsoclaims the benefit of Application No. 60/542,928, filed Feb. 5, 2005;and, application Ser. No. 10/870,198 is also a continuation-in-part ofapplication Ser. No. 10/669,824, filed Sep. 23, 2003 (pending), which isa continuation-in-part of application Ser. No. 09/823,676, filed Mar.30, 2001 (issued as U.S. Pat. No. 6,717,034). This application is acontinuation-in-part of application Ser. No. 10/838,616, filed May 4,2004(pending), which claims the benefit of Application No. 60/565,948,filed Apr. 26, 2004, and is a continuation-in-part of application Ser.No. 10/685,922, filed Oct. 14, 2003 (abandoned). This application is acontinuation-in-part of International Application No. PCT/US2007/17321,filed Aug. 7, 2006(pending), which claims the benefit of Application No.60/836,243, filed Aug. 7, 2006. This application is acontinuation-in-part of application Ser. No. 11/705,903, filed Feb. 12,2007(pending), which is a continuation-in-part of InternationalApplication No. PCT/US2006/34615, filed Aug. 31, 2006 (converted), whichclaims the benefit of Application No. 60/713,952, filed Aug. 31, 2005.This application is a continuation-in-part of application Ser. No.11/821,448, filed Jun. 22, 2007(pending), which claims priority toApplication No. 60/817,886, filed Jun. 29, 2006. This application is acontinuation-in-part of application Ser. No. 11/981,667, filed Oct. 31,2007(pending). This application is also a continuation-in-part ofapplication Ser. No. 11/981,576 filed Oct. 31, 2007(pending). Thisapplication is a continuation-in-part of International Application No.PCT/US2007/09124, filed Apr. 12, 2007(pending), which claims priority toApplication No. 60/791,663, filed Apr. 12, 2006. The contents of allapplications herein are incorporated by reference in their entirety.

FIELD OF THE INVENTION

The present invention relates to compositions and methods fortransforming plants for the purpose of improving plant traits, includingyield and fruit quality.

BACKGROUND OF THE INVENTION

Biotechnological Improvement of Plants

To date, almost all improvements in agricultural crops have beenachieved using traditional plant breeding techniques. In recent years,biotechnology approaches involving the expression of single transgenesin crops have resulted in the successful commercial introduction of newplant traits, including herbicide resistance (glyphosate (Roundup)resistance), insect resistance (expression of Bacillus thuringiensistoxins) and virus resistance (over expression of viral coat proteins).Thus, plant genomics may be used to achieve control over polygenictraits. Some of the traits that may be improved, resulting in betteryield and crop quality, are listed below.

Control of Cellular Processes in Plants with Transcription Factors

Strategies for manipulating traits by altering a plant cell'stranscription factor content can result in plants and crops with newand/or improved commercially valuable properties. For example,manipulation of the levels of selected transcription factors may resultin increased expression of economically useful proteins or biomoleculesin plants or improvement in other agriculturally relevantcharacteristics. Conversely, blocked or reduced expression of atranscription factor may reduce biosynthesis of unwanted compounds orremove an undesirable trait. Therefore, manipulating transcriptionfactor levels in a plant offers tremendous potential in agriculturalbiotechnology for modifying a plant's traits, including traits thatimprove a plants survival, yield and product quality.

SUMMARY OF THE INVENTION

The present invention relates to compositions and methods for modifyingthe genotype of a higher plant for the purpose of impart desirablecharacteristics. These characteristics are generally yield and/orquality-related, and may specifically pertain to the fruit of the plant.The method steps involve first transforming a host plant cell with anucleic acid construct or DNA construct (such as an expression vector ora plasmid); the nucleic acid construct comprises a polynucleotide thatencodes a transcription factor polypeptide, and the polynucleotide ishomologous to any of the polynucleotides of the invention. These includethe transcription factor polynucleotides found in the Sequence Listing.

Once the host plant cell is transformed with the nucleic acid construct,a plant may be regenerated from the transformed host plant cell. Thisplant may then be grown to produce a plant having the desired yield orquality characteristic. Examples of yield and quality characteristicsthat may be improved by these method steps include increased brightcoloration, dark leaf color, etiolated seedlings, increased anthocyaninin leaves, increased anthocyanin in flowers, and increased anthocyaninin fruit, increased seedling anthocyanin, increased seedling vigor,longer internodes, more anthocyanin, more trichomes, and fewertrichomes.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING AND FIGURES

The Sequence Listing provides exemplary polynucleotide and polypeptidesequences of the invention. The traits associated with the use of thesequences are included in the Examples.

CD-ROMs Copy 1, Copy 2 and Copy 3 are read-only memory computer-readablecompact discs and contain a copy of the Sequence Listing in ASCII textformat filed under PCT Section 801(a). The Sequence Listing is named“MBI-0070-1CIP_ST25.txt” and is 4,887 kilobytes in size. The SequenceListing files associated with these CD-ROMS were created on Jun. 5,2008. The copies of the Sequence Listing on the CD-ROM discs are herebyincorporated by reference in their entirety.

FIG. 1 shows a conservative estimate of phylogenetic relationships amongthe orders of flowering plants (modified from Angiosperm Phylogeny Group(1998)). Those plants with a single cotyledon (monocots) are amonophyletic clade nested within at least two major lineages of dicots;the eudicots are further divided into rosids and asterids. Arabidopsisis a rosid eudicot classified within the order Brassicales; rice is amember of the monocot order Poales. FIG. 1 was adapted from Daly et al.(2001).

FIG. 2 shows a phylogenic dendogram depicting phylogenetic relationshipsof higher plant taxa, including clades containing tomato andArabidopsis; adapted from Ku et al. (2000) and Chase et al. (1993).

FIG. 3 is a schematic diagram of activator and target vectors used fortransformation of tomato to achieve regulated expression of Arabidopsistranscription factors in tomato. The activator vector contained apromoter and a LexA-GAL4 or a-LacI-GAL4 transactivator (thetransactivator comprises a LexA or LacI DNA binding domain fused to theGAL4 activation domain, and encodes a LexA-Gal4 or LacI-Gal4transcriptional activator product), a GFP marker, and a neomycinphosphotransferase II (nptII) selectable marker. The target vectorcontains a transactivator binding site (opLexA) operably linked to atransgene encoding a polypeptide of interest (for example, atranscription factor of the invention), and a sulfonamide selectablemarker (in this case, sulII; which encodes the dihydropteroate synthaseenzyme for sulfonamide-resistance) necessary for the selection andidentification of transformed plants. Binding of the transcriptionalactivator product encoded by the activator vector to the transactivatorbinding sites of the target vector initiates transcription of thetransgenes of interest.

DESCRIPTION OF THE INVENTION

The present invention relates to polynucleotides for modifyingphenotypes of plants, including those associated with improved plant orfruit yield, or improved fruit quality. Throughout this disclosure,various information sources are referred to and/or are specificallyincorporated. The information sources include scientific journalarticles, patent documents, textbooks, and World Wide Web browser-activeand inactive page addresses, for example. While the reference to theseinformation sources clearly indicates that they can be used by one ofskill in the art, each and every one of the information sources citedherein are specifically incorporated in their entirety, whether or not aspecific mention of “incorporation by reference” is noted. The contentsand teachings of each and every one of the information sources can berelied on and used to make and use embodiments of the invention.

As used herein and in the appended claims, the singular forms “a,” “an,”and “the” include plural reference unless the context clearly dictatesotherwise. Thus, for example, a reference to “a plant” includes aplurality of such plants.

Definitions

“Nucleic acid molecule” refers to an oligonucleotide, polynucleotide orany fragment thereof. It may be DNA or RNA of genomic or syntheticorigin, double-stranded or single-stranded, and combined withcarbohydrate, lipids, protein, or other materials to perform aparticular activity such as transformation or form a useful compositionsuch as a peptide nucleic acid (PNA).

“Polynucleotide” is a nucleic acid molecule comprising a plurality ofpolymerized nucleotides, e.g., at least about 15 consecutive polymerizednucleotides, optionally at least about 30 consecutive nucleotides, atleast about 50 consecutive nucleotides. A polynucleotide may be anucleic acid, oligonucleotide, nucleotide, or any fragment thereof. Inmany instances, a polynucleotide comprises a nucleotide sequenceencoding a polypeptide (or protein) or a domain or fragment thereof.Additionally, the polynucleotide may comprise a promoter, an intron, anenhancer region, a polyadenylation site, a translation initiation site,5′ or 3′ untranslated regions, a reporter gene, a selectable marker, orthe like. The polynucleotide can be single stranded or double strandedDNA or RNA. The polynucleotide optionally comprises modified bases or amodified backbone. The polynucleotide can be, e.g., genomic DNA or RNA,a transcript (such as an mRNA), a cDNA, a polymerase chain reaction(PCR) product, a cloned DNA, a synthetic DNA or RNA, or the like. Thepolynucleotide can be combined with carbohydrate, lipids, protein, orother materials to perform a particular activity such as transformationor form a useful composition such as a peptide nucleic acid (PNA). Thepolynucleotide can comprise a sequence in either sense or antisenseorientations. “Oligonucleotide” is substantially equivalent to the termsamplimer, primer, oligomer, element, target, and probe and is preferablysingle stranded.

“Gene” or “gene sequence” refers to the partial or complete codingsequence of a gene, its complement, and its 5′ or 3′ untranslatedregions. A gene is also a functional unit of inheritance, and inphysical terms is a particular segment or sequence of nucleotides alonga molecule of DNA (or RNA, in the case of RNA viruses) involved inproducing a polypeptide chain. The latter may be subjected to subsequentprocessing such as splicing and folding to obtain a functional proteinor polypeptide. A gene may be isolated, partially isolated, or be foundwith an organism's genome. By way of example, a transcription factorgene encodes a transcription factor polypeptide, which may be functionalor require processing to function as an initiator of transcription.

Operationally, genes may be defined by the cis-trans test, a genetictest that determines whether two mutations occur in the same gene andwhich may be used to determine the limits of the genetically active unit(Rieger et al. (1976)). A gene generally includes regions preceding(“leaders”; upstream) and following (“trailers”; downstream) of thecoding region. A gene may also include intervening, non-codingsequences, referred to as “introns”, located between individual codingsegments, referred to as “exons”. Most genes have an associated promoterregion, a regulatory sequence 5′ of the transcription initiation codon(there are some genes that do not have an identifiable promoter). Thefunction of a gene may also be regulated by enhancers, operators, andother regulatory elements.

A “recombinant polynucleotide” is a polynucleotide that is not in itsnative state, e.g., the polynucleotide comprises a nucleotide sequencenot found in nature, or the polynucleotide is in a context other thanthat in which it is naturally found, e.g., separated from nucleotidesequences with which it typically is in proximity in nature, or adjacent(or contiguous with) nucleotide sequences with which it typically is notin proximity. For example, the sequence at issue can be cloned into avector, or otherwise recombined with one or more additional nucleicacid.

An “isolated polynucleotide” is a polynucleotide whether naturallyoccurring or recombinant, that is present outside the cell in which itis typically found in nature, whether purified or not. Optionally, anisolated polynucleotide is subject to one or more enrichment orpurification procedures, e.g., cell lysis, extraction, centrifugation,precipitation, or the like.

A “polypeptide” is an amino acid sequence comprising a plurality ofconsecutive polymerized amino acid residues e.g., at least about 15consecutive polymerized amino acid residues, optionally at least about30 consecutive polymerized amino acid residues, at least about 50consecutive polymerized amino acid residues. In many instances, apolypeptide comprises a polymerized amino acid residue sequence that isa transcription factor or a domain or portion or fragment thereof.Additionally, the polypeptide may comprise 1) a localization domain, 2)an activation domain, 3) a repression domain, 4) an oligomerizationdomain, or 5) a DNA-binding domain, or the like. The polypeptideoptionally comprises modified amino acid residues, naturally occurringamino acid residues not encoded by a codon, non-naturally occurringamino acid residues.

“Protein” refers to an amino acid sequence, oligopeptide, peptide,polypeptide or portions thereof whether naturally occurring orsynthetic.

“Portion”, as used herein, refers to any part of a protein used for anypurpose, but especially for the screening of a library of moleculeswhich specifically bind to that portion or for the production ofantibodies.

A “recombinant polypeptide” is a polypeptide produced by translation ofa recombinant polynucleotide. A “synthetic polypeptide” is a polypeptidecreated by consecutive polymerization of isolated amino acid residuesusing methods well known in the art. An “isolated polypeptide,” whethera naturally occurring or a recombinant polypeptide, is more enriched in(or out of) a cell than the polypeptide in its natural state in awild-type cell, e.g., more than about 5% enriched, more than about 10%enriched, or more than about 20%, or more than about 50%, or more,enriched, i.e., alternatively denoted: 105%, 110%, 120%, 150% or more,enriched relative to wild type standardized at 100%. Such an enrichmentis not the result of a natural response of a wild-type plant.Alternatively, or additionally, the isolated polypeptide is separatedfrom other cellular components with which it is typically associated,e.g., by any of the various protein purification methods herein.

“Homology” refers to sequence similarity between a reference sequenceand at least a fragment of a newly sequenced clone insert or its encodedamino acid sequence. Additionally, the terms “homology” and “homologoussequence(s)” may refer to one or more polypeptide sequences that aremodified by chemical or enzymatic means. The homologous sequence may bea sequence modified by lipids, sugars, peptides, organic or inorganiccompounds, by the use of modified amino acids or the like. Proteinmodification techniques are illustrated in Ausubel et al. (1998).

“Identity” or “similarity” refers to sequence similarity between twopolynucleotide sequences or between two polypeptide sequences, withidentity being a more strict comparison. The phrases “percent identity”and “% identity” refer to the percentage of sequence similarity found ina comparison of two or more polynucleotide sequences or two or morepolypeptide sequences. “Sequence similarity” refers to the percentsimilarity in base pair sequence (as determined by any suitable method)between two or more polynucleotide sequences. Two or more sequences canbe anywhere from 0-100% similar, or any integer value therebetween.Identity or similarity can be determined by comparing a position in eachsequence that may be aligned for purposes of comparison. When a positionin the compared sequence is occupied by the same nucleotide base oramino acid, then the molecules are identical at that position. A degreeof similarity or identity between polynucleotide sequences is a functionof the number of identical or matching nucleotides at positions sharedby the polynucleotide sequences. A degree of identity of polypeptidesequences is a function of the number of identical amino acids atpositions shared by the polypeptide sequences. A degree of homology orsimilarity of polypeptide sequences is a function of the number of aminoacids at positions shared by the polypeptide sequences.

With regard to polypeptides, the terms “substantial identity” or“substantially identical” may refer to sequences of sufficientsimilarity and structure to the transcription factors in the SequenceListing to produce similar function when expressed, overexpressed, orknocked-out in a plant; in the present invention, this function isimproved yield and/or fruit quality. Polypeptide sequences that are atleast about 55% identical to the instant polypeptide sequences areconsidered to have “substantial identity” with the latter. Sequenceshaving lesser degrees of identity but comparable biological activity areconsidered to be equivalents. The structure required to maintain properfunctionality is related to the tertiary structure of the polypeptide.There are discreet domains and motifs within a transcription factor thatmust be present within the polypeptide to confer function andspecificity. These specific structures are required so that interactivesequences will be properly oriented to retain the desired activity.“Substantial identity” may thus also be used with regard tosubsequences, for example, motifs that are of sufficient structure andsimilarity, being at least about 55% identical to similar motifs inother related sequences. Thus, related polypeptides within the G1421clade have the physical characteristics of substantial identity alongtheir full length and within their AP2-related domains. Thesepolypeptides also share functional characteristics, as the polypeptideswithin this clade bind to a transcription-regulating region of DNA andimprove yield and/or fruit quality in a plant when the polypeptides areoverexpressed.

“Alignment” refers to a number of nucleotide or amino acid residuesequences aligned by lengthwise comparison so that components in common(i.e., nucleotide bases or amino acid residues) may be visually andreadily identified. The fraction or percentage of components in commonis related to the homology or identity between the sequences. Alignmentsmay be used to identify conserved domains and relatedness within thesedomains. An alignment may suitably be determined by means of computerprograms known in the art, such as MacVector (1999) (Accelrys, Inc., SanDiego, Calif.).

A “conserved domain” or “conserved region” as used herein refers to aregion in heterologous polynucleotide or polypeptide sequences wherethere is substantial identity between the distinct sequences.bZIPT2-related domains are examples of conserved domains. With respectto polynucleotides encoding presently disclosed transcription factors, aconserved domain is encoded by a sequence preferably at least 10 basepairs (bp) in length. A conserved domain, with respect to presentlydisclosed polypeptides refers to a domain within a transcription factorfamily that exhibits a higher degree of sequence homology or substantialidentity, such as at least 55%, at least about 56%, at least about 57%,at least about 58%, at least about 59%, at least about 60%, at leastabout 61%, at least about 62%, at least about 63%, at least about 64%,at least about 65%, at least about 66%, at least about 67%, at leastabout 68%, at least about 69%, at least about 70%, at least about 71%,at least about 72%, at least about 73%, at least about 74%, at leastabout 75%, at least about 76%, at least about 77%, at least about 78%,at least about 79%, at least about 80%, at least about 81%, at leastabout 82%, at least about 83%, at least about 84%, at least about 85%,at least about 86%, at least about 87%, at least about 88%, at leastabout 89%, at least about 90%, at least about 91%, at least about 92%,at least about 93%, at least about 94%, at least about 95%, at leastabout 96%, at least about 97%, at least about 98%, at least about 99%,or about 100% amino acid residue sequence identity to a polypeptidesequence of consecutive amino acid residues such as those of thepolypeptides found in the present Sequence Listing.

A fragment or domain can be referred to as outside a conserved domain,outside a consensus sequence, or outside a consensus DNA-binding sitethat is known to exist or that exists for a particular transcriptionfactor class, family, or sub-family. In this case, the fragment ordomain will not include the exact amino acids of a consensus sequence orconsensus DNA-binding site of a transcription factor class, family orsub-family, or the exact amino acids of a particular transcriptionfactor consensus sequence or consensus DNA-binding site. Furthermore, aparticular fragment, region, or domain of a polypeptide, or apolynucleotide encoding a polypeptide, can be “outside a conserveddomain” if all the amino acids of the fragment, region, or domain falloutside of a defined conserved domain(s) for a polypeptide or protein.Sequences having lesser degrees of identity but comparable biologicalactivity are considered to be equivalents.

As one of ordinary skill in the art recognizes, conserved domains may beidentified as regions or domains of identity to a specific consensussequence. Thus, by using alignment methods well known in the art, theconserved domains of the plant transcription factors of the invention(e.g., bZIPT2, MYB-related, CCAAT-box binding, AP2, and AT-hook familytranscription factors) may be determined. An alignment of any of thepolypeptides of the invention with another polypeptide allows one ofskill in the art to identify conserved domains for any of thepolypeptides listed or referred to in this disclosure.

“Complementary” refers to the natural hydrogen bonding by base pairingbetween purines and pyrimidines. For example, the sequence A-C-G-T(5′->3′) forms hydrogen bonds with its complements A-C-G-T (5′->3′) orA-C-G-U (5′->3′). Two single-stranded molecules may be consideredpartially complementary, if only some of the nucleotides bond, or“completely complementary” if all of the nucleotides bond. The degree ofcomplementarity between nucleic acid strands affects the efficiency andstrength of the hybridization and amplification reactions. “Fullycomplementary” refers to the case where bonding occurs between everybase pair and its complement in a pair of sequences, and the twosequences have the same number of nucleotides.

The terms “highly stringent” or “highly stringent condition” refer toconditions that permit hybridization of DNA strands whose sequences arehighly complementary, wherein these same conditions excludehybridization of significantly mismatched DNAs. Polynucleotide sequencescapable of hybridizing under stringent conditions with thepolynucleotides of the present invention may be, for example, variantsof the disclosed polynucleotide sequences, including allelic or splicevariants, or sequences that encode orthologs or paralogs of presentlydisclosed polypeptides. Nucleic acid hybridization methods are disclosedin detail by Kashima et al. (1985), Sambrook et al. (1989), and by Hamesand Higgins (1985), which references are incorporated herein byreference.

In general, stringency is determined by the temperature, ionic strength,and concentration of denaturing agents (e.g., formamide) used in ahybridization and washing procedure (for a more detailed description ofestablishing and determining stringency, see below). The degree to whichtwo nucleic acids hybridize under various conditions of stringency iscorrelated with the extent of their similarity. Thus, similar nucleicacid sequences from a variety of sources, such as within a plant'sgenome (as in the case of paralogs) or from another plant (as in thecase of orthologs) that may perform similar functions can be isolated onthe basis of their ability to hybridize with known transcription factorsequences. Numerous variations are possible in the conditions and meansby which nucleic acid hybridization can be performed to isolatetranscription factor sequences having similarity to transcription factorsequences known in the art and are not limited to those explicitlydisclosed herein. Such an approach may be used to isolate polynucleotidesequences having various degrees of similarity with disclosedtranscription factor sequences, such as, for example, transcriptionfactors having 60% identity, or more preferably greater than about 70%identity, most preferably 72% or greater identity with disclosedtranscription factors.

The terms “paralog” and “ortholog” are defined below in the sectionentitled “Orthologs and Paralogs”. In brief, orthologs and paralogs areevolutionarily related genes that have similar sequences and functions.Orthologs are structurally related genes in different species that arederived by a speciation event. Paralogs are structurally related geneswithin a single species that are derived by a duplication event.

The term “equivalog” describes members of a set of homologous proteinsthat are conserved with respect to function since their last commonancestor. Related proteins are grouped into equivalog families, andotherwise into protein families with other hierarchically definedhomology types. This definition is provided at the Institute for GenomicResearch (TIGR) World Wide Web (www) website, “tigr.org” under theheading “Terms associated with TIGRFAMs”.

The term “variant”, as used herein, may refer to polynucleotides orpolypeptides that differ from the presently disclosed polynucleotides orpolypeptides, respectively, in sequence from each other, and as setforth below.

With regard to polynucleotide variants, differences between presentlydisclosed polynucleotides and polynucleotide variants are limited sothat the nucleotide sequences of the former and the latter are closelysimilar overall and, in many regions, identical. Due to the degeneracyof the genetic code, differences between the former and latternucleotide sequences may be silent (i.e., the amino acids encoded by thepolynucleotide are the same, and the variant polynucleotide sequenceencodes the same amino acid sequence as the presently disclosedpolynucleotide. Variant nucleotide sequences may encode different aminoacid sequences, in which case such nucleotide differences will result inamino acid substitutions, additions, deletions, insertions, truncationsor fusions with respect to the similar disclosed polynucleotidesequences. These variations result in polynucleotide variants encodingpolypeptides that share at least one functional characteristic. Thedegeneracy of the genetic code also dictates that many different variantpolynucleotides can encode identical and/or substantially similarpolypeptides in addition to those sequences illustrated in the SequenceListing.

Also within the scope of the invention is a variant of a transcriptionfactor nucleic acid listed in the Sequence Listing, that is, one havinga sequence that differs from the one of the polynucleotide sequences inthe Sequence Listing, or a complementary sequence, that encodes afunctionally equivalent polypeptide (i.e., a polypeptide having somedegree of equivalent or similar biological activity) but differs insequence from the sequence in the Sequence Listing, due to degeneracy inthe genetic code. Included within this definition are polymorphisms thatmay or may not be readily detectable using a particular oligonucleotideprobe of the polynucleotide encoding polypeptide, and improper orunexpected hybridization to allelic variants, with a locus other thanthe normal chromosomal locus for the polynucleotide sequence encodingpolypeptide.

“Allelic variant” or “polynucleotide allelic variant” refers to any oftwo or more alternative forms of a gene occupying the same chromosomallocus. Allelic variation arises naturally through mutation, and mayresult in phenotypic polymorphism within populations. Gene mutations maybe “silent” or may encode polypeptides having altered amino acidsequence. “Allelic variant” and “polypeptide allelic variant” may alsobe used with respect to polypeptides, and in this case the terms referto a polypeptide encoded by an allelic variant of a gene.

“Splice variant” or “polynucleotide splice variant” as used hereinrefers to alternative forms of RNA transcribed from a gene. Splicevariation naturally occurs as a result of alternative sites beingspliced within a single transcribed RNA molecule or between separatelytranscribed RNA molecules, and may result in several different forms ofmRNA transcribed from the same gene. This, splice variants may encodepolypeptides having different amino acid sequences, which may or may nothave similar functions in the organism. “Splice variant” or “polypeptidesplice variant” may also refer to a polypeptide encoded by a splicevariant of a transcribed mRNA.

As used herein, “polynucleotide variants” may also refer topolynucleotide sequences that encode paralogs and orthologs of thepresently disclosed polypeptide sequences. “Polypeptide variants” mayrefer to polypeptide sequences that are paralogs and orthologs of thepresently disclosed polypeptide sequences.

Differences between presently disclosed polypeptides and polypeptidevariants are limited so that the sequences of the former and the latterare closely similar overall and, in many regions, identical. Presentlydisclosed polypeptide sequences and similar polypeptide variants maydiffer in amino acid sequence by one or more substitutions, additions,deletions, fusions and truncations, which may be present in anycombination. These differences may produce silent changes and result ina functionally equivalent transcription factor. Thus, it will be readilyappreciated by those of skill in the art, that any of a variety ofpolynucleotide sequences is capable of encoding the transcriptionfactors and transcription factor homolog polypeptides of the invention.A polypeptide sequence variant may have “conservative” changes, whereina substituted amino acid has similar structural or chemical properties.Deliberate amino acid substitutions may thus be made on the basis ofsimilarity in polarity, charge, solubility, hydrophobicity,hydrophilicity, and/or the amphipathic nature of the residues, as longas the functional or biological activity of the transcription factor isretained. For example, negatively charged amino acids may includeaspartic acid and glutamic acid, positively charged amino acids mayinclude lysine and arginine, and amino acids with uncharged polar headgroups having similar hydrophilicity values may include leucine,isoleucine, and valine; glycine and alanine; asparagine and glutamine;serine and threonine; and phenylalanine and tyrosine. More rarely, avariant may have “non-conservative” changes, for example, replacement ofa glycine with a tryptophan. Similar minor variations may also includeamino acid deletions or insertions, or both. Related polypeptides maycomprise, for example, additions and/or deletions of one or moreN-linked or O-linked glycosylation sites, or an addition and/or adeletion of one or more cysteine residues. Guidance in determining whichand how many amino acid residues may be substituted, inserted or deletedwithout abolishing functional or biological activity may be found usingcomputer programs well known in the art, for example, DNASTAR software(see U.S. Pat. No. 5,840,544).

“Fragment”, with respect to a polynucleotide, refers to a clone or anypart of a polynucleotide molecule that retains a usable, functionalcharacteristic. Useful fragments include oligonucleotides andpolynucleotides that may be used in hybridization or amplificationtechnologies or in the regulation of replication, transcription ortranslation. A polynucleotide fragment” refers to any subsequence of apolynucleotide, typically, of at least about 9 consecutive nucleotides,preferably at least about 30 nucleotides, more preferably at least about50 nucleotides, of any of the sequences provided herein. Exemplarypolynucleotide fragments are the first sixty consecutive nucleotides ofthe transcription factor polynucleotides listed in the Sequence Listing.Exemplary fragments also include fragments that comprise a region thatencodes an conserved domain of a transcription factor. Exemplaryfragments also include fragments that comprise a conserved domain of atranscription factor. Exemplary fragments include fragments thatcomprise a conserved domain of a transcription factor, for example,amino acids: 84-146 of G1421, SEQ ID NO: 146, or 59-150 of G1818, SEQ IDNO: 202, or 9-111 of G663, SEQ ID NO: 66, which comprise, are comprisedwithin, or approximate, the AP2 DNA binding domain, the CAAT DNAbinding/subunit association domains, or the SANT/Myb DNA binding domainof these polypeptides, respectively.

Fragments may also include subsequences of polypeptides and proteinmolecules, or a subsequence of the polypeptide. Fragments may have usesin that they may have antigenic potential. In some cases, the fragmentor domain is a subsequence of the polypeptide which performs at leastone biological function of the intact polypeptide in substantially thesame manner, or to a similar extent, as does the intact polypeptide. Forexample, a polypeptide fragment can comprise a recognizable structuralmotif or functional domain such as a DNA-binding site or domain thatbinds to a DNA promoter region, an activation domain, or a domain forprotein-protein interactions, and may initiate transcription. Fragmentscan vary in size from as few as three amino acid residues to the fulllength of the intact polypeptide, but are preferably at least about 30amino acid residues in length and more preferably at least about 60amino acid residues in length.

The invention also encompasses production of DNA sequences that encodetranscription factors and transcription factor derivatives, or fragmentsthereof, entirely by synthetic chemistry. After production, thesynthetic sequence may be inserted into any of the many availableexpression vectors and cell systems using reagents well known in theart. Moreover, synthetic chemistry may be used to introduce mutationsinto a sequence encoding transcription factors or any fragment thereof.

“Derivative” refers to the chemical modification of a nucleic acidmolecule or amino acid sequence. Chemical modifications can includereplacement of hydrogen by an alkyl, acyl, or amino group orglycosylation, pegylation, or any similar process that retains orenhances biological activity or lifespan of the molecule or sequence.

The term “plant” includes whole plants, shoot vegetativeorgans/structures (for example, leaves, stems and tubers), roots,flowers and floral organs/structures (for example, bracts, sepals,petals, stamens, carpels, anthers and ovules), seed (including embryo,endosperm, and seed coat) and fruit (the mature ovary), plant tissue(for example, vascular tissue, ground tissue, and the like) and cellsfor example, guard cells, egg cells, and the like), and progeny of same.The class of plants that can be used in the method of the invention isgenerally as broad as the class of higher and lower plants amenable totransformation techniques, including angiosperms (monocotyledonous anddicotyledonous plants), gymnosperms, ferns, horsetails, psilophytes,lycophytes, bryophytes, and multicellular algae (see for example, FIG.1, adapted from Daly et al. (2001); FIG. 2, adapted from Ku et al.(2000); and see also Tudge (2000).

A “transgenic plant” refers to a plant that contains genetic materialnot found in a wild-type plant of the same species, variety or cultivar.The genetic material may include a transgene, an insertional mutagenesisevent (such as by transposon or T-DNA insertional mutagenesis), anactivation tagging sequence, a mutated sequence, a homologousrecombination event or a sequence modified by chimeraplasty. Typically,the foreign genetic material has been introduced into the plant by humanmanipulation, but any method can be used as one of skill in the artrecognizes. A transgenic plant includes transformed or transgenic seedthat comprise an expression vector or polynucleotide of the invention.

A transgenic plant may contain an expression vector or cassette. Theexpression cassette typically comprises a polypeptide-encoding sequenceoperably linked (i.e., under regulatory control of) to appropriateinducible or constitutive regulatory sequences that allow for thecontrolled expression of polypeptide. The expression cassette can beintroduced into a plant by transformation or by breeding aftertransformation of a parent plant. A plant refers to a whole plant aswell as to a plant part, such as seed, fruit, leaf, or root, planttissue, plant cells or any other plant material, e.g., a plant explant,as well as to progeny thereof, and to in vitro systems that mimicbiochemical or cellular components or processes in a cell.

“Wild type” or “wild-type”, as used herein, refers to a plant cell,seed, plant component, plant tissue, plant organ or whole plant that hasnot been genetically modified or treated in an experimental sense.Wild-type cells, seed, components, tissue, organs or whole plants may beused as controls to compare levels of expression and the extent andnature of trait modification with cells, tissue or plants of the samespecies in which a transcription factor expression is altered, e.g., inthat it has been knocked out, overexpressed, or ectopically expressed.

A “control plant” as used in the present invention refers to a plantcell, seed, plant component, plant tissue, plant organ or whole plantused to compare against transgenic or genetically modified plant for thepurpose of identifying an enhanced phenotype in the transgenic orgenetically modified plant. A control plant may in some cases be atransgenic plant line that comprises an empty vector or marker gene, butdoes not contain the recombinant polynucleotide of the present inventionthat is expressed in the transgenic or genetically modified plant beingevaluated. In general, a control plant is a plant of the same line orvariety as the transgenic or genetically modified plant being tested. Asuitable control plant would include a genetically unaltered ornon-transgenic plant of the parental line used to generate a transgenicplant herein.

A “trait” refers to a physiological, morphological, biochemical, orphysical characteristic of a plant or particular plant material or cell.In some instances, this characteristic is visible to the human eye, suchas seed or plant size, or can be measured by biochemical techniques,such as detecting the protein, starch, or oil content of seed or leaves,or by observation of a metabolic or physiological process, e.g. bymeasuring tolerance to water deprivation or particular salt or sugarconcentrations, or by the observation of the expression level of a geneor genes, e.g., by employing Northern analysis, RT-PCR, microarray geneexpression assays, or reporter gene expression systems, or byagricultural observations such as osmotic stress tolerance or yield. Anytechnique can be used to measure the amount of, comparative level of, ordifference in any selected chemical compound or macromolecule in thetransgenic plants, however.

“Trait modification” refers to a detectable difference in acharacteristic in a plant ectopically expressing a polynucleotide orpolypeptide of the present invention relative to a plant not doing so,such as a wild-type plant. In some cases, the trait modification can beevaluated quantitatively. For example, the trait modification can entailat least about a 2% increase or decrease, or an even greater difference,in an observed trait as compared with a control or wild-type plant. Itis known that there can be a natural variation in the modified trait.Therefore, the trait modification observed entails a change of thenormal distribution and magnitude of the trait in the plants as comparedto control or wild-type plants.

When two or more plants have “similar morphologies”, “substantiallysimilar morphologies”, “a morphology that is substantially similar”, orare “morphologically similar”, the plants have comparable forms orappearances, including analogous features such as overall dimensions,height, width, mass, root mass, shape, glossiness, color, stem diameter,leaf size, leaf dimension, leaf density, internode distance, branching,root branching, number and form of inflorescences, and other macroscopiccharacteristics, and the individual plants are not readilydistinguishable based on morphological characteristics alone.

“Modulates” refers to a change in activity (biological, chemical, orimmunological) or lifespan resulting from specific binding between amolecule and either a nucleic acid molecule or a protein.

The term “transcript profile” refers to the expression levels of a setof genes in a cell in a particular state, particularly by comparisonwith the expression levels of that same set of genes in a cell of thesame type in a reference state. For example, the transcript profile of aparticular transcription factor in a suspension cell is the expressionlevels of a set of genes in a cell knocking out or overexpressing thattranscription factor compared with the expression levels of that sameset of genes in a suspension cell that has normal levels of thattranscription factor. The transcript profile can be presented as a listof those genes whose expression level is significantly different betweenthe two treatments, and the difference ratios. Differences andsimilarities between expression levels may also be evaluated andcalculated using statistical and clustering methods.

“Ectopic expression” or “altered expression” in reference to apolynucleotide indicates that the pattern of expression in, e.g., atransgenic plant or plant tissue, is different from the expressionpattern in a wild-type or control plant of the same species. The patternof expression may also be compared with a reference expression patternin a wild-type plant of the same species. For example, thepolynucleotide or polypeptide is expressed in a cell or tissue typeother than a cell or tissue type in which the sequence is expressed inthe wild-type plant, or by expression at a time other than at the timethe sequence is expressed in the wild-type plant, or by a response todifferent inducible agents, such as hormones or environmental signals,or at different expression levels (either higher or lower) compared withthose found in a wild-type plant. The term also refers to alteredexpression patterns that are produced by lowering the levels ofexpression to below the detection level or completely abolishingexpression. The resulting expression pattern can be transient or stable,constitutive or inducible. In reference to a polypeptide, the term“ectopic expression or altered expression” further may relate to alteredactivity levels resulting from the interactions of the polypeptides withexogenous or endogenous modulators or from interactions with factors oras a result of the chemical modification of the polypeptides.

The term “overexpression” as used herein refers to a greater expressionlevel of a gene in a plant, plant cell or plant tissue, compared toexpression in a wild-type plant, cell or tissue, at any developmental ortemporal stage for the gene. Overexpression can occur when, for example,the genes encoding one or more transcription factors are under thecontrol of a strong promoter (e.g., the cauliflower mosaic virus 35Stranscription initiation region). Overexpression may also under thecontrol of an inducible or tissue specific promoter. Thus,overexpression may occur throughout a plant, in specific tissues of theplant, or in the presence or absence of particular environmentalsignals, depending on the promoter used.

Overexpression may take place in plant cells normally lacking expressionof polypeptides functionally equivalent or identical to the presenttranscription factors. Overexpression may also occur in plant cellswhere endogenous expression of the present transcription factors orfunctionally equivalent molecules normally occurs, but such normalexpression is at a lower level. Overexpression thus results in a greaterthan normal production, or “overproduction” of the transcription factorin the plant, cell or tissue.

The term “transcription regulating region” refers to a DNA regulatorysequence that regulates expression of one or more genes in a plant whena transcription factor having one or more specific binding domains bindsto the DNA regulatory sequence. Transcription factors of the presentinvention generally possess at least one conserved domain characteristicof a particular transcription factor family. Examples of such conserveddomains of the sequences of the invention may be found in Table 6. Thetranscription factors of the invention may also comprise an amino acidsubsequence that forms a transcription activation domain that regulatesexpression of one or more abiotic stress tolerance genes in a plant whenthe transcription factor binds to the regulating region.

DETAILED DESCRIPTION

Transcription Factors Modify Expression of Endogenous Genes

A transcription factor may include, but is not limited to, anypolypeptide that can activate or repress transcription of a single geneor a number of genes. As one of ordinary skill in the art recognizes,transcription factors can be identified by the presence of a region ordomain of structural similarity or identity to a specific consensussequence or the presence of a specific consensus DNA-binding site orDNA-binding site motif (see, for example, Riechmann et al. (2000). Theplant transcription factors may belong to, for example, thebZIPT2-related or other transcription factor families.

Generally, the transcription factors encoded by the present sequencesare involved in cell differentiation and proliferation and theregulation of growth. Accordingly, one skilled in the art wouldrecognize that by expressing the present sequences in a plant, one maychange the expression of autologous genes or induce the expression ofintroduced genes. By affecting the expression of similar autologoussequences in a plant that have the biological activity of the presentsequences, or by introducing the present sequences into a plant, one mayalter a plant's phenotype to one with improved traits related toimproved yield and/or fruit quality. The sequences of the invention mayalso be used to transform a plant and introduce desirable traits notfound in the wild-type cultivar or strain. Plants may then be selectedfor those that produce the most desirable degree of over- orunder-expression of target genes of interest and coincident traitimprovement.

The sequences of the present invention may be from any species,particularly plant species, in a naturally occurring form or from anysource whether natural, synthetic, semi-synthetic or recombinant. Thesequences of the invention may also include fragments of the presentamino acid sequences. Where “amino acid sequence” is recited to refer toan amino acid sequence of a naturally occurring protein molecule, “aminoacid sequence” and like terms are not meant to limit the amino acidsequence to the complete native amino acid sequence associated with therecited protein molecule.

In addition to methods for modifying a plant phenotype by employing oneor more polynucleotides and polypeptides of the invention describedherein, the polynucleotides and polypeptides of the invention have avariety of additional uses. These uses include their use in therecombinant production (i.e., expression) of proteins; as regulators ofplant gene expression, as diagnostic probes for the presence ofcomplementary or partially complementary nucleic acids (including fordetection of natural coding nucleic acids); as substrates for furtherreactions, for example, mutation reactions, PCR reactions, or the like;as substrates for cloning for example, including digestion or ligationreactions; and for identifying exogenous or endogenous modulators of thetranscription factors. In many instances, a polynucleotide comprises anucleotide sequence encoding a polypeptide (or protein) or a domain orfragment thereof. Additionally, the polynucleotide may comprise apromoter, an intron, an enhancer region, a polyadenylation site, atranslation initiation site, 5′ or 3′ untranslated regions, a reportergene, a selectable marker, or the like. The polynucleotide can be singlestranded or double stranded DNA or RNA. The polynucleotide optionallycomprises modified bases or a modified backbone. The polynucleotide canbe, for example, genomic DNA or RNA, a transcript (such as an mRNA), acDNA, a PCR product, a cloned DNA, a synthetic DNA or RNA, or the like.The polynucleotide can comprise a sequence in either sense or antisenseorientations.

Expression of genes that encode transcription factors that modifyexpression of endogenous genes, polynucleotides, and proteins are wellknown in the art. In addition, transgenic plants comprising isolatedpolynucleotides encoding transcription factors may also modifyexpression of endogenous genes, polynucleotides, and proteins. Examplesinclude Peng et al. (1997) and Peng et al. (1999). In addition, manyothers have demonstrated that an Arabidopsis transcription factorexpressed in an exogenous plant species elicits the same or very similarphenotypic response (see, for example, Fu et al. (2001); Nandi et al.(2000); Coupland (1995); and Weigel and Nilsson (1995)).

In another example, Mandel et al. (1992b) and Suzuki et al. (2001) teachthat a transcription factor expressed in another plant species elicitsthe same or very similar phenotypic response of the endogenous sequence,as often predicted in earlier studies of Arabidopsis transcriptionfactors in Arabidopsis (see Mandel et al. (1992b); Suzuki et al.(2001)).

Other examples include Müller et al. (2001); Kim et al. (2001); Kyozukaand Shimamoto (2002); Boss and Thomas (2002); He et al. (2000); andRobson et al. (2001).

In yet another example, Gilmour et al. (1998) teach an Arabidopsis AP2transcription factor, CBF1, which, when overexpressed in transgenicplants, increases plant freezing tolerance. Jaglo et al. (2001) furtheridentified sequences in Brassica napus that encode CBF-like genes andthat transcripts for these genes accumulated rapidly in response to lowtemperature. Transcripts encoding CBF-like proteins were also found toaccumulate rapidly in response to low temperature in wheat, as well asin tomato. An alignment of the CBF proteins from Arabidopsis, B. napus,wheat, rye, and tomato revealed the presence of conserved consecutiveamino acid residues which bracket the AP2/EREBP DNA binding domains ofthe proteins and distinguish them from other members of the AP2/EREBPprotein family (Jaglo et al. (2001).

Transcription factors mediate cellular responses and control traitsthrough altered expression of genes containing cis-acting nucleotidesequences that are targets of the introduced transcription factor. It iswell appreciated in the art that the effect of a transcription factor oncellular responses or a cellular trait is determined by the particulargenes whose expression is either directly or indirectly (for example, bya cascade of transcription factor binding events and transcriptionalchanges) altered by transcription factor binding. In a global analysisof transcription comparing a standard condition with one in which atranscription factor is overexpressed, the resulting transcript profileassociated with transcription factor overexpression is related to thetrait or cellular process controlled by that transcription factor. Forexample, the PAP2 gene and other genes in the MYB family have been shownto control anthocyanin biosynthesis through regulation of the expressionof genes known to be involved in the anthocyanin biosynthetic pathway(Bruce et al. (2000); Borevitz et al. (2000)). Further, globaltranscript profiles have been used successfully as diagnostic tools forspecific cellular states (for example, cancerous vs. non-cancerous;Bhattacharjee et al. (2001); Xu et al. (2001)). Consequently, it isevident to one skilled in the art that similarity of transcript profileupon overexpression of different transcription factors would indicatesimilarity of transcription factor function.

Polypeptides and Polynucleotides of the Invention

The present invention provides, among other things, transcriptionfactors, and transcription factor homolog polypeptides, and isolated orrecombinant polynucleotides encoding the polypeptides, or novel sequencevariant polypeptides or polynucleotides encoding novel variants oftranscription factors derived from the specific sequences provided here.

Transcription factors are generally characterized by at least twodomains responsible for transcription regulatory activity. Transcriptionfactor domains are art-recognized and may be identified in publishedsequences, e.g., in a database available from the “National Center forBiotechnology Information “NCBI”, or with a publicly available databasethat may be used to conduct a domain-oriented specialized search such aswith the NCBI Conserved Domain Database. These domains may include a 1)a localization domain; 2) an activation domain; 3) a repression domain;4) an oligomerization domain for protein-protein interactions; or 5) aDNA binding domain that activates transcription. DNA binding domains,for example, tend to be recognizable domains that are used to identifysequences within a particular transcription factor family, and, as withall these domains, are known to be correlated with transcription factorfunction. Conservative mutations within these domains will result inclosely related transcription factor polypeptides having similaractivity transcription regulatory activity and functions in plant cells.Although all conservative amino acid substitutions in these domains willnot necessarily result in the closely related transcription factorshaving DNA binding or regulatory activity, those of ordinary skill inthe art would expect that many of these conservative substitutions wouldresult in a protein having the DNA binding or regulatory activity.Further, amino acid substitutions outside of the functional domains andother conserved domains in the closely related transcription factorpolypeptides are unlikely to greatly affect activity the regulatoryactivity of the transcription factors.

The polynucleotides of the invention can be or were ectopicallyexpressed in overexpressor plant cells and the changes in the expressionlevels of a number of genes, polynucleotides, and/or proteins of theplant cells observed. Therefore, the polynucleotides and polypeptidescan be employed to change expression levels of a genes, polynucleotides,and/or proteins of plants. These polypeptides and polynucleotides may beemployed to modify a plant's characteristics, particularly improvementof yield and/or fruit quality. The polynucleotides of the invention canbe or were ectopically expressed in overexpressor or knockout plants andthe changes in the characteristic(s) or trait(s) of the plants observed.Therefore, the polynucleotides and polypeptides can be employed toimprove the characteristics of plants. The polypeptide sequences of thesequence listing, including Arabidopsis sequences, such as those inTable 6, conferred improved characteristics when these polypeptides wereoverexpressed in tomato plants. These polynucleotides have been shown toconfer bright coloration, dark leaf color, etiolated seedlings,increased anthocyanin in leaves, increased anthocyanin in flowers, andincreased anthocyanin in fruit, increased seedling anthocyanin,increased seedling vigor, longer internodes, more anthocyanin, moretrichomes, and/or fewer trichomes. Paralogs and orthologs of thesesequences, listed herein, are expected to function in a similar mannerby increasing these positive effects on fruit quality and/or yield.

The invention also encompasses sequences that are complementary to thepolynucleotides of the invention. The polynucleotides are also usefulfor screening libraries of molecules or compounds for specific bindingand for creating transgenic plants having improved yield and/or fruitquality. Altering the expression levels of equivalogs of thesesequences, including paralogs and orthologs in the Sequence Listing, andother orthologs that are structurally and sequentially similar to theformer orthologs, has been shown and is expected to confer similarphenotypes, including improved biomass, yield and/or fruit quality inplants.

In some cases, exemplary polynucleotides encoding the polypeptides ofthe invention were identified in the Arabidopsis thaliana GenBankdatabase using publicly available sequence analysis programs andparameters. Sequences initially identified were then furthercharacterized to identify sequences comprising specified sequencestrings corresponding to sequence motifs present in families of knowntranscription factors. In addition, further exemplary polynucleotidesencoding the polypeptides of the invention were identified in the plantGenBank database using publicly available sequence analysis programs andparameters. Sequences initially identified were then furthercharacterized to identify sequences comprising specified sequencestrings corresponding to sequence motifs present in families of knowntranscription factors. Polynucleotide sequences meeting such criteriawere confirmed as transcription factors.

Additional polynucleotides of the invention were identified by screeningArabidopsis thaliana and/or other plant cDNA libraries with probescorresponding to known transcription factors under low stringencyhybridization conditions. Additional sequences, including full lengthcoding sequences were subsequently recovered by the rapid amplificationof cDNA ends (RACE) procedure, using a commercially available kitaccording to the manufacturer's instructions. Where necessary, multiplerounds of RACE are performed to isolate 5′ and 3′ ends. The full-lengthcDNA was then recovered by a routine end-to-end PCR using primersspecific to the isolated 5′ and 3′ ends. Exemplary sequences areprovided in the Sequence Listing.

The invention also entails an agronomic composition comprising apolynucleotide of the invention in conjunction with a suitable carrierand a method for altering a plant's trait using the composition.

Examples of specific polynucleotide and polypeptides of the invention,and equivalog sequences, along with descriptions of the gene familiesthat comprise these polynucleotides and polypeptides, are provided inTable 6, in the Sequence Listing, and in the description provided below.

Homologous Sequences

Sequences homologous, i.e., that share significant sequence identity orsimilarity, to those provided in the Sequence Listing, derived fromArabidopsis thaliana or from other plants of choice, are also an aspectof the invention. Homologous sequences can be derived from any plantincluding monocots and dicots and in particular agriculturally importantplant species, including but not limited to, crops such as soybean,wheat, corn (maize), potato, cotton, rice, rape, oilseed rape (includingcanola), sunflower, alfalfa, clover, sugarcane, and turf; or fruits andvegetables, such as banana, blackberry, blueberry, strawberry, andraspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant,grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers,pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato,tomatillo, watermelon, rosaceous fruits (such as apple, peach, pear,cherry and plum) and vegetable brassicas (such as broccoli, cabbage,cauliflower, Brussels sprouts, and kohlrabi). Other crops, includingfruits and vegetables, whose phenotype can be changed and which comprisehomologous sequences include barley; rye; millet; sorghum; currant;avocado; citrus fruits such as oranges, lemons, grapefruit andtangerines, artichoke, cherries; nuts such as the walnut and peanut;endive; leek; roots such as arrowroot, beet, cassava, turnip, radish,yam, and sweet potato; and beans. The homologous sequences may also bederived from woody species, such pine, poplar and eucalyptus, or mint orother labiates. In addition, homologous sequences may be derived fromplants that are evolutionarily related to crop plants, but which may nothave yet been used as crop plants. Examples include deadly nightshade(Atropa belladona), related to tomato; jimson weed (Datura strommium),related to peyote; and teosinte (Zea species), related to corn (maize).

Homologous sequences can comprise orthologous or paralogous sequences,described below. Several different methods are known by those of skillin the art for identifying and defining these functionally homologoussequences. General methods for identifying orthologs and paralogs,including phylogenetic methods, sequence similarity and hybridizationmethods, are described herein; an ortholog or paralog, includingequivalogs, may be identified by one or more of the methods describedbelow.

Orthologs and Paralogs

Within a single plant species, gene duplication may cause two copies ofa particular gene, giving rise to two or more genes with similarsequence and often similar function known as paralogs. A paralog istherefore a similar gene formed by duplication within the same species.Paralogs typically cluster together or in the same clade (a group ofsimilar genes) when a gene family phylogeny is analyzed using programssuch as CLUSTAL (Thompson et al. (1994); Higgins et al. (1996)). Groupsof similar genes can also be identified with pair-wise BLAST analysis(Feng and Doolittle (1987)). For example, a clade of very similar MADSdomain transcription factors from Arabidopsis all share a commonfunction in flowering time (Ratcliffe et al. (2001)), and a group ofvery similar AP2 domain transcription factors from Arabidopsis areinvolved in tolerance of plants to freezing (Gilmour et al. (1998)).Analysis of groups of similar genes with similar function that fallwithin one clade can yield sub-sequences that are particular to theclade. These sub-sequences, known as consensus sequences, can not onlybe used to define the sequences within each clade, but define thefunctions of these genes; genes within a clade may contain paralogoussequences, or orthologous sequences that share the same function (seealso, for example, Mount (2001))

Transcription factor gene sequences are conserved across diverseeukaryotic species lines (Goodrich et al. (1993); Lin et al. (1991);Sadowski et al. (1988)). Plants are no exception to this observation;diverse plant species possess transcription factors that have similarsequences and functions. Speciation, the production of new species froma parental species, gives rise to two or more genes with similarsequence and similar function. These genes, termed orthologs, often havean identical function within their host plants and are ofteninterchangeable between species without losing function. Because plantshave common ancestors, many genes in any plant species will have acorresponding orthologous gene in another plant species. Once aphylogenic tree for a gene family of one species has been constructedusing a program such as CLUSTAL (Thompson et al. (1994); Higgins et al.(1996)) potential orthologous sequences can be placed into thephylogenetic tree and their relationship to genes from the species ofinterest can be determined. Orthologous sequences can also be identifiedby a reciprocal BLAST strategy. Once an orthologous sequence has beenidentified, the function of the ortholog can be deduced from theidentified function of the reference sequence.

As described by Eisen (1998), evolutionary information may be used topredict gene function. It is common for groups of genes that arehomologous in sequence to have diverse, although usually related,functions. However, in many cases, the identification of homologs is notsufficient to make specific predictions because not all homologs havethe same function. Thus, an initial analysis of functional relatednessbased on sequence similarity alone may not provide one with a means todetermine where similarity ends and functional relatedness begins.Fortunately, it is well known in the art that protein function can beclassified using phylogenetic analysis of gene trees combined with thecorresponding species. Functional predictions can be greatly improved byfocusing on how the genes became similar in sequence (i.e., byevolutionary processes) rather than on the sequence similarity itself(Eisen (1998)). In fact, many specific examples exist in which genefunction has been shown to correlate well with gene phylogeny (Eisen(1998)). Thus, “[t]he first step in making functional predictions is thegeneration of a phylogenetic tree representing the evolutionary historyof the gene of interest and its homologs. Such trees are distinct fromclusters and other means of characterizing sequence similarity becausethey are inferred by techniques that help convert patterns of similarityinto evolutionary relationships . . . . After the gene tree is inferred,biologically determined functions of the various homologs are overlaidonto the tree. Finally, the structure of the tree and the relativephylogenetic positions of genes of different functions are used to tracethe history of functional changes, which is then used to predictfunctions of [as yet] uncharacterized genes” (Eisen (1998)).

By using a phylogenetic analysis, one skilled in the art would recognizethat the ability to deduce similar functions conferred byclosely-related polypeptides is predictable. This predictability hasbeen confirmed by our own many studies in which we have found that awide variety of polypeptides have orthologous or closely-relatedhomologous sequences that function as does the first, closely-relatedreference sequence. For example, distinct transcription factors,including:

(i) AP2 family Arabidopsis G47 (found in U.S. Pat. No. 7,135,616), aphylogenetically-related sequence from soybean, and twophylogenetically-related homologs from rice all can confer greatertolerance to drought, hyperosmotic stress, or delayed flowering ascompared to control plants;

(ii) CAAT family Arabidopsis G481 (found in PCT patent publicationWO2004076638), and numerous phylogenetically-related sequences fromeudicots and monocots can confer greater tolerance to drought-relatedstress as compared to control plants;

(iii) Myb-related Arabidopsis G682 (found in U.S. Pat. Nos. 7,223,904and 7,193,129) and numerous phylogenetically-related sequences fromeudicots and monocots can confer greater tolerance to heat,drought-related stress, cold, and salt as compared to control plants;

(iv) WRKY family Arabidopsis G1274 (found in U.S. Pat. No. 7,196,245)and numerous closely-related sequences from eudicots and monocots havebeen shown to confer increased water deprivation tolerance, and

(v) AT-hook family soy sequence G3456 (found in US patent publication20040128712A1) and numerous phylogenetically-related sequences fromeudicots and monocots, increased biomass compared to control plants whenthese sequences are overexpressed in plants.

The polypeptides sequences belong to distinct clades of polypeptidesthat include members from diverse species. In each case, most or all ofthe clade member sequences derived from both eudicots and monocots havebeen shown to confer increased yield or tolerance to one or more abioticstresses when the sequences were overexpressed. These studies eachdemonstrate that evolutionarily conserved genes from diverse species arelikely to function similarly (i.e., by regulating similar targetsequences and controlling the same traits), and that polynucleotidesfrom one species may be transformed into closely-related ordistantly-related plant species to confer or improve traits.

At the polypeptide level, the sequences of the invention will typicallyshare at least about 40%, at least about 41%, at least about 42%, atleast about 43%, at least about 44%, at least about 45%, at least about46%, at least about 47%, at least about 48%, at least about 49%, atleast about 50%, at least about 51%, at least about 52%, at least about53%, at least about 54%, at least about 55%, at least about 56%, atleast about 57%, at least about 58%, at least about 59%, at least about60%, at least about 61%, at least about 62%, at least about 63%, atleast about 64%, at least about 65%, at least about 66%, at least about67%, at least about 68%, at least about 69%, at least about 70%, atleast about 71%, at least about 72%, at least about 73%, at least about74%, at least about 75%, at least about 76%, at least about 77%, atleast about 78%, at least about 79%, at least about 80%, at least about81%, at least about 82%, at least about 83%, at least about 84%, atleast about 85%, at least about 86%, at least about 87%, at least about88%, at least about 89%, at least about 90%, at least about 91%, atleast about 92%, at least about 93%, at least about 94%, at least about95%, at least about 96%, at least about 97%, at least about 98%, atleast about 99%, or about 100% amino acid sequence identity, and havesimilar functions with the polypeptides listed in Table 6 when thesesequences are overexpressed in plants.

Polypeptides that are phylogenetically related to the polypeptides ofTable 6 may also have conserved domains that share at least 55%, atleast about 56%, at least about 57%, at least about 58%, at least about59%, at least about 60%, at least about 61%, at least about 62%, atleast about 63%, at least about 64%, at least about 65%, at least about66%, at least about 67%, at least about 68%, at least about 69%, atleast about 70%, at least about 71%, at least about 72%, at least about73%, at least about 74%, at least about 75%, at least about 76%, atleast about 77%, at least about 78%, at least about 79%, at least about80%, at least about 81%, at least about 82%, at least about 83%, atleast about 84%, at least about 85%, at least about 86%, at least about87%, at least about 88%, at least about 89%, at least about 90%, atleast about 91%, at least about 92%, at least about 93%, at least about94%, at least about 95%, at least about 96%, at least about 97%, atleast about 98%, at least about 99%, or about 100% amino acid sequenceidentity, and have similar functions in that the polypeptides of theinvention may, when overexpressed in plants, confer at least oneregulatory activity and altered trait selected from the group consistingof bright coloration, dark leaf color, etiolated seedlings, increasedanthocyanin in leaves, increased anthocyanin in flowers, and increasedanthocyanin in fruit, increased seedling anthocyanin, increased seedlingvigor, longer internodes, more anthocyanin, more trichomes, and fewertrichomes, as compared to a control plant.

At the nucleotide level, the sequences of the invention will typicallyshare at least about 30% or 40% nucleotide sequence identity, preferablyat least about 50%, 55%, at least about 56%, at least about 57%, atleast about 58%, at least about 59%, at least about 60%, at least about61%, at least about 62%, at least about 63%, at least about 64%, atleast about 65%, at least about 66%, at least about 67%, at least about68%, at least about 69%, at least about 70%, at least about 71%, atleast about 72%, at least about 73%, at least about 74%, at least about75%, at least about 76%, at least about 77%, at least about 78%, atleast about 79%, at least about 80%, at least about 81%, at least about82%, at least about 83%, at least about 84%, at least about 85%, atleast about 86%, at least about 87%, at least about 88%, at least about89%, at least about 90%, at least about 91%, at least about 92%, atleast about 93%, at least about 94%, at least about 95%, at least about96%, at least about 97%, at least about 98%, at least about 99%, orabout 100%, sequence identity to one or more of the listed full-lengthsequences, or to a listed sequence but excluding or outside of theregion(s) encoding a known consensus sequence or consensus DNA-bindingsite, or outside of the region(s) encoding one or all conserved domains.The degeneracy of the genetic code enables major variations in thenucleotide sequence of a polynucleotide while maintaining the amino acidsequence of the encoded protein.

Percent identity can be determined electronically, e.g., by using theMEGALIGN program (DNASTAR, Inc. Madison, Wis.). The MEGALIGN program cancreate alignments between two or more sequences according to differentmethods, for example, the clustal method (see, for example, Higgins andSharp (1988). The clustal algorithm groups sequences into clusters byexamining the distances between all pairs. The clusters are alignedpairwise and then in groups. Other alignment algorithms or programs maybe used, including FASTA, BLAST, or ENTREZ, FASTA and BLAST, and whichmay be used to calculate percent similarity. These are available as apart of the GCG sequence analysis package (University of Wisconsin,Madison, Wis.), and can be used with or without default settings. ENTREZis available through the National Center for Biotechnology Information.In one embodiment, the percent identity of two sequences can bedetermined by the GCG program with a gap weight of 1, e.g., each aminoacid gap is weighted as if it were a single amino acid or nucleotidemismatch between the two sequences (see U.S. Pat. No. 6,262,333).

Software for performing BLAST analyses is publicly available, e.g.,through the National Center for Biotechnology Information (see internetwebsite at www.ncbi.nlm.nih.gov/). This algorithm involves firstidentifying high scoring sequence pairs (HSPs) by identifying shortwords of length W in the query sequence, which either match or satisfysome positive-valued threshold score T when aligned with a word of thesame length in a database sequence. T is referred to as the neighborhoodword score threshold (Altschul (1990); Altschul et al. (1993)). Theseinitial neighborhood word hits act as seeds for initiating searches tofind longer HSPs containing them. The word hits are then extended inboth directions along each sequence for as far as the cumulativealignment score can be increased. Cumulative scores are calculatedusing, for nucleotide sequences, the parameters M (reward score for apair of matching residues; always >0) and N (penalty score formismatching residues; always <0). For amino acid sequences, a scoringmatrix is used to calculate the cumulative score. Extension of the wordhits in each direction are halted when: the cumulative alignment scorefalls off by the quantity X from its maximum achieved value; thecumulative score goes to zero or below, due to the accumulation of oneor more negative-scoring residue alignments; or the end of eithersequence is reached. The BLAST algorithm parameters W, T, and Xdetermine the sensitivity and speed of the alignment. The BLASTN program(for nucleotide sequences) uses as defaults a wordlength (W) of 11, anexpectation (E) of 10, a cutoff of 100, M=5, N=−4, and a comparison ofboth strands. For amino acid sequences, the BLASTP program uses asdefaults a wordlength (W) of 3, an expectation (E) of 10, and theBLOSUM62 scoring matrix (see Henikoff & Henikoff (1991, 1992)). Unlessotherwise indicated for comparisons of predicted polynucleotides,“sequence identity” refers to the % sequence identity generated from atblastx using the NCBI version of the algorithm at the default settingsusing gapped alignments with the filter “off' (see, for example,internet website at www.ncbi.nlm.nih.gov/).

Other techniques for alignment are described by Doolittle (1996).Preferably, an alignment program that permits gaps in the sequence isutilized to align the sequences. The Smith-Waterman is one type ofalgorithm that permits gaps in sequence alignments (see Shpaer (1997).Also, the GAP program using the Needleman and Wunsch alignment methodcan be utilized to align sequences. An alternative search strategy usesMPSRCH software, which runs on a MASPAR computer. MPSRCH uses aSmith-Waterman algorithm to score sequences on a massively parallelcomputer. This approach improves ability to pick up distantly relatedmatches, and is especially tolerant of small gaps and nucleotidesequence errors. Nucleic acid-encoded amino acid sequences can be usedto search both protein and DNA databases.

The percentage similarity between two polypeptide sequences, e.g.,sequence A and sequence B, is calculated by dividing the length ofsequence A, minus the number of gap residues in sequence A, minus thenumber of gap residues in sequence B, into the sum of the residuematches between sequence A and sequence B, times one hundred. Gaps oflow or of no similarity between the two amino acid sequences are notincluded in determining percentage similarity. Percent identity betweenpolynucleotide sequences can also be counted or calculated by othermethods known in the art, e.g., the Jotun Hein method (see, for example,Hein (1990)) Identity between sequences can also be determined by othermethods known in the art, e.g., by varying hybridization conditions (seeUS Patent Application No. 20010010913).

Thus, the invention provides methods for identifying a sequence similaror paralogous or orthologous or homologous to one or morepolynucleotides as noted herein, or one or more target polypeptidesencoded by the polynucleotides, or otherwise noted herein and mayinclude linking or associating a given plant phenotype or gene functionwith a sequence. In the methods, a sequence database is provided(locally or across an internet or intranet) and a query is made againstthe sequence database using the relevant sequences herein and associatedplant phenotypes or gene functions.

In addition, one or more polynucleotide sequences or one or morepolypeptides encoded by the polynucleotide sequences may be used tosearch against a BLOCKS (Bairoch et al. (1997)), PFAM, and otherdatabases which contain previously identified and annotated motifs,sequences and gene functions. Methods that search for primary sequencepatterns with secondary structure gap penalties (Smith et al. (1992)) aswell as algorithms such as Basic Local Alignment Search Tool (BLAST;Altschul (1990); Altschul et al. (1993)), BLOCKS (Henikoff and Henikoff(1991)), Hidden Markov Models (HMM; Eddy (1996); Sonnhammer et al.(1997)), and the like, can be used to manipulate and analyzepolynucleotide and polypeptide sequences encoded by polynucleotides.These databases, algorithms and other methods are well known in the artand are described in Ausubel et al. (1997), and in Meyers (1995).

A further method for identifying or confirming that specific homologoussequences control the same function is by comparison of the transcriptprofile(s) obtained upon overexpression or knockout of two or morerelated polypeptides. Since transcript profiles are diagnostic forspecific cellular states, one skilled in the art will appreciate thatgenes that have a highly similar transcript profile (e.g., with greaterthan 50% regulated transcripts in common, or with greater than 70%regulated transcripts in common, or with greater than 90% regulatedtranscripts in common) will have highly similar functions. Fowler andThomashow (2002), have shown that three paralogous AP2 family genes(CBF1, CBF2 and CBF3) are induced upon cold treatment, and each of whichcan condition improved freezing tolerance, and all have highly similartranscript profiles. Once a polypeptide has been shown to provide aspecific function, its transcript profile becomes a diagnostic tool todetermine whether paralogs or orthologs have the same function.

Furthermore, methods using manual alignment of sequences similar orhomologous to one or more polynucleotide sequences or one or morepolypeptides encoded by the polynucleotide sequences may be used toidentify regions of similarity and B-box zinc finger domains. Suchmanual methods are well-known of those of skill in the art and caninclude, for example, comparisons of tertiary structure between apolypeptide sequence encoded by a polynucleotide that comprises a knownfunction and a polypeptide sequence encoded by a polynucleotide sequencethat has a function not yet determined. Such examples of tertiarystructure may comprise predicted alpha helices, beta-sheets, amphipathichelices, leucine zipper motifs, zinc finger motifs, proline-richregions, cysteine repeat motifs, and the like.

Orthologs and paralogs of presently disclosed polypeptides may be clonedusing compositions provided by the present invention according tomethods well known in the art. cDNAs can be cloned using mRNA from aplant cell or tissue that expresses one of the present sequences.Appropriate mRNA sources may be identified by interrogating Northernblots with probes designed from the present sequences, after which alibrary is prepared from the mRNA obtained from a positive cell ortissue. Polypeptide-encoding cDNA is then isolated using, for example,PCR, using primers designed from a presently disclosed gene sequence, orby probing with a partial or complete cDNA or with one or more sets ofdegenerate probes based on the disclosed sequences. The cDNA library maybe used to transform plant cells. Expression of the cDNAs of interest isdetected using, for example, microarrays, Northern blots, quantitativePCR, or any other technique for monitoring changes in expression.Genomic clones may be isolated using similar techniques to those.

Examples of orthologs of the Arabidopsis polypeptide sequences and theirfunctionally similar orthologs are listed in Table 6 and the SequenceListing. In addition to the sequences in Table 6 and the SequenceListing, the invention encompasses isolated nucleotide sequences thatare phylogenetically and structurally similar to sequences listed in theSequence Listing) and can function in a plant by increasing yield and/orand abiotic stress tolerance when ectopically expressed in a plant.

Since a significant number of these sequences are phylogenetically andsequentially related to each other and have been shown to increase yieldfrom a plant and/or abiotic stress tolerance, one skilled in the artwould predict that other similar, phylogenetically related sequencesfalling within the present clades of polypeptides would also performsimilar functions when ectopically expressed.

Identifying Polynucleotides or Nucleic Acids by Hybridization

Polynucleotides homologous to the sequences illustrated in the SequenceListing and tables can be identified, e.g., by hybridization to eachother under stringent or under highly stringent conditions. Singlestranded polynucleotides hybridize when they associate based on avariety of well characterized physical-chemical forces, such as hydrogenbonding, solvent exclusion, base stacking and the like. The stringencyof a hybridization reflects the degree of sequence identity of thenucleic acids involved, such that the higher the stringency, the moresimilar are the two polynucleotide strands. Stringency is influenced bya variety of factors, including temperature, salt concentration andcomposition, organic and non-organic additives, solvents, etc. presentin both the hybridization and wash solutions and incubations (and numberthereof), as described in more detail in the references cited below(e.g., Sambrook et al. (1989); Berger and Kimmel (1987); and Andersonand Young (1985)).

Encompassed by the invention are polynucleotide sequences that arecapable of hybridizing to the claimed polynucleotide sequences,including any of the transcription factor polynucleotides within theSequence Listing, and fragments thereof under various conditions ofstringency (see, for example, Wahl and Berger (1987); and Kimmel(1987)). In addition to the nucleotide sequences in the SequenceListing, full length cDNA, orthologs, and paralogs of the presentnucleotide sequences may be identified and isolated using well-knownmethods. The cDNA libraries, orthologs, and paralogs of the presentnucleotide sequences may be screened using hybridization methods todetermine their utility as hybridization target or amplification probes.

With regard to hybridization, conditions that are highly stringent, andmeans for achieving them, are well known in the art. See, for example,Sambrook et al. (1989); Berger and Kimmel (1987) pp. 467-469; andAnderson and Young (1985).

Stability of DNA duplexes is affected by such factors as basecomposition, length, and degree of base pair mismatch. Hybridizationconditions may be adjusted to allow DNAs of different sequencerelatedness to hybridize. The melting temperature (T_(m)) is defined asthe temperature when 50% of the duplex molecules have dissociated intotheir constituent single strands. The melting temperature of a perfectlymatched duplex, where the hybridization buffer contains formamide as adenaturing agent, may be estimated by the following equations:

(I) DNA-DNA:T _(m)(° C.)=81.5+16.6(log [Na+])+0.41(% G+C)−0.62(% formamide)−500/L(II) DNA-RNA:T _(m)(° C.)=79.8+18.5(log [Na+])+0.58(% G+C)+0.12(% G+C)²−0.5(%formamide)−820/L(III) RNA-RNA:T _(m)(° C.)=79.8+18.5(log [Na+])+0.58(% G+C)+0.12(% G+C)²−0.35(%formamide)−820/L

where L is the length of the duplex formed, [Na+] is the molarconcentration of the sodium ion in the hybridization or washingsolution, and % G+C is the percentage of (guanine+cytosine) bases in thehybrid. For imperfectly matched hybrids, approximately 1° C. is requiredto reduce the melting temperature for each 1% mismatch.

Hybridization experiments are generally conducted in a buffer of pHbetween 6.8 to 7.4, although the rate of hybridization is nearlyindependent of pH at ionic strengths likely to be used in thehybridization buffer (Anderson and Young (1985)). In addition, one ormore of the following may be used to reduce non-specific hybridization:sonicated salmon sperm DNA or another non-complementary DNA, bovineserum albumin, sodium pyrophosphate, sodium dodecylsulfate (SDS),polyvinyl-pyrrolidone, ficoll and Denhardt's solution. Dextran sulfateand polyethylene glycol 6000 act to exclude DNA from solution, thusraising the effective probe DNA concentration and the hybridizationsignal within a given unit of time. In some instances, conditions ofeven greater stringency may be desirable or required to reducenon-specific and/or background hybridization. These conditions may becreated with the use of higher temperature, lower ionic strength andhigher concentration of a denaturing agent such as formamide.

Stringency conditions can be adjusted to screen for moderately similarfragments such as homologous sequences from distantly related organisms,or to highly similar fragments such as genes that duplicate functionalenzymes from closely related organisms. The stringency can be adjustedeither during the hybridization step or in the post-hybridizationwashes. Salt concentration, formamide concentration, hybridizationtemperature and probe lengths are variables that can be used to alterstringency (as described by the formula above). As a general guidelineshigh stringency is typically performed at T_(m)−5° C. to T_(m)−20° C.,moderate stringency at T_(m)−20° C. to T_(m)−35° C. and low stringencyat T_(m)−35° C. to T_(m)−50° C. for duplex >150 base pairs.Hybridization may be performed at low to moderate stringency (25-50° C.below T_(m)), followed by post-hybridization washes at increasingstringencies. Maximum rates of hybridization in solution are determinedempirically to occur at T_(m)−25° C. for DNA-DNA duplex and T_(m)−15° C.for RNA-DNA duplex. Optionally, the degree of dissociation may beassessed after each wash step to determine the need for subsequent,higher stringency wash steps.

High stringency conditions may be used to select for nucleic acidsequences with high degrees of identity to the disclosed sequences. Anexample of stringent hybridization conditions obtained in a filter-basedmethod such as a Southern or northern blot for hybridization ofcomplementary nucleic acids that have more than 100 complementaryresidues is about 5° C. to 20° C. lower than the thermal melting point(T_(m)) for the specific sequence at a defined ionic strength and pH.Conditions used for hybridization may include about 0.02 M to about 0.15M sodium chloride, about 0.5% to about 5% casein, about 0.02% SDS orabout 0.1% N-laurylsarcosine, about 0.001 M to about 0.03 M sodiumcitrate, at hybridization temperatures between about 50° C. and about70° C. More preferably, high stringency conditions are about 0.02 Msodium chloride, about 0.5% casein, about 0.02% SDS, about 0.001 Msodium citrate, at a temperature of about 50° C. Nucleic acid moleculesthat hybridize under stringent conditions will typically hybridize to aprobe based on either the entire DNA molecule or selected portions,e.g., to a unique subsequence, of the DNA.

Stringent salt concentration will ordinarily be less than about 750 mMNaCl and 75 mM trisodium citrate. Increasingly stringent conditions maybe obtained with less than about 500 mM NaCl and 50 mM trisodiumcitrate, to even greater stringency with less than about 250 mM NaCl and25 mM trisodium citrate. Low stringency hybridization can be obtained inthe absence of organic solvent, e.g., formamide, whereas high stringencyhybridization may be obtained in the presence of at least about 35%formamide, and more preferably at least about 50% formamide. Stringenttemperature conditions will ordinarily include temperatures of at leastabout 30° C., more preferably of at least about 37° C., and mostpreferably of at least about 42° C. with formamide present. Varyingadditional parameters, such as hybridization time, the concentration ofdetergent, e.g., sodium dodecyl sulfate (SDS) and ionic strength, arewell known to those skilled in the art. Various levels of stringency areaccomplished by combining these various conditions as needed.

The washing steps that follow hybridization may also vary in stringency;the post-hybridization wash steps primarily determine hybridizationspecificity, with the most critical factors being temperature and theionic strength of the final wash solution. Wash stringency can beincreased by decreasing salt concentration or by increasing temperature.Stringent salt concentration for the wash steps will preferably be lessthan about 30 mM NaCl and 3 mM trisodium citrate, and most preferablyless than about 15 mM NaCl and 1.5 mM trisodium citrate.

Thus, hybridization and wash conditions that may be used to bind andremove polynucleotides with less than the desired homology to thenucleic acid sequences or their complements that encode the presenttranscription factors include, for example:

hybridization at 6×SSC at 65° C.;

50% formamide, 4×SSC at 42° C.;

0.5×SSC, 0.1% SDS at 65° C.; or

0.1×SSC to 2×SSC, 0.1% SDS at 50° C.-65° C.;

with, for example, two wash steps of 10 minutes each, or 10-30 minuteseach, such as with:

about 6×SSC at 65° C.;

about 20% (v/v) formamide in 0.1×SSC at 42° C.;

about 0.1×-0.5×SSC, 0.1% SDS at 65° C.; or

about 20% (v/v) formamide in 0.1×SSC at 42° C. with a subsequent washstep for 10 minutes with 0.2×SSC and 0.1% SDS at 65° C.

Useful variations on these conditions will be readily apparent to thoseskilled in the art.

A person of skill in the art would not expect substantial variationamong polynucleotide species encompassed within the scope of the presentinvention because the highly stringent conditions set forth in the aboveformulae yield structurally similar polynucleotides.

If desired, one may employ wash steps of even greater stringency,including about 0.2×SSC, 0.1% SDS at 65° C. and washing twice, each washstep being about 30 min, or about 0.1×SSC, 0.1% SDS at 65° C. andwashing twice for 30 min. The temperature for the wash solutions willordinarily be at least about 25° C., and for greater stringency at leastabout 42° C. Hybridization stringency may be increased further by usingthe same conditions as in the hybridization steps, with the washtemperature raised about 3° C. to about 5° C., and stringency may beincreased even further by using the same conditions except the washtemperature is raised about 6° C. to about 9° C. For identification ofless closely related homologs, wash steps may be performed at a lowertemperature, e.g., 50° C.

An example of a low stringency wash step employs a solution andconditions of at least 25° C. in 30 mM NaCl, 3 mM trisodium citrate, and0.1% SDS over 30 min. Greater stringency may be obtained at 42° C. in 15mM NaCl, with 1.5 mM trisodium citrate, and 0.1% SDS over 30 min. Evenhigher stringency wash conditions are obtained at 65° C.-68° C. in asolution of 15 mM NaCl, 1.5 mM trisodium citrate, and 0.1% SDS. Washprocedures will generally employ at least two final wash steps.Additional variations on these conditions will be readily apparent tothose skilled in the art (see, for example, US Patent Application No.20010010913).

Stringency conditions can be selected such that an oligonucleotide thatis perfectly complementary to the coding oligonucleotide hybridizes tothe coding oligonucleotide with at least about a 5-10× higher signal tonoise ratio than the ratio for hybridization of the perfectlycomplementary oligonucleotide to a nucleic acid encoding a transcriptionfactor known as of the filing date of the application. It may bedesirable to select conditions for a particular assay such that a highersignal to noise ratio, that is, about 15× or more, is obtained.Accordingly, a subject nucleic acid will hybridize to a unique codingoligonucleotide with at least a 2× or greater signal to noise ratio ascompared to hybridization of the coding oligonucleotide to a nucleicacid encoding known polypeptide. The particular signal will depend onthe label used in the relevant assay, e.g., a fluorescent label, acolorimetric label, a radioactive label, or the like. Labeledhybridization or PCR probes for detecting related polynucleotidesequences may be produced by oligolabeling, nick translation,end-labeling, or PCR amplification using a labeled nucleotide.

Encompassed by the invention are polynucleotide sequences that arecapable of hybridizing to the claimed polynucleotide sequences, forexample, to SEQ ID NO: 2N−1, where N=1 to 447, and fragments thereofunder various conditions of stringency (see, e.g., Wahl and Berger(1987); Kimmel (1987)). Estimates of homology are provided by eitherDNA-DNA or DNA-RNA hybridization under conditions of stringency as iswell understood by those skilled in the art (Hames and Higgins (1985).Stringency conditions can be adjusted to screen for moderately similarfragments, such as homologous sequences from distantly relatedorganisms, to highly similar fragments, such as genes that duplicatefunctional enzymes from closely related organisms. Post-hybridizationwashes determine stringency conditions.

Identifying Polynucleotides or Nucleic Acids with Expression Libraries

In addition to hybridization methods, transcription factor homologpolypeptides can be obtained by screening an expression library usingantibodies specific for one or more transcription factors. With theprovision herein of the disclosed transcription factor, andtranscription factor homolog nucleic acid sequences, the encodedpolypeptide(s) can be expressed and purified in a heterologousexpression system (e.g., E. coli) and used to raise antibodies(monoclonal or polyclonal) specific for the polypeptide(s) in question.Antibodies can also be raised against synthetic peptides derived fromtranscription factor, or transcription factor homolog, amino acidsequences. Methods of raising antibodies are well known in the art andare described in Harlow and Lane (1988). Such antibodies can then beused to screen an expression library produced from the plant from whichit is desired to clone additional transcription factor homologs, usingthe methods described above. The selected cDNAs can be confirmed bysequencing and enzymatic activity.

Producing Polypeptides

The polynucleotides of the invention include sequences that encodetranscription factors and transcription factor homolog polypeptides andsequences complementary thereto, as well as unique fragments of codingsequence, or sequence complementary thereto. Such polynucleotides canbe, for example, DNA or RNA, the latter including mRNA, cRNA, syntheticRNA, genomic DNA, cDNA synthetic DNA, oligonucleotides, etc. Thepolynucleotides are either double-stranded or single-stranded, andinclude either, or both sense (i.e., coding) sequences and antisense(i.e., non-coding, complementary) sequences. The polynucleotides includethe coding sequence of a transcription factor, or transcription factorhomolog polypeptide, in isolation, in combination with additional codingsequences (e.g., a purification tag, a localization signal, as afusion-protein, as a pre-protein, or the like), in combination withnon-coding sequences (for example, introns or inteins, regulatoryelements such as promoters, enhancers, terminators, and the like),and/or in a vector or host environment in which the polynucleotideencoding a transcription factor or transcription factor homologpolypeptide is an endogenous or exogenous gene.

A variety of methods exist for producing the polynucleotides of theinvention. Procedures for identifying and isolating DNA clones are wellknown to those of skill in the art, and are described in, for example,Berger and Kimmel (1987); Sambrook et al. (1989) and Ausubel et al.(1998; supplemented through 2000).

Alternatively, polynucleotides of the invention, can be produced by avariety of in vitro amplification methods adapted to the presentinvention by appropriate selection of specific or degenerate primers.Examples of protocols sufficient to direct persons of skill through invitro amplification methods, including the polymerase chain reaction(PCR) the ligase chain reaction (LCR), Qβ-replicase amplification andother RNA polymerase mediated techniques (for example, NASBA), e.g., forthe production of the homologous nucleic acids of the invention arefound in Berger and Kimmel (1987), Sambrook (1989), and Ausubel (2000),as well as Mullis et al. (1990). Improved methods for cloning in vitroamplified nucleic acids are described in U.S. Pat. No. 5,426,039.Improved methods for amplifying large nucleic acids by PCR aresummarized in Cheng et al. (1994) and the references cited therein, inwhich PCR amplicons of up to 40 kb are generated. One of skill willappreciate that essentially any RNA can be converted into a doublestranded DNA suitable for restriction digestion, PCR expansion andsequencing using reverse transcriptase and a polymerase. See, e.g.,Ausubel (2000), Sambrook (1989) and Berger and Kimmel (1987).

Alternatively, polynucleotides and oligonucleotides of the invention canbe assembled from fragments produced by solid-phase synthesis methods.Typically, fragments of up to approximately 100 bases are individuallysynthesized and then enzymatically or chemically ligated to produce adesired sequence, e.g., a polynucleotide encoding all or part of atranscription factor. For example, chemical synthesis using thephosphoramidite method is described, e.g., by Beaucage et al. (1981) andMatthes et al. (1984). According to such methods, oligonucleotides aresynthesized, purified, annealed to their complementary strand, ligatedand then optionally cloned into suitable vectors. And if so desired, thepolynucleotides and polypeptides of the invention can be custom orderedfrom any of a number of commercial suppliers.

Sequence Variations

It will readily be appreciated by those of skill in the art, that any ofa variety of polynucleotide sequences are capable of encoding thetranscription factors and transcription factor homolog polypeptides ofthe invention. Due to the degeneracy of the genetic code, many differentpolynucleotides can encode identical and/or substantially similarpolypeptides in addition to those sequences illustrated in the SequenceListing. Nucleic acids having a sequence that differs from the sequencesshown in the Sequence Listing, or complementary sequences, that encodefunctionally equivalent peptides (i.e., peptides having some degree ofequivalent or similar biological activity) but differ in sequence fromthe sequence shown in the Sequence Listing due to degeneracy in thegenetic code, are also within the scope of the invention.

Altered polynucleotide sequences encoding polypeptides include thosesequences with deletions, insertions, or substitutions of differentnucleotides, resulting in a polynucleotide encoding a polypeptide withat least one functional characteristic of the instant polypeptides.Included within this definition are polymorphisms that may or may not bereadily detectable using a particular oligonucleotide probe of thepolynucleotide encoding the instant polypeptides, and improper orunexpected hybridization to allelic variants, with a locus other thanthe normal chromosomal locus for the polynucleotide sequence encodingthe instant polypeptides.

Allelic variant refers to any of two or more alternative forms of a geneoccupying the same chromosomal locus. Allelic variation arises naturallythrough mutation, and may result in phenotypic polymorphism withinpopulations. Gene mutations can be silent (i.e., no change in theencoded polypeptide) or may encode polypeptides having altered aminoacid sequence. The term allelic variant is also used herein to denote aprotein encoded by an allelic variant of a gene. Splice variant refersto alternative forms of RNA transcribed from a gene. Splice variationarises naturally through use of alternative splicing sites within atranscribed RNA molecule, or less commonly between separatelytranscribed RNA molecules, and may result in several mRNAs transcribedfrom the same gene. Splice variants may encode polypeptides havingaltered amino acid sequence. The term splice variant is also used hereinto denote a protein encoded by a splice variant of an mRNA transcribedfrom a gene.

Those skilled in the art would recognize that, for example, G1818, SEQID NO: 202, represents a single transcription factor; allelic variationand alternative splicing may be expected to occur. Allelic variants ofSEQ ID NO: 201 can be cloned by probing cDNA or genomic libraries fromdifferent individual organisms according to standard procedures. Allelicvariants of the DNA sequence shown in SEQ ID NO: 201, including thosecontaining silent mutations and those in which mutations result in aminoacid sequence changes, are within the scope of the present invention, asare proteins which are allelic variants of SEQ ID NO: 202. cDNAsgenerated from alternatively spliced mRNAs, which retain the propertiesof the transcription factor are included within the scope of the presentinvention, as are polypeptides encoded by such cDNAs and mRNAs. Allelicvariants and splice variants of these sequences can be cloned by probingcDNA or genomic libraries from different individual organisms or tissuesaccording to standard procedures known in the art (see U.S. Pat. No.6,388,064).

Thus, in addition to the sequences set forth in the Sequence Listing,the invention also encompasses related nucleic acid molecules thatinclude allelic or splice variants of the sequences of the invention,for example, allelic or splice variants of the Sequence Listing,including, but not limited to, SEQ ID NO: 2N−1, where N=1 to 447, andinclude sequences that are complementary to any of the above nucleotidesequences. Related nucleic acid molecules also include nucleotidesequences encoding a polypeptide comprising a substitution,modification, addition and/or deletion of one or more amino acidresidues compared to the polypeptide sequences of Sequence Listing. Suchrelated polypeptides may comprise, for example, additions and/ordeletions of one or more N-linked or O-linked glycosylation sites, or anaddition and/or a deletion of one or more cysteine residues.

Sequence alterations that do not change the amino acid sequence encodedby the polynucleotide are termed “silent” variations. With the exceptionof the codons ATG and TGG, encoding methionine and tryptophan,respectively, any of the possible codons for the same amino acid can besubstituted by a variety of techniques, e.g., site-directed mutagenesis,available in the art. Accordingly, any and all such variations of asequence selected from the above table are a feature of the invention.

In addition to silent variations, other conservative variations thatalter one, or a few amino acid residues in the encoded polypeptide, canbe made without altering the function of the polypeptide, theseconservative variants are, likewise, a feature of the invention.

For example, substitutions, deletions and insertions introduced into thesequences provided in the Sequence Listing, are also envisioned by theinvention. Such sequence modifications can be engineered into a sequenceby site-directed mutagenesis (Wu (1993) or the other methods notedbelow. Amino acid substitutions are typically of single residues;insertions usually will be on the order of about from 1 to 10 amino acidresidues; and deletions will range about from 1 to 30 residues. Inpreferred embodiments, deletions or insertions are made in adjacentpairs, e.g., a deletion of two residues or insertion of two residues.Substitutions, deletions, insertions or any combination thereof can becombined to arrive at a sequence. The mutations that are made in thepolynucleotide encoding the transcription factor should not place thesequence out of reading frame and should not create complementaryregions that could produce secondary mRNA structure. Preferably, thepolypeptide encoded by the DNA performs the desired function.

Conservative substitutions are those in which at least one residue inthe amino acid sequence has been removed and a different residueinserted in its place.

Similar substitutions are those in which at least one residue in theamino acid sequence has been removed and a different residue inserted inits place. Substitutions that are less conservative can be selected bypicking residues that differ more significantly in their effect onmaintaining (a) the structure of the polypeptide backbone in the area ofthe substitution, for example, as a sheet or helical conformation, (b)the charge or hydrophobicity of the molecule at the target site, or (c)the bulk of the side chain. The substitutions which in general areexpected to produce the greatest changes in protein properties will bethose in which (a) a hydrophilic residue, e.g., seryl or threonyl, issubstituted for (or by) a hydrophobic residue, e.g., leucyl, isoleucyl,phenylalanyl, valyl or alanyl; (b) a cysteine or proline is substitutedfor (or by) any other residue; (c) a residue having an electropositiveside chain, e.g., lysyl, arginyl, or histidyl, is substituted for (orby) an electronegative residue, e.g., glutamyl or aspartyl; or (d) aresidue having a bulky side chain, e.g., phenylalanine, is substitutedfor (or by) one not having a side chain, e.g., glycine.

Further Modifying Sequences of the Invention—Mutation/Forced Evolution

In addition to generating silent or conservative substitutions as noted,above, the present invention optionally includes methods of modifyingthe sequences of the Sequence Listing. In the methods, nucleic acid orprotein modification methods are used to alter the given sequences toproduce new sequences and/or to chemically or enzymatically modify givensequences to change the properties of the nucleic acids or proteins.

Thus, in one embodiment, given nucleic acid sequences are modified,e.g., according to standard mutagenesis or artificial evolution methodsto produce modified sequences. The modified sequences may be createdusing purified natural polynucleotides isolated from any organism or maybe synthesized from purified compositions and chemicals using chemicalmeans well know to those of skill in the art. For example, Ausubel(2000), provides additional details on mutagenesis methods. Artificialforced evolution methods are described, for example, by Stemmer (1994a),Stemmer (1994b), and U.S. Pat. Nos. 5,811,238, 5,837,500, and 6,242,568.Methods for engineering synthetic transcription factors and otherpolypeptides are described, for example, by Zhang et al. (2000), Liu etal. (2001), and Isalan et al. (2001). Many other mutation and evolutionmethods are also available and expected to be within the skill of thepractitioner.

Similarly, chemical or enzymatic alteration of expressed nucleic acidsand polypeptides can be performed by standard methods. For example,sequence can be modified by addition of lipids, sugars, peptides,organic or inorganic compounds, by the inclusion of modified nucleotidesor amino acids, or the like. For example, protein modificationtechniques are illustrated in Ausubel (2000). Further details onchemical and enzymatic modifications can be found herein. Thesemodification methods can be used to modify any given sequence, or tomodify any sequence produced by the various mutation and artificialevolution modification methods noted herein.

Accordingly, the invention provides for modification of any givennucleic acid by mutation, evolution, chemical or enzymatic modification,or other available methods, as well as for the products produced bypracticing such methods, e.g., using the sequences herein as a startingsubstrate for the various modification approaches.

For example, optimized coding sequence containing codons preferred by aparticular prokaryotic or eukaryotic host can be used e.g., to increasethe rate of translation or to produce recombinant RNA transcripts havingdesirable properties, such as a longer half-life, as compared withtranscripts produced using a non-optimized sequence. Translation stopcodons can also be modified to reflect host preference. For example,preferred stop codons for Saccharomyces cerevisiae and mammals are TAAand TGA, respectively. The preferred stop codon for monocotyledonousplants is TGA, whereas insects and E. coli prefer to use TAA as the stopcodon.

The polynucleotide sequences of the present invention can also beengineered in order to alter a coding sequence for a variety of reasons,including but not limited to, alterations which modify the sequence tofacilitate cloning, processing and/or expression of the gene product.For example, alterations are optionally introduced using techniqueswhich are well known in the art, e.g., site-directed mutagenesis, toinsert new restriction sites, to alter glycosylation patterns, to changecodon preference, to introduce splice sites, etc.

Furthermore, a fragment or domain derived from any of the polypeptidesof the invention can be combined with domains derived from othertranscription factors or synthetic domains to modify the biologicalactivity of a transcription factor. For instance, a DNA-binding domainderived from a transcription factor of the invention can be combinedwith the activation domain of another transcription factor or with asynthetic activation domain. A transcription activation domain assistsin initiating transcription from a DNA-binding site. Examples includethe transcription activation region of VP16 or GAL4 (Moore et al.(1998); Aoyama et al. (1995)), peptides derived from bacterial sequences(Ma and Ptashne (1987)) and synthetic peptides (Giniger and Ptashne(1987)).

Expression and Modification of Polypeptides

Typically, polynucleotide sequences of the invention are incorporatedinto recombinant DNA (or RNA) molecules that direct expression ofpolypeptides of the invention in appropriate host cells, transgenicplants, in vitro translation systems, or the like. Due to the inherentdegeneracy of the genetic code, nucleic acid sequences which encodesubstantially the same or a functionally equivalent amino acid sequencecan be substituted for any listed sequence to provide for cloning andexpressing the relevant homolog.

The transgenic plants of the present invention comprising recombinantpolynucleotide sequences are generally derived from parental plants,which may themselves be non-transformed (or non-transgenic) plants.These transgenic plants may either have a transcription factor gene“knocked out” (for example, with a genomic insertion by homologousrecombination, an antisense or ribozyme construct) or expressed to anormal or wild-type extent. However, overexpressing transgenic “progeny”plants will exhibit greater mRNA levels, wherein the mRNA encodes atranscription factor, that is, a DNA-binding protein that is capable ofbinding to a DNA regulatory sequence and inducing transcription, andpreferably, expression of a plant trait gene, such as a gene thatimproves plant and/or fruit quality and/or yield. Preferably, the mRNAexpression level will be at least three-fold greater than that of theparental plant, or more preferably at least ten-fold greater mRNA levelscompared to said parental plant, and most preferably at least fifty-foldgreater compared to said parental plant.

Modified Amino Acid Residues

Polypeptides of the invention may contain one or more modified aminoacid residues. The presence of modified amino acids may be advantageousin, for example, increasing polypeptide half-life, reducing polypeptideantigenicity or toxicity, increasing polypeptide storage stability, orthe like. Amino acid residue(s) are modified, for example,co-translationally or post-translationally during recombinant productionor modified by synthetic or chemical means.

Non-limiting examples of a modified amino acid residue includeincorporation or other use of acetylated amino acids, glycosylated aminoacids, sulfated amino acids, prenylated (e.g., farnesylated,geranylgeranylated) amino acids, PEG modified (e.g., “PEGylated”) aminoacids, biotinylated amino acids, carboxylated amino acids,phosphorylated amino acids, etc. References adequate to guide one ofskill in the modification of amino acid residues are replete throughoutthe literature.

The modified amino acid residues may prevent or increase affinity of thepolypeptide for another molecule, including, but not limited to,polynucleotide, proteins, carbohydrates, lipids and lipid derivatives,and other organic or synthetic compounds.

Identification of Additional Protein Factors

A transcription factor provided by the present invention can also beused to identify additional endogenous or exogenous molecules that canaffect a phenotype or trait of interest. Such molecules includeendogenous molecules that are acted upon either at a transcriptionallevel by a transcription factor of the invention to modify a phenotypeas desired. For example, the transcription factors can be employed toidentify one or more downstream genes that are subject to a regulatoryeffect of the transcription factor. In one approach, a transcriptionfactor or transcription factor homolog of the invention is expressed ina host cell, e.g., a transgenic plant cell, tissue or explant, andexpression products, either RNA or protein, of likely or random targetsare monitored, e.g., by hybridization to a microarray of nucleic acidprobes corresponding to genes expressed in a tissue or cell type ofinterest, by two-dimensional gel electrophoresis of protein products, orby any other method known in the art for assessing expression of geneproducts at the level of RNA or protein. Alternatively, a transcriptionfactor of the invention can be used to identify promoter sequences (suchas binding sites on DNA sequences) involved in the regulation of adownstream target. After identifying a promoter sequence, interactionsbetween the transcription factor and the promoter sequence can bemodified by changing specific nucleotides in the promoter sequence orspecific amino acids in the transcription factor that interact with thepromoter sequence to alter a plant trait. Typically, transcriptionfactor DNA-binding sites are identified by gel shift assays. Afteridentifying the promoter regions, the promoter region sequences can beemployed in double-stranded DNA arrays to identify molecules that affectthe interactions of the transcription factors with their promoters(Bulyk et al. (1999)).

The identified transcription factors are also useful to identifyproteins that modify the activity of the transcription factor. Suchmodification can occur by covalent modification, such as byphosphorylation, or by protein-protein (homo or -heteropolymer)interactions. Any method suitable for detecting protein-proteininteractions can be employed. Among the methods that can be employed areco-immunoprecipitation, cross-linking and co-purification throughgradients or chromatographic columns, and the two-hybrid yeast system.

The two-hybrid system detects protein interactions in vivo and isdescribed in Chien et al. (1991) and is commercially available fromClontech (Palo Alto, Calif.). In such a system, plasmids are constructedthat encode two hybrid proteins: one consists of the DNA-binding domainof a transcription activator protein fused to the transcription factorpolypeptide and the other consists of the transcription activatorprotein's activation domain fused to an unknown protein that is encodedby a cDNA that has been recombined into the plasmid as part of a cDNAlibrary. The DNA-binding domain fusion plasmid and the cDNA library aretransformed into a strain of the yeast Saccharomyces cerevisiae thatcontains a reporter gene (e.g., lacZ) whose regulatory region containsthe transcription activator's binding site. Either hybrid protein alonecannot activate transcription of the reporter gene. Interaction of thetwo hybrid proteins reconstitutes the functional activator protein andresults in expression of the reporter gene, which is detected by anassay for the reporter gene product. Then, the library plasmidsresponsible for reporter gene expression are isolated and sequenced toidentify the proteins encoded by the library plasmids. After identifyingproteins that interact with the transcription factors, assays forcompounds that interfere with the transcription factor protein-proteininteractions can be preformed.

Subsequences

Also contemplated are uses of polynucleotides, also referred to hereinas oligonucleotides, typically having at least 12 bases, preferably atleast 50 bases, which hybridize under stringent conditions to apolynucleotide sequence described above. The polynucleotides may be usedas probes, primers, sense and antisense agents, and the like, accordingto methods as noted above.

Subsequences of the polynucleotides of the invention, includingpolynucleotide fragments and oligonucleotides are useful as nucleic acidprobes and primers. An oligonucleotide suitable for use as a probe orprimer is at least about 15 nucleotides in length, more often at leastabout 18 nucleotides, often at least about 21 nucleotides, frequently atleast about 30 nucleotides, or about 40 nucleotides, or more in length.A nucleic acid probe is useful in hybridization protocols, e.g., toidentify additional polypeptide homologs of the invention, includingprotocols for microarray experiments. Primers can be annealed to acomplementary target DNA strand by nucleic acid hybridization to form ahybrid between the primer and the target DNA strand, and then extendedalong the target DNA strand by a DNA polymerase enzyme. Primer pairs canbe used for amplification of a nucleic acid sequence, e.g., by thepolymerase chain reaction (PCR) or other nucleic-acid amplificationmethods. See Sambrook (1989), and Ausubel (2000).

In addition, the invention includes an isolated or recombinantpolypeptide including a subsequence of at least about 15 contiguousamino acids encoded by the recombinant or isolated polynucleotides ofthe invention. For example, such polypeptides, or domains or fragmentsthereof, can be used as immunogens, e.g., to produce antibodies specificfor the polypeptide sequence, or as probes for detecting a sequence ofinterest. A subsequence can range in size from about 15 amino acids inlength up to and including the full length of the polypeptide.

To be encompassed by the present invention, an expressed polypeptidewhich comprises such a polypeptide subsequence performs at least onebiological function of the intact polypeptide in substantially the samemanner, or to a similar extent, as does the intact polypeptide. Forexample, a polypeptide fragment can comprise a recognizable structuralmotif or functional domain such as a DNA binding domain that activatestranscription, e.g., by binding to a specific DNA promoter region anactivation domain, or a domain for protein-protein interactions.

Vectors, Promoters, and Expression Systems

This section describes vectors, promoters, and expression systems thatmay be used with the present invention. Expression constructs that havebeen used to transform plants for testing in field trials are alsodescribed in Example III. The present invention includes recombinantconstructs comprising one or more of the nucleic acid sequences herein.The constructs typically comprise a vector, such as a plasmid, a cosmid,a phage, a virus (e.g., a plant virus), a bacterial artificialchromosome (BAC), a yeast artificial chromosome (YAC), or the like, intowhich a nucleic acid sequence of the invention has been inserted, in aforward or reverse orientation. In a preferred aspect of thisembodiment, the construct further comprises regulatory sequences,including, for example, a promoter, operably linked to the sequence.Large numbers of suitable vectors and promoters are known to those ofskill in the art, and are commercially available.

General texts that describe molecular biological techniques usefulherein, including the use and production of vectors, promoters and manyother relevant topics, include Berger and Kimmel (1987), Sambrook (1989)and Ausubel (2000). Any of the identified sequences can be incorporatedinto a cassette or vector, e.g., for expression in plants. A number ofexpression vectors suitable for stable transformation of plant cells orfor the establishment of transgenic plants have been described includingthose described in Weissbach and Weissbach (1989) and Gelvin et al.(1990). Specific examples include those derived from a Ti plasmid ofAgrobacterium tumefaciens, as well as those disclosed byHerrera-Estrella et al. (1983), Bevan (1984), and Klee (1985) fordicotyledonous plants.

Alternatively, non-Ti vectors can be used to transfer the DNA intomonocotyledonous plants and cells by using free DNA delivery techniques.Such methods can involve, for example, the use of liposomes,electroporation, microprojectile bombardment, silicon carbide whiskers,and viruses. By using these methods transgenic plants such as wheat,rice (Christou (1991) and corn (Gordon-Kamm (1990) can be produced. Animmature embryo can also be a good target tissue for monocots for directDNA delivery techniques by using the particle gun (Weeks et al. (1993);Vasil (1993a); Wan and Lemeaux (1994), and for Agrobacterium-mediatedDNA transfer (Ishida et al. (1996)).

Typically, plant transformation vectors include one or more cloned plantcoding sequence (genomic or cDNA) under the transcriptional control of5′ and 3′ regulatory sequences and a dominant selectable marker. Suchplant transformation vectors typically also contain a promoter (e.g., aregulatory region controlling inducible or constitutive,environmentally- or developmentally-regulated, or cell- ortissue-specific expression), a transcription initiation start site, anRNA processing signal (such as intron splice sites), a transcriptiontermination site, and/or a polyadenylation signal.

A potential utility for the transcription factor polynucleotidesdisclosed herein is the isolation of promoter elements from these genesthat can be used to program expression in plants of any genes. Eachtranscription factor gene disclosed herein is expressed in a uniquefashion, as determined by promoter elements located upstream of thestart of translation, and additionally within an intron of thetranscription factor gene or downstream of the termination codon of thegene. As is well known in the art, for a significant portion of genes,the promoter sequences are located entirely in the region directlyupstream of the start of translation. In such cases, typically thepromoter sequences are located within 2.0 KB of the start oftranslation, or within 1.5 KB of the start of translation, frequentlywithin 1.0 KB of the start of translation, and sometimes within 0.5 KBof the start of translation.

The promoter sequences can be isolated according to methods known to oneskilled in the art.

Examples of constitutive plant promoters which can be useful forexpressing the transcription factor sequence include: the cauliflowermosaic virus (CaMV) 35S promoter, which confers constitutive, high-levelexpression in most plant tissues (see, e.g., Odell et al. (1985)); thenopaline synthase promoter (An et al. (1988)); and the octopine synthasepromoter (Fromm et al. (1989)).

The transcription factors of the invention may be operably linked with aspecific promoter that causes the transcription factor to be expressedin response to environmental, tissue-specific or temporal signals. Avariety of plant gene promoters that regulate gene expression inresponse to environmental, hormonal, chemical, developmental signals,and in a tissue-active manner can be used for expression of atranscription factor sequence in plants. Choice of a promoter is basedlargely on the phenotype of interest and is determined by such factorsas tissue (e.g., seed, fruit, root, pollen, vascular tissue, flower,carpel, etc.), inducibility (e.g., in response to wounding, heat, cold,drought, light, pathogens, etc.), timing, developmental stage, and thelike. Numerous known promoters have been characterized and can favorablybe employed to promote expression of a polynucleotide of the inventionin a transgenic plant or cell of interest. For example, tissue specificpromoters include: seed-specific promoters (such as the napin, phaseolinor DC3 promoter described in U.S. Pat. No. 5,773,697), fruit-specificpromoters that are active during fruit ripening (such as the dru 1promoter (U.S. Pat. No. 5,783,393), or the 2A11 promoter (U.S. Pat. No.4,943,674) and the tomato polygalacturonase promoter (Bird et al.(1988)), root-specific promoters, such as those disclosed in U.S. Pat.Nos. 5,618,988, 5,837,848 and 5,905,186, pollen-active promoters such asPTA29, PTA26 and PTA 13 (U.S. Pat. No. 5,792,929), promoters active invascular tissue (Ringli and Keller (1998)), flower-specific (Kaiser etal. (1995)), pollen (Baerson et al. (1994)), carpels (Ohl et al.(1990)), pollen and ovules (Baerson et al. (1993)), auxin-induciblepromoters (such as that described in van der Kop et al. (1999) orBaumann et al. (1999)), cytokinin-inducible promoter (Guevara-Garcia(1998)), promoters responsive to gibberellin (Shi et al. (1998),Willmott et al. (1998)) and the like. Additional promoters are thosethat elicit expression in response to heat (Ainley et al. (1993)), light(e.g., the pea rbcS-3A promoter, Kuhlemeier et al. (1989)), and themaize rbcS promoter, Schaffner and Sheen (1991)); wounding (e.g., wuni,Siebertz et al. (1989)); pathogens (such as the PR-1 promoter describedin Buchel et al. (1999) and the PDF1.2 promoter described in Manners etal. (1998), and chemicals such as methyl jasmonate or salicylic acid(Gatz (1997)). In addition, the timing of the expression can becontrolled by using promoters such as those acting at senescence (Ganand Amasino (1995)); or late seed development (Odell et al. (1994)).Examples of promoters that can be used to provide expression oftranscription factors or other proteins in fruit tissue are provided inTable 1.

TABLE 1 Promoters, promoter constructs and expression patterns that maybe used to regulate protein expression in fruit PID and SEQ ID NO: ofpromoter Promoter construct General expression patterns ReferencesCaMV35S P6506 Constitutive, high levels of expression Odell et al (1985)(“35S”) SEQ ID NO: in all throughout the plant and fruit 1586 SHOOTMERISTEMLESS P5318 Expressed in meristematic tissues, Long and Barton(STM) SEQ ID NO: including apical meristems, cambium. (1998) 1581 Lowlevels of expression also in some Long and Barton differentiatingtissues. In fruit, most (2000) strongly expressed in vascular tissuesand endosperm. ASYMMETRIC LEAVES 1 P5319 Expressed predominately inByrne et al (2000) (AS1) SEQ ID NO: differentiating tissues. In fruit,most Ori et al. (2000) 1582 strongly expressed in vascular tissues andin endosperm. LIPID TRANSFER P5287 In vegetative tissues, expression isThoma et al. PROTEIN 1 SEQ ID NO: predominately in the epidermis. Low(1994) (LTP1) 1574 levels of expression are also evident in vasculartissue. In the fruit, expression is strongest in the pith-likecolumella/placental tissue. RIBULOSE-1,5- P5284 Expression predominatelyin highly Wanner and BISPHOSPHATE SEQ ID NO: photosynthetic vegetativetissues. Gruissem (1991) CARBOXYLASE, SMALL 1573 Fruit expressionpredominately in the SUBUNIT 3 pericarp. (RbcS3) ROOT SYSTEM P5310Expression generally limited to roots. Taylor and INDUCIBLE 1 SEQ ID NO:Also expressed in the vascular tissues Scheuring (1994) (RSI-1) 1579 ofthe fruit. APETALA 1 P5326 Light expression in leaves increases Mandelet al. (AP1) SEQ ID NO: with maturation. Highest expression (1992a) 1584in flower primordia and flower Hempel et al. organs. In fruits,predominately in (1997) pith-like columella/placental tissue.POLYGALACTURONASE P5297 High expression throughout the fruit, Nicholasset al. (PG) SEQ ID NO: comparable to 35S. Strongest late in (1995) 1577fruit development. Montgomery et al. (1993) PHYTOENE P5303 Moderateexpression in fruit tissues. Corona et al. DESATURASE SEQ ID NO: (1996)(PD) 1578 CRUCIFERIN 1 P5324 Expressed at low levels in fruit Breen andCrouch (Cru) SEQ ID NO: vascular tissue and columella. Seen (1992) 1583and endosperm expression. Sjodahl et al. (1995)

Plant expression vectors can also include RNA processing signals thatcan be positioned within, upstream or downstream of the coding sequence.In addition, the expression vectors can include additional regulatorysequences from the 3′-untranslated region of plant genes, e.g., a 3′terminator region to increase mRNA stability of the mRNA, such as thePI-II terminator region of potato or the octopine or nopaline synthase3′ terminator regions.

Expression Hosts

The present invention also relates to host cells which are transducedwith vectors of the invention, and the production of polypeptides of theinvention (including fragments thereof) by recombinant techniques. Hostcells are genetically engineered (i.e., nucleic acids are introduced,e.g., transduced, transformed or transfected) with the vectors of thisinvention, which may be, for example, a cloning vector or an expressionvector comprising the relevant nucleic acids herein. The vector isoptionally a plasmid, a viral particle, a phage, a naked nucleic acid,etc. The engineered host cells can be cultured in conventional nutrientmedia modified as appropriate for activating promoters, selectingtransformants, or amplifying the relevant gene. The culture conditions,such as temperature, pH and the like, are those previously used with thehost cell selected for expression, and will be apparent to those skilledin the art and in the references cited herein, including, Sambrook(1989) and Ausubel (2000).

The host cell can be a eukaryotic cell, such as a yeast cell, or a plantcell, or the host cell can be a prokaryotic cell, such as a bacterialcell. Plant protoplasts are also suitable for some applications. Forexample, the DNA fragments are introduced into plant tissues, culturedplant cells or plant protoplasts by standard methods includingelectroporation (Fromm et al. (1985)), infection by viral vectors suchas cauliflower mosaic virus (CaMV) (Hohn et al. (1982); U.S. Pat. No.4,407,956), high velocity ballistic penetration by small particles withthe nucleic acid either within the matrix of small beads or particles,or on the surface (Klein et al. (1987)), use of pollen as vector (WO85/01856), or use of Agrobacterium tumefaciens or A. rhizogenes carryinga T-DNA plasmid in which DNA fragments are cloned. The T-DNA plasmid istransmitted to plant cells upon infection by Agrobacterium tumefaciens,and a portion is stably integrated into the plant genome (Horsch et al.(1984); Fraley et al. (1983)).

The cell can include a nucleic acid of the invention that encodes apolypeptide, wherein the cell expresses a polypeptide of the invention.The cell can also include vector sequences, or the like. Furthermore,cells and transgenic plants that include any polypeptide or nucleic acidabove or throughout this specification, e.g., produced by transductionof a vector of the invention, are an additional feature of theinvention.

For long-term, high-yield production of recombinant proteins, stableexpression can be used. Host cells transformed with a nucleotidesequence encoding a polypeptide of the invention are optionally culturedunder conditions suitable for the expression and recovery of the encodedprotein from cell culture. The protein or fragment thereof produced by arecombinant cell may be secreted, membrane-bound, or containedintracellularly, depending on the sequence and/or the vector used. Aswill be understood by those of skill in the art, expression vectorscontaining polynucleotides encoding mature proteins of the invention canbe designed with signal sequences which direct secretion of the maturepolypeptides through a prokaryotic or eukaryotic cell membrane.

Potential Applications of the Presently Disclosed Sequences that ImprovePlant Yield and/or Fruit Yield or Quality

The genes identified by the experiment presently disclosed representpotential regulators of plant yield and/or fruit yield or quality. Assuch, these sequences, or their functional equivalogs, orthologs orparalogs, can be introduced into plant species, including commercialplant species, in order to produce higher yield and/or quality,including higher fruit yield and/or quality.

Production of Transgenic Plants

Modification of Traits

The polynucleotides of the invention are favorably employed to producetransgenic plants with various traits, or characteristics, that havebeen modified in a desirable manner, e.g., to improve the fruit qualitycharacteristics of a plant. For example, alteration of expression levelsor patterns (e.g., spatial or temporal expression patterns) of one ormore of the transcription factors (or transcription factor homologs) ofthe invention, as compared with the levels of the same protein found ina wild-type plant, can be used to modify a plant's traits. Anillustrative example of trait modification, improved characteristics, byaltering expression levels of a particular transcription factor isdescribed further in the Examples and the Sequence Listing.

Homologous Genes Introduced into transgenic Plants.

Homologous genes that may be derived from any plant, or from any sourcewhether natural, synthetic, semi-synthetic or recombinant, and thatshare significant sequence identity or similarity to those provided bythe present invention, may be introduced into plants, for example, cropplants, to confer desirable or improved traits. Consequently, transgenicplants may be produced that comprise a recombinant expression vector orcassette with a promoter operably linked to one or more sequenceshomologous to presently disclosed sequences. The promoter may be, forexample, a plant or viral promoter.

The invention thus provides for methods for preparing transgenic plants,and for modifying plant traits. These methods include introducing into aplant a recombinant expression vector or cassette comprising afunctional promoter operably linked to one or more sequences homologousto presently disclosed sequences. Plants and kits for producing theseplants that result from the application of these methods are alsoencompassed by the present invention.

Genes, Traits and Utilities that Affect Plant Characteristics

Plant transcription factors can modulate gene expression, and, in turn,be modulated by the environmental experience of a plant. Significantalterations in a plant's environment invariably result in a change inthe plant's transcription factor gene expression pattern. Alteredtranscription factor expression patterns generally result in phenotypicchanges in the plant. Transcription factor gene product(s) in transgenicplants then differ(s) in amounts or proportions from that found inwild-type or non-transformed plants, and those transcription factorslikely represent polypeptides that are used to alter the response to theenvironmental change. By way of example, it is well accepted in the artthat analytical methods based on altered expression patterns may be usedto screen for phenotypic changes in a plant far more effectively thancan be achieved using traditional methods.

Antisense and Co-suppression

In addition to expression of the nucleic acids of the invention as genereplacement or plant phenotype modification nucleic acids, the nucleicacids are also useful for sense and anti-sense suppression ofexpression, e.g. to down-regulate expression of a nucleic acid of theinvention, e.g. as a further mechanism for modulating plant phenotype.That is, the nucleic acids of the invention, or subsequences oranti-sense sequences thereof, can be used to block expression ofnaturally occurring homologous nucleic acids. A variety of sense andanti-sense technologies are known in the art, e.g. as set forth inLichtenstein and Nellen (1997). Antisense regulation is also describedin Crowley et al. (1985); Rosenberg et al. (1985); Preiss et al. (1985);Melton (1985); Izant and Weintraub (1985); and Kim and Wold (1985).Additional methods for antisense regulation are known in the art.Antisense regulation has been used to reduce or inhibit expression ofplant genes in, for example in European Patent Publication No. 271988.Antisense RNA may be used to reduce gene expression to produce a visibleor biochemical phenotypic change in a plant (Smith et al. (1988); Smithet al. (1990)). In general, sense or anti-sense sequences are introducedinto a cell, where they are optionally amplified, e.g. by transcription.Such sequences include both simple oligonucleotide sequences andcatalytic sequences such as ribozymes.

For example, a reduction or elimination of expression (i.e., a“knock-out”) of a transcription factor or transcription factor homologpolypeptide in a transgenic plant, e.g., to modify a plant trait, can beobtained by introducing an antisense construct corresponding to thepolypeptide of interest as a cDNA. For antisense suppression, thetranscription factor or homolog cDNA is arranged in reverse orientation(with respect to the coding sequence) relative to the promoter sequencein the expression vector. The introduced sequence need not be thefull-length cDNA or gene, and need not be identical to the cDNA or genefound in the plant type to be transformed. Typically, the antisensesequence need only be capable of hybridizing to the target gene or RNAof interest. Thus, where the introduced sequence is of shorter length, ahigher degree of homology to the endogenous transcription factorsequence will be needed for effective antisense suppression. Whileantisense sequences of various lengths can be utilized, preferably, theintroduced antisense sequence in the vector will be at least 30nucleotides in length, and improved antisense suppression will typicallybe observed as the length of the antisense sequence increases.Preferably, the length of the antisense sequence in the vector will begreater than 100 nucleotides. Transcription of an antisense construct asdescribed results in the production of RNA molecules that are thereverse complement of mRNA molecules transcribed from the endogenoustranscription factor gene in the plant cell.

Suppression of endogenous transcription factor gene expression can alsobe achieved using RNA interference, or RNAi. RNAi is apost-transcriptional, targeted gene-silencing technique that usesdouble-stranded RNA (dsRNA) to incite degradation of messenger RNA(mRNA) containing the same sequence as the dsRNA (Constans (2002)).Small interfering RNAs, or siRNAs are produced in at least two steps: anendogenous ribonuclease cleaves longer dsRNA into shorter, 21-23nucleotide-long RNAs. The siRNA segments then mediate the degradation ofthe target mRNA (Zamore (2001). RNAi has been used for gene functiondetermination in a manner similar to antisense oligonucleotides(Constans (2002)). Expression vectors that continually express siRNAs intransiently and stably transfected have been engineered to express smallhairpin RNAs (shRNAs), which get processed in vivo into siRNAs-likemolecules capable of carrying out gene-specific silencing (Brummelkampet al. (2002), and Paddison, et al. (2002)). Post-transcriptional genesilencing by double-stranded RNA is discussed in further detail byHammond et al. (2001), Fire et al. (1998) and Timmons and Fire (1998).Vectors in which RNA encoded by a transcription factor or transcriptionfactor homolog cDNA is over-expressed can also be used to obtainco-suppression of a corresponding endogenous gene, e.g., in the mannerdescribed in U.S. Pat. No. 5,231,020 to Jorgensen. Such co-suppression(also termed sense suppression) does not require that the entiretranscription factor cDNA be introduced into the plant cells, nor doesit require that the introduced sequence be exactly identical to theendogenous transcription factor gene of interest. However, as withantisense suppression, the suppressive efficiency will be enhanced asspecificity of hybridization is increased, e.g., as the introducedsequence is lengthened, and/or as the sequence similarity between theintroduced sequence and the endogenous transcription factor gene isincreased.

Vectors expressing an untranslatable form of the transcription factormRNA, e.g., sequences comprising one or more stop codon, or nonsensemutation) can also be used to suppress expression of an endogenoustranscription factor, thereby reducing or eliminating its activity andmodifying one or more traits. Methods for producing such constructs aredescribed in U.S. Pat. No. 5,583,021. Preferably, such constructs aremade by introducing a premature stop codon into the transcription factorgene. Alternatively, a plant trait can be modified by gene silencingusing double-strand RNA (Sharp (1999)). Another method for abolishingthe expression of a gene is by insertion mutagenesis using the T-DNA ofAgrobacterium tumefaciens. After generating the insertion mutants, themutants can be screened to identify those containing the insertion in atranscription factor or transcription factor homolog gene. Plantscontaining a single transgene insertion event at the desired gene can becrossed to generate homozygous plants for the mutation. Such methods arewell known to those of skill in the art (see for example Koncz et al.(1992a, 1992b)).

Alternatively, a plant phenotype can be altered by eliminating anendogenous gene, such as a transcription factor or transcription factorhomolog, e.g., by homologous recombination (Kempin et al. (1997)).

A plant trait can also be modified by using the Cre-lox system (forexample, as described in U.S. Pat. No. 5,658,772). A plant genome can bemodified to include first and second lox sites that are then contactedwith a Cre recombinase. If the lox sites are in the same orientation,the intervening DNA sequence between the two sites is excised. If thelox sites are in the opposite orientation, the intervening sequence isinverted.

The polynucleotides and polypeptides of this invention can also beexpressed in a plant in the absence of an expression cassette bymanipulating the activity or expression level of the endogenous gene byother means, such as, for example, by ectopically expressing a gene byT-DNA activation tagging (Ichikawa et al. (1997); Kakimoto et al.(1996)). This method entails transforming a plant with a gene tagcontaining multiple transcriptional enhancers and once the tag hasinserted into the genome, expression of a flanking gene coding sequencebecomes deregulated. In another example, the transcriptional machineryin a plant can be modified so as to increase transcription levels of apolynucleotide of the invention (see, e.g., PCT Publications WO 96/06166and WO 98/53057 which describe the modification of the DNA-bindingspecificity of zinc finger proteins by changing particular amino acidsin the DNA-binding motif).

The transgenic plant can also include the machinery necessary forexpressing or altering the activity of a polypeptide encoded by anendogenous gene, for example, by altering the phosphorylation state ofthe polypeptide to maintain it in an activated state.

Transgenic plants (or plant cells, or plant explants, or plant tissues)incorporating the polynucleotides of the invention and/or expressing thepolypeptides of the invention can be produced by a variety of wellestablished techniques as described above. Following construction of avector, most typically an expression cassette, including apolynucleotide, e.g., encoding a transcription factor or transcriptionfactor homolog, of the invention, standard techniques can be used tointroduce the polynucleotide into a plant, a plant cell, a plant explantor a plant tissue of interest. Optionally, the plant cell, explant ortissue can be regenerated to produce a transgenic plant.

The plant can be any higher plant, including gymnosperms,monocotyledonous and dicotyledonous plants. Suitable protocols areavailable for Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae(carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed,broccoli, etc.), Curcurbitaceae (melons and cucumber), Gramineae (wheat,corn, rice, barley, millet, etc.), Solanaceae (potato, tomato, tobacco,peppers, etc.), and various other crops. See protocols described inAmmirato et al. (1984); Shimamoto et al. (1989); Fromm et al. (1990);and Vasil et al. (1990).

Transformation and regeneration of both monocotyledonous anddicotyledonous plant cells is now routine, and the selection of the mostappropriate transformation technique will be determined by thepractitioner. The choice of method will vary with the type of plant tobe transformed; those skilled in the art will recognize the suitabilityof particular methods for given plant types. Suitable methods caninclude, but are not limited to: electroporation of plant protoplasts;liposome-mediated transformation; polyethylene glycol (PEG) mediatedtransformation; transformation using viruses; micro-injection of plantcells; micro-projectile bombardment of plant cells; vacuum infiltration;and Agrobacterium tumefaciens mediated transformation. Transformationmeans introducing a nucleotide sequence into a plant in a manner tocause stable or transient expression of the sequence.

Successful examples of the modification of plant characteristics bytransformation with cloned sequences which serve to illustrate thecurrent knowledge in this field of technology, and which are hereinincorporated by reference, include: U.S. Pat. Nos. 5,571,706; 5,677,175;5,510,471; 5,750,386; 5,597,945; 5,589,615; 5,750,871; 5,268,526;5,780,708; 5,538,880; 5,773,269; 5,736,369 and 5,610,042.

Following transformation, plants are preferably selected using adominant selectable marker incorporated into the transformation vector.Typically, such a marker will confer antibiotic or herbicide resistanceon the transformed plants, and selection of transformants can beaccomplished by exposing the plants to appropriate concentrations of theantibiotic or herbicide.

After transformed plants are selected and grown to maturity, thoseplants showing a modified trait are identified using methods well knownin the art that are specifically directed to improved fruit or yieldcharacteristics. Methods that may be used are provided in Examples IIthrough VI. The modified trait can be any of those traits describedabove. Additionally, to confirm that the modified trait is due tochanges in expression levels or activity of the polypeptide orpolynucleotide of the invention can be determined by analyzing mRNAexpression using Northern blots, RT-PCR or microarrays, or proteinexpression using immunoblots or Western blots or gel shift assays.

Integrated Systems—Sequence Identity

Additionally, the present invention may be an integrated system,computer or computer readable medium that comprises an instruction setfor determining the identity of one or more sequences in a database. Inaddition, the instruction set can be used to generate or identifysequences that meet any specified criteria. Furthermore, the instructionset may be used to associate or link certain functional benefits, suchimproved characteristics, with one or more identified sequence.

For example, the instruction set can include, e.g., a sequencecomparison or other alignment program, e.g., an available program suchas, for example, the Wisconsin Package Version 10.0, such as BLAST,FASTA, PILEUP, FINDPATTERNS or the like (GCG, Madison, Wis.). Publicsequence databases such as GenBank, EMBL, Swiss-Prot and PIR or privatesequence databases such as PHYTOSEQ sequence database (Incyte Genomics,Wilmington, Del.) can be searched.

Alignment of sequences for comparison can be conducted by the localhomology algorithm of Smith and Waterman (1981), by the homologyalignment algorithm of Needleman and Wunsch (1970, by the search forsimilarity method of Pearson and Lipman (1988), or by computerizedimplementations of these algorithms. After alignment, sequencecomparisons between two (or more) polynucleotides or polypeptides aretypically performed by comparing sequences of the two sequences over acomparison window to identify and compare local regions of sequencesimilarity. The comparison window can be a segment of at least about 20contiguous positions, usually about 50 to about 200, more usually about100 to about 150 contiguous positions. A description of the method isprovided in Ausubel (2000).

A variety of methods for determining sequence relationships can be used,including manual alignment and computer assisted sequence alignment andanalysis. This later approach is a preferred approach in the presentinvention, due to the increased throughput afforded by computer assistedmethods. As noted above, a variety of computer programs for performingsequence alignment are available, or can be produced by one of skill.

One example algorithm that is suitable for determining percent sequenceidentity and sequence similarity is the BLAST algorithm, which isdescribed in Altschul et al. (1990). Software for performing BLASTanalyses is publicly available, e.g., through the National Library ofMedicine's National Center for Biotechnology Information (ncbi.nlm.nih;see at world wide web (www) National Institutes of Health US government(gov) website). This algorithm involves first identifying high scoringsequence pairs (HSPs) by identifying short words of length W in thequery sequence, which either match or satisfy some positive-valuedthreshold score T when aligned with a word of the same length in adatabase sequence. T is referred to as the neighborhood word scorethreshold (Altschul (1993); Altschul et al. (1990)). These initialneighborhood word hits act as seeds for initiating searches to findlonger HSPs containing them. The word hits are then extended in bothdirections along each sequence for as far as the cumulative alignmentscore can be increased. Cumulative scores are calculated using, fornucleotide sequences, the parameters M (reward score for a pair ofmatching residues; always >0) and N (penalty score for mismatchingresidues; always <0). For amino acid sequences, a scoring matrix is usedto calculate the cumulative score. Extension of the word hits in eachdirection are halted when: the cumulative alignment score falls off bythe quantity X from its maximum achieved value; the cumulative scoregoes to zero or below, due to the accumulation of one or morenegative-scoring residue alignments; or the end of either sequence isreached. The BLAST algorithm parameters W, T, and X determine thesensitivity and speed of the alignment. The BLASTN program (fornucleotide sequences) uses as defaults a wordlength (W) of 11, anexpectation (E) of 10, a cutoff of 100, M=5, N=−4, and a comparison ofboth strands. For amino acid sequences, the BLASTP program uses asdefaults a wordlength (W) of 3, an expectation (E) of 10, and theBLOSUM62 scoring matrix (see Henikoff and Henikoff (1992)). Unlessotherwise indicated, “sequence identity” here refers to the % sequenceidentity generated from a tblastx using the NCBI version of thealgorithm at the default settings using gapped alignments with thefilter “off” (see, for example, NIH NLM NCBI website at ncbi.nlm.nih).

In addition to calculating percent sequence identity, the BLASTalgorithm also performs a statistical analysis of the similarity betweentwo sequences (see, e.g. Karlin and Altschul (1993)). One measure ofsimilarity provided by the BLAST algorithm is the smallest sumprobability (P(N)), which provides an indication of the probability bywhich a match between two nucleotide or amino acid sequences would occurby chance. For example, a nucleic acid is considered similar to areference sequence (and, therefore, in this context, homologous) if thesmallest sum probability in a comparison of the test nucleic acid to thereference nucleic acid is less than about 0.1, or less than about 0.01,and or even less than about 0.001. An additional example of a usefulsequence alignment algorithm is PILEUP. PILEUP creates a multiplesequence alignment from a group of related sequences using progressive,pairwise alignments. The program can align, e.g., up to 300 sequences ofa maximum length of 5,000 letters.

The integrated system, or computer typically includes a user inputinterface allowing a user to selectively view one or more sequencerecords corresponding to the one or more character strings, as well asan instruction set which aligns the one or more character strings witheach other or with an additional character string to identify one ormore region of sequence similarity. The system may include a link of oneor more character strings with a particular phenotype or gene function.Typically, the system includes a user readable output element thatdisplays an alignment produced by the alignment instruction set.

The methods of this invention can be implemented in a localized ordistributed computing environment. In a distributed environment, themethods may be implemented on a single computer comprising multipleprocessors or on a multiplicity of computers. The computers can belinked, e.g. through a common bus, but more preferably the computer(s)are nodes on a network. The network can be a generalized or a dedicatedlocal or wide-area network and, in certain preferred embodiments, thecomputers may be components of an intra-net or an internet.

Thus, the invention provides methods for identifying a sequence similaror homologous to one or more polynucleotides as noted herein, or one ormore target polypeptides encoded by the polynucleotides, or otherwisenoted herein and may include linking or associating a given plantphenotype or gene function with a sequence. In the methods, a sequencedatabase is provided (locally or across an inter or intra net) and aquery is made against the sequence database using the relevant sequencesherein and associated plant phenotypes or gene functions.

Any sequence herein can be entered into the database, before or afterquerying the database. This provides for both expansion of the databaseand, if done before the querying step, for insertion of controlsequences into the database. The control sequences can be detected bythe query to ensure the general integrity of both the database and thequery. As noted, the query can be performed using a web browser basedinterface. For example, the database can be a centralized publicdatabase such as those noted herein, and the querying can be done from aremote terminal or computer across an internet or intranet. Any sequenceherein can be used to identify a similar, homologous, paralogous, ororthologous sequence in another plant. This provides means foridentifying endogenous sequences in other plants that may be useful toalter a trait of progeny plants, which results from crossing two plantsof different strain. For example, sequences that encode an ortholog ofany of the sequences herein that naturally occur in a plant with adesired trait can be identified using the sequences disclosed herein.The plant is then crossed with a second plant of the same species butwhich does not have the desired trait to produce progeny which can thenbe used in further crossing experiments to produce the desired trait inthe second plant. Therefore the resulting progeny plant contains notransgenes; expression of the endogenous sequence may also be regulatedby treatment with a particular chemical or other means, such as EMR.Some examples of such compounds well known in the art include: ethylene;cytokinins; phenolic compounds, which stimulate the transcription of thegenes needed for infection; specific monosaccharides and acidicenvironments which potentiate vir gene induction; acidic polysaccharideswhich induce one or more chromosomal genes; and opines; other mechanismsinclude light or dark treatment (for a review of examples of suchtreatments, see Winans (1992), Eyal et al. (1992), Chrispeels et al.(2000), or Piazza et al. (2002)).

Of particular interest is the structure of a transcription factor in theregion of its conserved domain(s). Structural analyses may be performedby comparing the structure of the known transcription factor around itsconserved domain with those of orthologs and paralogs. Analysis of anumber of polypeptides within a transcription factor group or clade,including the functionally or sequentially similar polypeptides providedin the Sequence Listing, may also provide an understanding of structuralelements required to regulate transcription within a given family.

Methods for Increasing Plant Yield or Quality by Modifying TranscriptionFactor Expression

The present invention includes compositions and methods for increasingthe yield and quality of a plant or its products, including thosederived from a crop plant. These methods incorporate steps described inthe Examples listed below, and may be achieved by inserting a nucleicacid sequence of the invention into the genome of a plant cell: (i) apromoter that functions in the cell; and (ii) a nucleic acid sequencethat is substantially identical to a transcription factor polynucleotideof the Sequence Listing (for example, SEQ ID NOs: 2n−1, where n=1-447)or a conserved domain found in the Sequence Listing (for example, SEQ IDNOs: 895-1420), where the promoter is operably linked to the nucleicacid sequence. A transformed plant may then be generated from the cell.One may either obtain transformed seeds from that plant or its progeny,or propagate the transformed plant asexually. Alternatively, thetransformed plant may be grow and harvested for plant products directly.

EXAMPLES

It is to be understood that this invention is not limited to theparticular devices, machines, materials and methods described. Althoughparticular embodiments are described, equivalent embodiments may be usedto practice the invention.

The invention, now being generally described, will be more readilyunderstood by reference to the following examples, which are includedmerely for purposes of illustration of certain aspects and embodimentsof the present invention and are not intended to limit the invention. Itwill be recognized by one of skill in the art that a transcriptionfactor that is associated with a particular first trait may also beassociated with at least one other, unrelated and inherent second traitwhich was not predicted by the first trait.

Example I Isolation and Cloning of Full-length Plant TranscriptionFactor cDNAs

Putative transcription factor sequences (genomic or ESTs) related toknown transcription factors were identified in the Arabidopsis thalianaGenBank database using the tblastn sequence analysis program usingdefault parameters and a P-value cutoff threshold of B4 or B5 or lower,depending on the length of the query sequence. Putative transcriptionfactor sequence hits were then screened to identify those containingparticular sequence strings. If the sequence hits contained suchsequence strings, the sequences were confirmed as transcription factors.

Alternatively, Arabidopsis thaliana cDNA libraries derived fromdifferent tissues or treatments, or genomic libraries were screened toidentify novel members of a transcription family using a low stringencyhybridization approach. Probes were synthesized using gene specificprimers in a standard PCR reaction (annealing temperature 60° C.) andlabeled with ³²P dCTP using the High Prime DNA Labeling Kit (RocheDiagnostics Corp., Indianapolis, Ind.). Purified radiolabelled probeswere added to filters immersed in Church hybridization medium (0.5 MNaPO₄ pH 7.0, 7% SDS, 1% w/v bovine serum albumin) and hybridizedovernight at 60° C. with shaking. Filters were washed two times for 45to 60 minutes with 1×SCC, 1% SDS at 60° C.

To identify additional sequence 5′ or 3′ of a partial cDNA sequence in acDNA library, 5′ and 3′ rapid amplification of cDNA ends (RACE) wasperformed using the MARATHON cDNA amplification kit (Clontech, PaloAlto, Calif.). Generally, the method entailed first isolating poly(A)mRNA, performing first and second strand cDNA synthesis to generatedouble stranded cDNA, blunting cDNA ends, followed by ligation of theMARATHON Adaptor to the cDNA to form a library of adaptor-ligated dscDNA.

Gene-specific primers were designed to be used along with adaptorspecific primers for both 5′ and 3′ RACE reactions. Nested primers,rather than single primers, were used to increase PCR specificity. Using5′ and 3′ RACE reactions, 5′ and 3′ RACE fragments were obtained,sequenced and cloned. The process can be repeated until 5′ and 3′ endsof the full-length gene were identified. Then the full-length cDNA wasgenerated by PCR using primers specific to 5′ and 3′ ends of the gene byend-to-end PCR.

Example II Strategy to Produce a Tomato Population Expressing allTranscription Factors

The cauliflower mosaic virus 35S promoter was chosen to control theexpression of transcription factors in tomato for the purpose ofevaluating complex traits in fruit development. This promoter isconstitutively expressed in various tissues, including fruit.

Transgenic tomato lines expressing all Arabidopsis transcription factorsdriven by the CaMV 35S promoter relied on the use of a two-componentsystem similar to that developed by Guyer et al. (1998) that uses theDNA binding domain of the yeast GAL4 transcriptional activator fused tothe activation domains of the maize C1 or the herpes simplex virus VP 16transcriptional activators, respectively. Modifications used either theE. coli lactose repressor DNA binding domain (LacI) or the E. coli LexADNA binding domain fused to the GAL4 activation domain. The LexA-basedsystem was the most reliable in activating tissue-specific GFPexpression in tomato and was used to generate the tomato population. Adiagram of the test transformation vectors is shown in FIG. 3.Arabidopsis transcription factor genes replaced the GFP gene in thetarget vector. The 35S promoter was used in the activator plasmid. Bothfamilies of vectors were used to transform tomato to yield one set oftransgenic lines harboring different target vector constructs oftranscription factor genes and a second population harboring theactivator vector constructs of promoter-LexA/GAL4 fusions. Transgenicplants harboring the activator vector construct of promoter-LexA/GAL4fusions were screened to identify plants with appropriate and high levelexpression of GUS. In addition, five of each of the transgenic plantsharboring the target vector constructs of transcription factor geneswere grown and crossed with a 35S activator line. F1 progeny wereassayed to ensure that the transgene was capable of being activated bythe LexA/GAL4 activator protein. The best plants constitutivelyexpressing transcription factors were selected for subsequent crossingto the ten transgenic activator lines. Several of these initial lineshave been evaluated and preliminary results of seedling traits indicatethat similar phenotypes observed in Arabidopsis were also observed intomato when the same transcription factor was constitutivelyoverexpressed. Thus, each parental line harboring either apromoter-LexA/GAL4 activator or an activatible Arabidopsis transcriptionfactors gene were pre-selected based on a functional assessment. Theseparental lines were used in sexual crosses to generate, 000 F1(hemizygous for the activator and target genes) lines representing thecomplete set of Arabidopsis transcription factors under the regulationof the 35S promoter. The transgenic tomato population was grown fieldconditions for evaluation.

Example III Test Constructs

The Two-Component Multiplication System vectors have an activator vectorand a target vector. The LexA version of these is shown in FIG. 3. TheLacI versions are identical except that LacI replaces LexA portions.Both LacI and LexA DNA binding regions were tested in otherwiseidentical vectors. These regions were made from portions of the testvectors described above, using standard cloning methods. They werecloned into a binary vector that had been previously tested in tomatotransformations. These vectors were then introduced into Arabidopsis andtomato plants to verify their functionality. The LexA-based system wasdetermined to be the most reliable in activating tissue-specific GFPexpression in tomato and was used to generate the tomato population.

A useful feature of the PTF Tool Kit vectors described in FIG. 3 is theuse of two different resistance markers, one in the activator vector andanother in the target vector. This greatly facilitates identifying theactivator and target plant transcription factor genes in plantsfollowing crosses. The presence of both the activator and target in thesame plant can be confirmed by resistance to both markers. Additionally,plants homozygous for one or both genes can be identified by scoring thesegregation ratios of resistant progeny. These resistance markers areuseful for making the technology easier to use for the breeder.

Another useful feature of the PTF Tool Kit activator vector described inFIG. 3 is the use of a target GFP construct to characterize theexpression pattern of each of the 10 activator promoters listed inTable 1. The Activator vector contains a construct consisting ofmultiple copies of the LexA (or LacI) binding sites and a TATA boxupstream of the gene encoding the green fluorescence protein (GFP). ThisGFP reporter construct verifies that the activator gene is functionaland that the promoter has the desired expression pattern beforeextensive plant crossing and characterizations proceed. The GFP reportergene is also useful in plants derived from crossing the activator andtarget parents because it provides an easy method to detect the patternof expression of expressed plant transcription factor genes.

Example IV Tomato Transformation and Sulfonamide Selection

After the activator and target vectors were constructed, the vectorswere used to transform Agrobacterium tumefaciens cells. Since the targetvector comprised a polypeptide or interest (in the example given in FIG.3, the polypeptide of interest was green fluorescent protein; otherpolypeptides of interest may include transcription factor polypeptidesof the invention), it was expected that plants containing both vectorswould be conferred with improved and useful traits. Methods forgenerating transformed plants with expression vectors are well known inthe art; this Example also describes a novel method for transformingtomato plants with a sulfonamide selection marker. In this Example,tomato cotyledon explants were transformed with Agrobacterium culturescomprising target vectors having a sulfonamide selection marker.

Seed Sterilization

T63 seeds were surface sterilized in a sterilization solution of 20%bleach (containing 6% sodium hypochlorite) for 20 minutes with constantstirring. Two drops of Tween 20 were added to the sterilization solutionas a wetting agent. Seeds were rinsed five times with sterile distilledwater, blotted dry with sterile filter paper and transferred to SigmaP4928 phytacons (25 seeds per phytacon) containing 84 ml of MSO medium(the formula for MS medium may be found in Murashige and Skoog (1962);MSO is supplemented as indicated in Table 2).

Seed Germination and Explanting

Phytacons were placed in a growth room at 24° C. with a 16 hourphotoperiod. Seedlings were grown for seven days.

Explanting plates were prepared by placing a 9 cm Whatman No. 2 filterpaper onto a plate of 100 mm×25 mm Petri dish containing 25 ml of R1Fmedium. Tomato seedlings were cut and placed into a 100 mm×25 mm Petridish containing a 9 cm Whatman No. 2 filter paper and 3 ml of distilledwater. Explants were prepared by cutting cotyledons into three pieces.The two proximal pieces were transferred onto the explanting plate, andthe distal section was discarded. One hundred twenty explants wereplaced on each plate. A control plate was also prepared that was notsubjected to the Agrobacterium transformation procedure. Explants werekept in the dark at 24° C. for 24 hours.

Agrobacterium Culture Preparation and Cocultivation

The stock of Agrobacterium tumefaciens cells for transformation weremade as described by Nagel et al. (1990). Agrobacterium strain ABI wasgrown in 250 ml LB medium (Sigma) overnight at 28° C. with shaking untilan absorbance over 1 cm at 600 nm (A₆₀₀) of 0.5-1.0 was reached. Cellswere harvested by centrifugation at 4,000×g for 15 minutes at 4° C.Cells were then resuspended in 250 μl chilled buffer (1 mM HEPES, pHadjusted to 7.0 with KOH). Cells were centrifuged again as describedabove and resuspended in 125 μl chilled buffer. Cells were thencentrifuged and resuspended two more times in the same HEPES buffer asdescribed above at a volume of 100 μl and 750 μl, respectively.Resuspended cells were then distributed into 40 μl aliquots, quicklyfrozen in liquid nitrogen, and stored at −80° C.

Agrobacterium cells were transformed with vectors prepared as describedabove following the protocol described by Nagel et al. (1990). For eachDNA construct to be transformed, 50 to 100 ng DNA (generally resuspendedin 10 mM Tris-HCl, 1 mM EDTA, pH 8.0) were mixed with 40 μl ofAgrobacterium cells. The DNA/cell mixture was then transferred to achilled cuvette with a 2 mm electrode gap and subject to a 2.5 kV chargedissipated at 25 μF and 200 μF using a Gene Pulser II apparatus(Bio-Rad, Hercules, Calif.). After electroporation, cells wereimmediately resuspended in 1.0 ml LB and allowed to recover withoutantibiotic selection for 2-4 hours at 28° C. in a shaking incubator.After recovery, cells were plated onto selective medium of LB brothcontaining 100 μg/ml spectinomycin (Sigma) and incubated for 24-48 hoursat 28° C. Single colonies were then picked and inoculated in freshmedium. The presence of the vector construct was verified by PCRamplification and sequence analysis.

Agrobacteria were cultured in two sequential overnight cultures. On day1, the agrobacteria containing the target vectors having the sulfonamideselection vector (FIG. 3) were grown in 25 ml of liquid 523 medium(Moore et al. (1988)) plus 100 mg spectinomycin, 50 mg kanamycin, and 25mg chloramphenicol per liter. On day 2, five ml of the first overnightsuspension were added to 25 ml of AB medium to which is added 100 mgspectinomycin, 50 mg kanamycin, and 25 mg chloramphenicol per liter.Cultures were grown at 28° C. with constant shaking on a gyratoryshaker. The second overnight suspension was centrifuged in a 38 mlsterile Oakridge tubes for 5 minutes at 8000 rpm in a Beckman JA20rotor. The pellet was resuspended in 10 ml of MSO liquid mediumcontaining 600 μm acetosyringone (for each 20 ml of MSO medium, 40 μl of0.3 M stock acetosyringone were added). The Agrobacterium concentrationwas adjusted to an A₆₀₀ of 0.25.

Seven milliliters of the Agrobacterium suspension were added to each ofexplanting plates. After 20 min., the Agrobacterium suspension wasaspirated and the explants were blotted dry three times with sterilefilter paper. The plates were sealed with Parafilm and incubated in thedark at 21° C. for 48 hours.

Regeneration

Cocultivated explants were transferred after 48 hours in the dark to 100mm×25 mm Petri plates (20 explants per plate) containing 25 ml of R1SB10medium (this medium and subsequently used media contained sulfadiazine,the sulfonamide antibiotic used to select transformants). Plates werekept in the dark for 72 hours and then placed in low light. After 14days, the explants were transferred to fresh RZ1/2SB25 medium. After anadditional 14 days, the regenerating tissues at the edge of the explantswere excised away from the primary explants and were transferred ontofresh RZ1/2SB25 medium. After another 14 day interval, regeneratingtissues were again transferred to fresh ROSB25 medium. After thisperiod, the regenerating tissues were subsequently rotated betweenROSB25 and RZ1/2SB25 media at two week intervals. The well definedshoots that appeared were excised and transferred to ROSB100 medium forrooting.

Shoot Analysis

Once shoots were rooted on ROSB100 medium, small leaf pieces from therooted shoots were sampled and analyzed with a polymerase chain reactionprocedure (PCR) for the presence of the SulA gene. The PCR-positiveshoots (T0) were then grown to maturity in the greenhouses. Some T0plants were crossed to plants containing the CaMV 35S activator vector.The TO self pollinated seeds were saved for later crosses to differentactivator promoters.

TABLE 2 Media Compositions (amounts per liter) MSO R1F R1SB10 RZ1/2SB25ROSB25 ROSB100 Gibco MS Salts 4.3 g 4.3 g 4.3 g 4.3 g 4.3 g 4.3 g ROVitamins (100X) 10 ml 5 ml 10 ml 10 ml R1 Vitamins (100X) 10 ml 10 ml RZVitamins (100X) 5 ml Glucose 16.0 g 16.0 g 16.0 g 16.0 g 16.0 g 16.0 gTimentin ® 100 mg Carbenicillin 350 mg 350 mg 350 mg Noble Agar 8 11.510.3 10.45 10.45 10.45 MES 0.6 g 0.6 g 0.6 g 0.6 g Sulfadiazine freeacid 1 ml 2.5 ml 2.5 ml 10 ml (10 mg/ml stock) pH 5.7 5.7 5.7 5.7 5.75.7

TABLE 3 100x Vitamins (amounts per liter) RO R1 RZ Nicotinic acid 500 mg500 mg 500 mg Thiamine HCl 50 mg 50 mg 50 mg Pyridoxine HCl 50 mg 50 mg50 mg Myo-inositol 20 g 20 g 20 g Glycine 200 mg 200 mg 200 mg Zeatin0.65 mg 0.65 mg IAA 1.0 mg pH 5.7 5.7 5.7

TABLE 4 523 Medium (amounts per liter) Sucrose 10 g Casein EnzymaticHydrolysate 8 g Yeast Extract 4 g K₂HPO₄ 2 g MgSO₄•7H₂O 0.3 g pH 7.00

TABLE 5 AB Medium Part A Part B (10X stock) K₂HPO₄ 3 g MgSO₄•7H₂O 3 gNaH₂PO₄ 1 g CaCl₂ 0.1 g NH₄Cl 1 g FeSO₄•7H₂O 0.025 g KCl 0.15 g Glucose50 g pH 7.00 7.00 Volume 900 ml 1000 ml Prepared by autoclaving andmixing 900 ml Part A with 100 ml Part B.

Example V Population Characterization and Measurements

After the crosses were made (to generate plants having both activatorand target vectors), general characterization of the F1 population wasperformed in the field. General evaluation included photographs ofseedling and adult plant morphology, photographs of leaf shape, openflower morphology and of mature green and ripe fruit. Vegetative plantsize, a measure of plant biomass, was measured by ruler at approximatelytwo months after transplant. Plant volume was obtained by themultiplication of the three dimensions. In addition, observations weremade to determine fruit number per plant. Three red-ripe fruit wereharvested from each individual plant when possible and were used for thevarious assays. Two weeks later, six fruits per promoter::gene groupingwere harvested, with two fruits per plant harvested when possible. Thefruits were pooled, weighed, and seeds collected.

Source/sink activities. Source/sink activities were determined byscreening for lines in which Arabidopsis transcription factors weredriven by the RbcS-3 (leaf mesophyll expression), LTP1 (epidermis andvascular expression) and the PD (early fruit development) promoters.These promoters target source processes localized in photosyntheticallyactive cells (RbcS-3), sink processes localized in developing fruit (PD)or transport processes active in vascular tissues (LTP1) that linksource and sink activities. Leaf punches were collected within one hourof sunrise, in the seventh week after transplant, and stored in ethanol.The leaves were then stained with iodine, and plants with notably highor low levels of starch were noted.

Fruit ripening regulation. Screening for traits associated with fruitripening focused on transgenic tomato lines in which Arabidopsistranscription factors are driven by the PD (early fruit development) andPG (fruit ripening) promoters. These promoters target fruit regulatoryprocesses that lead to fruit maturation or which trigger ripening orcomponents of the ripening process. In order to identify linesexpressing transcription factors that impact ripening, fruits at 1 cmstage, a developmental time 7-10 days post anthesis and shortly afterfruit set were tagged. Tagging occurred over a single two-day period perfield trial at a time when plants are in the early fruiting stage toensure tagging of one to two fruits per plant, and four to six fruitsper line. Tagged fruit at the “breaker” stage on any given inspectionwere marked with a second colored and dated tag. Later inspectionsincluded monitoring of breaker-tagged fruit to identify any that havereached the full red ripe stage. To assess the regulation of componentsof the ripening process, fruit at the mature green and red ripe stagehave been harvested and fruit texture analyzed by force necessary tocompress equator of the fruit by 2 mm.

Example VI Screening CaMV 35S Activator Line Progeny with theTranscription Factor Target Lines to Identify Lines Expressing PlantTranscription Factors

The plant transcription factor target plants that were initiallyprepared lacked an activator gene to faciliate later crosses to variousactivator promoter lines. In order to find transformants that wereadequately expressed in the presence of an activator, the planttranscription factor plants were crossed to the CaMV 35S promoteractivator line and screened for transcription factor expression byRT-PCR. The mRNA was reverse transcribed into cDNA and the amount ofproduct was measured by quantitative PCR.

Because the parental lines were each heterozygous for the transgenes, T1hybrid progeny were sprayed with chlorsulfuron and cyanamide to find the25% of the progeny containing both the activator (chlorsulfuronresistant) and target (cyanamide resistant) transgenes. Segregationratios were measured and lines with abnormal ratios were discarded. Toohigh a ratio indicated multiple inserts, while too low a ratio indicateda variety of possible problems. The ideal inserts produced 50% resistantprogeny. Progeny containing both inserts appeared at 25% because theyalso required the other herbicidal markers from the Activator parentalline (50%×50%).

These T1 hybrid progeny were then screened in a 96 well format for planttranscription factor gene expression by RT-PCR to ensure expression ofthe target plant transcription factor gene, as certain chromosomalpositions can be silent or very poorly expressed or the gene can bedisrupted during the integration process. The 96 well format was alsoused for cDNA synthesis and PCR. This procedure involves the use of oneprimer in the transcribed portion of the vector and a secondgene-specific primer.

Because both the activator and target genes are dominant in theireffects, phenotypes were observable in hybrid progeny containing bothgenes. These T1F1 plants were examined for visual phenotypes. However,more detailed analysis for increased color, high solids and diseaseresistance were also conducted once the best lines were identified andreproduced on a larger scale.

Example VII Results of Overexpressing Specific Promoter::TranscriptionFactor Combinations in Tomato Plants

Using the methods described in the above Examples, a number ofArabidopsis sequences were identified that resulted in brightcoloration, dark leaf color, etiolated seedlings, increased anthocyaninin leaves, increased anthocyanin in flowers, and increased anthocyaninin fruit, increased seedling anthocyanin, increased seedling vigor,longer internodes, more anthocyanin, more trichomes, and fewertrichomes, among other improved traits when expressed in tomato plants.Table 6 shows a number of polypeptides of the invention shown to improvefruit or yield characteristics. SEQ ID NOs and GID (Gene IDentifiers)are listed in Columns 1 and 2. The conserved domains in amino acidcoordinates (beginning from the n-terminus of each polypeptide) of eachpolypeptide associates with particular Transcription Factor Family, andthe Transcription Factor Families to which the polypeptide belongs, arelisted in Columns 3 and 4. The PID (Plasmid IDentifier) and PID SEQ IDNOs are listed in Columns 5 and 6. The 35S promoter was used to driveexpression of the polynucleotides encoding the polypeptides and thetraits that were observed in tomato plants when each polypeptidesequence was overexpressed in tomato plants, relative to traits observedin control tomato plants, are listed in Column 7.

TABLE 6 Polypeptides of the invention, their conserved domains, familiesand the traits conferred by overexpressing the polypeptides in tomatoplants under the regulatory control of the CaMV 35S promoter Col. 4 Col.5 Col. 6 Col. 2 Col. 3 First Second SEQ ID Col. 7 SEQ TF family(conserved construct construct NO: of Experimental Col. 1 ID domainamino acid (expression containing second observation (trait GID NO:coordinates) system) TF construct relative to controls) G2 2 AP2(129-195, 221-288) P6506 (const. P8197 1550 Etiolated seedling 35Sprom.) G3 4 AP2 (28-95) P6506 (const. P3375 1425 Etiolated seedlings 35Sprom.) G8 6 AP2 (151-217, 243-293) P6506 (const. P6038 1499 Moreanthocyanin 35S prom.) G12 8 AP2 (27-94) P6506 (const. P6838 1512Etiolated seedlings 35S prom.) G15 10 AP2 (281-357, 383-451) P6506(const. P9218 1570 More anthocyanin 35S prom.) G33 12 AP2 (50-117) P6506(const. P3643 1440 Inc. seedling vigor 35S prom.) G35 14 AP2 (NA) P6506(const. P5130 1487 Dark leaf color 35S prom.) G47 16 AP2 (10-75) P6506(const. P3853 1445 Bright coloration 35S prom.) G201 18 MYB-(R1)R2R3(14-114) P6506 (const. P6426 1505 Bright coloration 35S prom.) G202 20MYB-(R1)R2R3 (13-116) P6506 (const. P3761 1442 More anthocyanin 35Sprom.) G214 22 MYB-related (25-71) P6506 (const. P5731 1494 Dark leafcolor 35S prom.) G261 24 HS (15-106) P6506 (const. P5145 1488 Etiolatedseedlings 35S prom.) G280 26 AT-hook (97-104, P6506 (const. P6901 1515Etiolated seedlings 130-137-155-162, 35S prom.) 185-192) G350 28 Z-C2H2(91-113, 150-170) P6506 (const. P6197 1501 More anthocyanin 35S prom.)G365 30 Z-C2H2 (70-90) P6506 (const. P6820 1510 Inc. seedling vigor 35Sprom.) G367 32 Z-C2H2 (63-84) P6506 (const. P5748 1495 More anthocyanin35S prom.) G368 34 Z-C2H2 (NA) P6506 (const. P5262 1489 Etiolatedseedlings 35S prom.) G369 36 Z-C2H2 (37-57) P6506 (const. P9035 1567More anthocyanin 35S prom.) G373 38 RING/C3HC4 (129-168) P6506 (const.P7058 1517 More anthocyanin 35S prom.) G398 40 HB (128-191) P6506(const. P5868 1497 Bright coloration 35S prom.) G448 42 IAA (11-20,83-95, P6506 (const. P9080 1568 Dark leaf color 111-128, 180-214) 35Sprom.) G459 44 IAA (12-21, 53-65, 76-92, P6506 (const. P7026 1516Etiolated seedlings 128-161) 35S prom.) G481 46 CAAT (20-109) P6506(const. P6812 1509 Inc. seedling vigor 35S prom.) G486 48 CAAT (3-66)P6506 (const. P3777 1443 Etiolated seedlings 35S prom.) G501 50 NAC(10-131) P6506 (const. P5272 1490 Dark leaf color 35S prom.) G504 52 NAC(16-178) P6506 (const. P4230 1452 Etiolated seedlings 35S prom.) G513 54NAC (16-161) P6506 (const. P5507 1491 More anthocyanin 35S prom.) G51756 NAC (6-153) P6506 (const. P7858 1543 Inc. seedling vigor 35S prom.)G559 58 bZIP (203-264) P6506 (const. P3585 1432 Inc. seedling vigor 35Sprom.) G567 60 bZIP (210-270) P6506 (const. P4762 1479 Inc. seedlingvigor 35S prom.) G594 62 HLH/MYC (144-202) P6506 (const. P6823 1511 Inc.seedling vigor 35S prom.) G619 64 ARF (64-406) P6506 (const. P5706 1493Etiolated seedlings 35S prom.) G619 64 ARF (64-406) P6506 (const. P57061493 Dark leaf color 35S prom.) G663 66 MYB-(R1)R2R3 (9-111) P6506(const. P5094 1485 More anthocyanin 35S prom.) G663 66 MYB-(R1)R2R3(9-111) P6506 (const. P5094 1485 Inc. seedling 35S prom.) anthocyaninG663 66 MYB-(R1)R2R3 (9-111) P6506 (const. P5094 1485 Inc. leaf, flower,and 35S prom.) fruit anthocyanin G668 68 MYB-(R1)R2R3 (14-115) P6506(const. P3574 1431 Bright leaf 35S prom.) coloration G674 70MYB-(R1)R2R3 (20-120) P6506 (const. P7123 1526 More anthocyanin 35Sprom.) G680 72 MYB-related (25-71) P6506 (const. P6409 1502 Inc.seedling vigor 35S prom.) G680 72 MYB-related (25-71) P6506 (const.P6409 1502 Dark leaf color 35S prom.) G729 74 GARP (224-272) P6506(const. P4528 1463 More anthocyanin 35S prom.) G779 76 HLH/MYC (117-174)P6506 (const. P3623 1436 Etiolated seedlings 35S prom.) G786 78 HLH/MYC(183-240) P6506 (const. P5110 1486 Dark leaf color 35S prom.) G812 80 HS(29-120) P6506 (const. P3650 1441 Etiolated seedlings 35S prom.) G860 82MADS (2-57) P6506 (const. P4033 1449 More trichomes 35S prom.) G860 82MADS (2-57) P6506 (const. P4033 1449 Bright coloration 35S prom.) G90484 RING/C3H2C3 (117-158) P6506 (const. P4748 1475 Inc. seedling vigor35S prom.) G913 86 AP2 (62-128) P6506 (const. P3598 1433 Brightcoloration 35S prom.) G936 88 GARP (59-107) P6506 (const. P7536 1535More anthocyanin 35S prom.) G940 90 EIL (86-96) P6506 (const. P6037 1498Etiolated seedlings 35S prom.) G975 92 AP2 (4-71) P6506 (const. P33671421 Etiolated seedlings 35S prom.) G977 94 AP2 (5-72) P6506 (const.P3630 1437 Inc. seedling vigor 35S prom.) G1004 96 AP2 (153-221) P6506(const. P4764 1480 Etiolated seedlings 35S prom.) G1020 98 AP2 (28-95)P6506 (const. P7091 1519 Inc. seedling vigor 35S prom.) G1038 100 GARP(198-247) P6506 (const. P7105 1523 Inc. seedling vigor 35S prom.) G1047102 bZIP (129-180) P6506 (const. P3368 1422 Inc. seedling vigor 35Sprom.) G1063 104 HLH/MYC (125-182) P6506 (const. P4411 1461 Etiolatedseedlings 35S prom.) G1070 106 AT-hook (105-113, P6506 (const. P36341439 Dark leaf color 114-259) 35S prom.) G1075 108 AT-hook (78-86,87-229) P6506 (const. P7111 1524 More trichomes 35S prom.) G1082 110BZIPT2 (1-53, 503-613) P6506 (const. P6171 1500 Inc. seedling vigor 35Sprom.) G1084 112 BZIPT2 (1-53, 490-619) P6506 (const. P4779 1482 Inc.seedling vigor 35S prom.) G1090 114 AP2 (17-84) P6506 (const. P7093 1520Inc. seedling vigor 35S prom.) G1100 116 RING/C3H2C3 (96-137) P6506(const. P6459 1507 Bright coloration 35S prom.) G1108 118 RING/C3H2C3(363-403) P6506 (const. P8231 1552 Inc. seedling vigor 35S prom.) G1145122 bZIP (227-270) P6506 (const. P4030 1448 More trichomes 35S prom.)G1137 120 HLH/MYC (257-314) P6506 (const. P3410 1426 Etiolated seedlings35S prom.) G1197 126 GARP (NA) P6506 (const. P5678 1492 Brightcoloration 35S prom.) G1198 128 bZIP (173-223) P6506 (const. P4766 1481Inc. seedling vigor 35S prom.) G1146 124 PAZ (886-896) P6506 (const.P7061 1518 Etiolated seedlings 35S prom.) G1228 130 HLH/MYC (172-231)P6506 (const. P3411 1427 Etiolated seedlings 35S prom.) G1245 132MYB-(R1)R2R3 (22-122) P6506 (const. P8193 1549 More anthocyanin 35Sprom.) G1275 134 WRKY (113-169) P6506 (const. P3412 1428 Etiolatedseedlings 35S prom.) G1276 136 AP2 (158-224, 250-305) P6506 (const.P7502 1531 Etiolated seedlings 35S prom.) G1290 138 AKR (270-366) P6506(const. P6462 1508 Long Internode 35S prom.) G1308 140 MYB-(R1)R2R3(1-128) P6506 (const. P3830 1444 Etiolated seedlings 35S prom.) G1326142 MYB-(R1)R2R3 (18-121) P6506 (const. P3417 1429 Bright coloration 35Sprom.) G1361 144 NAC (59-200) P6506 (const. P7770 1539 Inc. seedlingvigor 35S prom.) G1421 146 AP2 (84-146) P6506 (const. P3631 1438 Moretrichomes 35S prom.) G1463 148 NAC (9-156) P6506 (const. P4337 1453 Moreanthocyanin 35S prom.) G1464 150 NAC (12-160) P6506 (const. P4338 1454Bright coloration 35S prom.) G1476 152 Z-C2H2 (37-57) P6506 (const.P8068 1545 More trichomes 35S prom.) G1482 154 Z-CO-like (2-33, 60-102)P6506 (const. P4704 1469 More anthocyanin 35S prom.) G1492 156 GARP(34-83) P6506 (const. P4534 1464 More anthocyanin 35S prom.) G1537 158HB (14-74) P6506 (const. P7119 1525 More anthocyanin 35S prom.) G1539160 HB (76-136) P6506 (const. P7119 1525 More anthocyanin 35S prom.)G1543 162 HB (135-195) P6506 (const. P3424 1430 Etiolated seedlings 35Sprom.) G1555 164 GARP (28-177) P6506 (const. P7855 1542 More anthocyanin35S prom.) G1560 166 HS (61-152) P6506 (const. P6870 1514 Etiolatedseedlings 35S prom.) G1584 168 HB (49-109) P6506 (const. P7102 1522 Moreanthocyanin 35S prom.) G1594 170 HB (308-343) P6506 (const. P7171 1528Bright coloration 35S prom.) G1635 172 MYB-related (56-102) P6506(const. P3606 1435 Etiolated seedlings 35S prom.) G1655 174 HLH/MYC(129-186) P6506 (const. P4788 1484 Dark leaf color 35S prom.) G1662 176DBP (44-69, 295-330) P6506 (const. P4703 1468 Long Internode 35S prom.)G1671 178 NAC (1-158) P6506 (const. P4341 1455 Etiolated seedlings 35Sprom.) G1747 180 MYB-(R1)R2R3 (11-114) P6506 (const. P6456 1506 Brightcoloration 35S prom.) G1753 182 AP2 (12-80) P6506 (const. P7777 1540Dark leaf color 35S prom.) G1755 184 AP2 (71-133) P6506 (const. P44071460 Dark leaf color 35S prom.) G1756 186 WRKY (138-200) P6506 (const.P6848 1513 Dark leaf color 35S prom.) G1757 188 WRKY (158-218) P6506(const. P6412 1503 Dark leaf color 35S prom.) G1760 190 MADS (2-57)P6506 (const. P3371 1423 Etiolated seedlings 35S prom.) G1795 192 AP2(11-75) P6506 (const. P6424 1504 Fewer trichomes 35S prom.) G1795 192AP2 (11-75) P6506 (const. P6424 1504 Bright coloration 35S prom.) G1798194 MADS (1-57) P6506 (const. P8535 1558 Dark leaf color 35S prom.)G1798 194 MADS (1-57) P6506 (const. P8535 1558 More trichomes 35S prom.)G1809 196 bZIP (23-35, 68-147) P6506 (const. P3982 1447 Etiolatedseedlings 35S prom.) G1812 198 PCOMB (32-365) P6506 (const. P7789 1541Inc. seedling vigor 35S prom.) G1817 200 PMR (47-331) P6506 (const.P4758 1478 Bright coloration 35S prom.) G1818 202 CAAT (24-116) P6506(const. P4399 1458 Inc. seedling vigor 35S prom.) G1825 204 GARP(55-103) P6506 (const. P8217 1551 Etiolated seedlings 35S prom.) G1826206 GARP (87-135) P6506 (const. P8661 1565 More anthocyanin 35S prom.)G1836 208 CAAT (24-110) P6506 (const. P3603 1434 Inc. seedling vigor 35Sprom.) G1844 210 MADS (2-57) P6506 (const. P4403 1459 Inc. seedlingvigor 35S prom.) G1883 212 Z-Dof (82-124) P6506 (const. P5749 1496Bright coloration 35S prom.) G1895 214 Z-Dof (58-100) P6506 (const.P4546 1465 Etiolated seedlings 35S prom.) G1902 216 Z-Dof (31-59) P6506(const. P3973 1446 Etiolated seedlings 35S prom.) G1911 218 MYB-related(12-62) P6506 (const. P4781 1483 Dark leaf color 35S prom.) G1930 220AP2 (59-124, 179-273) P6506 (const. P3373 1424 Etiolated seedlings 35Sprom.) G1935 222 MADS (1-57) P6506 (const. P4393 1456 Etiolatedseedlings 35S prom.) G1942 224 HLH/MYC (188-246) P6506 (const. P41881451 Inc. seedling vigor 35S prom.) G1944 226 AT-hook (87-100) P6506(const. P4146 1450 Etiolated seedlings 35S prom.) G1985 228 Z-C2H2(37-57) P6506 (const. P8506 1556 Inc. seedling vigor 35S prom.) G1985228 Z-C2H2 (37-57) P6506 (const. P8506 1556 Etiolated seedlings 35Sprom.) G2052 230 NAC (7-158) P6506 (const. P4423 1462 Inc. seedlingvigor 35S prom.) G2128 232 GARP (49-100) P6506 (const. P4582 1466 Moreanthocyanin 35S prom.) G2141 234 HLH/MYC (306-364) P6506 (const. P47531476 Etiolated seedlings 35S prom.) G2146 236 HLH/MYC (132-189) P6506(const. P7492 1529 Dark leaf color 35S prom.) G2148 238 HLH/MYC(135-192) P6506 (const. P7877 1544 Dark leaf color 35S prom.) G2150 240HLH/MYC (194-252) P6506 (const. P4598 1467 Etiolated seedlings 35Sprom.) G2226 242 RING/C3H2C3 (103-144) P6506 (const. P8236 1553 Darkleaf color 35S prom.) G2251 244 RING/C3H2C3 (89-132) P6506 (const. P82491554 Dark leaf color 35S prom.) G2251 244 RING/C3H2C3 (89-132) P6506(const. P8249 1554 More trichomes 35S prom.) G2291 246 AP2 (113-180)P6506 (const. P7125 1527 Inc. seedling vigor 35S prom.) G2346 248 SBP(59-135) P6506 (const. P4734 1474 Inc. seedling vigor 35S prom.) G2425250 MYB-(R1)R2R3 (12-119) P6506 (const. P4396 1457 Inc. seedling vigor35S prom.) G2454 252 YABBY (25-64, 136-183) P6506 (const. P8594 1559More anthocyanin 35S prom.) G2484 254 Z-C4HC3 (202-250) P6506 (const.P7094 1521 Inc. seedling vigor 35S prom.) G2514 256 AP2 (16-82) P6506(const. P7503 1532 Dark leaf color 35S prom.) G2520 258 HLH/MYC(139-197) P6506 (const. P4755 1477 Etiolated seedlings 35S prom.) G2573260 AP2 (31-98) P6506 (const. P4715 1470 Dark leaf color 35S prom.)G2573 260 AP2 (31-98) P6506 (const. P4715 1470 Fewer trichomes 35Sprom.) G2574 262 WRKY (225-284) P6506 (const. P7507 1533 Moreanthocyanin 35S prom.) G2577 264 AP2 (208-281, 307-375) P6506 (const.P8647 1564 Bright coloration 35S prom.) G2583 266 AP2 (4-71) P6506(const. P4716 1471 Bright coloration 35S prom.) G2590 268 MADS (2-57)P6506 (const. P4719 1472 Etiolated seedlings 35S prom.) G2606 270 Z-C2H2(120-140, P6506 (const. P7753 1538 More anthocyanin 192-214) 35S prom.)G2674 272 HB (56-116) P6506 (const. P9272 1572 More anthocyanin 35Sprom.) G2686 274 WRKY (122-173) P6506 (const. P8080 1546 Moreanthocyanin 35S prom.) G2719 276 MYB-(R1)R2R3 (56-154) P6506 (const.P4723 1473 Inc. seedling vigor 35S prom.) G2741 278 GARP (149-197) P6506(const. P8498 1555 Inc. seedling vigor 35S prom.) G2742 280 GARP (28-76)P6506 (const. P8637 1563 More anthocyanin 35S prom.) G2747 282 ABI3/VP-1(19-113) P6506 (const. P8127 1547 More anthocyanin 35S prom.) G2763 284HLH/MYC (141-201) P6506 (const. P7493 1530 Dark leaf color 35S prom.)G2831 286 Z-C2H2 (72-92, 148-168) P6506 (const. P8618 1562 Moreanthocyanin 35S prom.) G2832 288 Z-C2H2 (11-31, 66-86, P6506 (const.P8612 1561 Dark leaf color 317-337) 35S prom.) G2859 290 HLH/MYC(150-208) P6506 (const. P8607 1560 Etiolated seedlings 35S prom.) G2885292 GARP (196-243) P6506 (const. P8143 1548 More trichomes 35S prom.)G2990 294 ZF-HB (54-109, 200-263) P6506 (const. P7515 1534 Moreanthocyanin 35S prom.) G3032 296 GARP (285-333) P6506 (const. P8674 1566Inc. seedling vigor 35S prom.) G3034 298 GARP (218-266) P6506 (const.P9194 1569 More anthocyanin 35S prom.) G3044 300 HLH/MYC (226-284) P6506(const. P7569 1537 Etiolated seedlings 35S prom.) G3061 302 Z-C2H2(73-90, 174-193) P6506 (const. P8510 1557 Bright coloration 35S prom.)G3070 304 Z-C2H2 (129-150) P6506 (const. P9236 1571 Bright coloration35S prom.) G3080 306 bZIP-ZW2 (76-106, P6506 (const. P7546 1536Etiolated seedlings 210-237) 35S prom.) Abbreviations: Inc. = increasedConst. 35S prom. = constitutive cauliflower mosaic virus promoter

Regulation of pigment levels in commercial species may be of valuebecause increased anthocyanin may lead to greater photoinhibition;protection from ultraviolet, or increase the antioxidant potential ofedible products. Dark leaf color may indicate altered light perceptionin a plant, which may positively impact ability to grow at a higherdensity and hence improve yield. Dark leaves may also indicate increasedphotosynthetic capacity.

Etiolation of seedlings may also demonstrate altered light perception ina plant, which may indicate an altered shade tolerance phenotype,potentially providing the ability to grow at a higher density andimprove yield.

Bright coloration can be a consequence of changes in epicuticular waxcontent or composition. Manipulation of wax composition, amount, ordistribution can be used to modify plant tolerance to drought, lowhumidity or resistance to insects.

Long internodes may also indicate a shade tolerance phenotype. Longinternodes may also indicate fast growth. In woody plants, longinternodes and fast growth may provide more biomass or fewer knots.

Increased seedling vigor, which helps plants establish quickly,particularly when abiotic or biotic stresses are present, was generallydemonstrated by seedling size about 125% of controls several days aftergermination.

Example VIII Orthologs and Paralogs of the Sequences of the Invention

The Sequence Listing includes sequences within the National Center forBiotechnology Information (NCBI) UniGene database determined to beorthologous to many of the transcription factor sequences of the presentinvention. These orthologous sequences, including SEQ ID NO: 1588 to3372, were identified by a reciprocal BLAST strategy. The reciprocalanalysis is performed by using an Arabidopsis sequence as a querysequence to identify homologs in diverse species, and a sequence fromanother species so identified is BLASTed against an Arabidopsis databaseto identify the most closely related Arabidopsis sequence. If the latterBLAST analysis returns as a “top hit” the original query sequence, theArabidopsis query sequence and the sequence from another species areconsidered putative orthologs. Thus, the function of the orthologs canbe deduced from the identified function of the query or referencesequence. This type of analysis can also be performed with querysequences from non-Arabidopsis species.

Paralogous sequences may also be identified by a BLAST analysisconducted within a database of sequences from a single species and usinga query sequence from that species.

Table 7 lists sequences discovered to be orthologous or paralogous to anumber of transcription factors of the instant Sequence Listing. Thecolumns headings include, from left to right: Column 1: the SEQ ID NO;Column 2: the corresponding Arabidopsis Gene identification (GID)numbers; Column 3: the sequence type (DNA or protein, PRT); Column 4:the species from which the sequence derives; and Column 5: therelationship to other sequences in this table and the Sequence Listing.

TABLE 7 Putative homologs of Arabidopsis transcription factor genesidentified using BLAST analysis Col. 1 Col. 3 SEQ DNA ID Col. 2 or Col.4 Col. 5 NO: GID PRT Species Relationship 1 G2 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1416 thaliana 2 G2 PRTArabidopsis Paralogous to G1416 thaliana 3 G3 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G10 thaliana 4 G3 PRT ArabidopsisParalogous to G10 thaliana 7 G12 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1277, G1379, thaliana G24; orthologous toG3656 8 G12 PRT Arabidopsis Paralogous to G1277, G1379, G24; Orthologousto G3656 thaliana 13 G35 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G2138 thaliana 14 G35 PRT Arabidopsis Paralogous toG2138 thaliana 15 G47 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G2133; thaliana orthologous to G3643, G3644, G3645, G3646,G3647, G3649, G3650, G3651 16 G47 PRT Arabidopsis Paralogous to G2133;Orthologous to G3643, G3644, G3645, thaliana G3646, G3647, G3649, G3650,G3651 17 G201 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G202, G243 thaliana 18 G201 PRT Arabidopsis Paralogous toG202, G243 thaliana 19 G202 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G201, G243 thaliana 20 G202 PRT ArabidopsisParalogous to G201, G243 thaliana 21 G214 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G680 thaliana 22 G214 PRTArabidopsis Paralogous to G680 thaliana 23 G261 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G265 thaliana 24 G261PRT Arabidopsis Paralogous to G265 thaliana 27 G350 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G351, G545 thaliana 28G350 PRT Arabidopsis Paralogous to G351, G545 thaliana 31 G367 DNAArabidopsis Predicted polypeptide sequence is paralogous to G2665thaliana 32 G367 PRT Arabidopsis Paralogous to G2665 thaliana 39 G398DNA Arabidopsis Predicted polypeptide sequence is paralogous to G399,G964 thaliana 40 G398 PRT Arabidopsis Paralogous to G399, G964 thaliana41 G448 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG450, G455, thaliana G456 42 G448 PRT Arabidopsis Paralogous to G450,G455, G456 thaliana 45 G481 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1364, G2345, thaliana G482, G485; orthologousto G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436, G3437,G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866, G3868,G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 46 G481 PRTArabidopsis Paralogous to G1364, G2345, G482, G485; Orthologous tothaliana G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866,G3868, G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 49 G501DNA Arabidopsis Predicted polypeptide sequence is paralogous to G502,G519, thaliana G767 50 G501 PRT Arabidopsis Paralogous to G502, G519,G767 thaliana 51 G504 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1425, G1454; thaliana orthologous to G3809 52 G504 PRTArabidopsis Paralogous to G1425, G1454; Orthologous to G3809 thaliana 53G513 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1426, G1455, thaliana G960 54 G513 PRT Arabidopsis Paralogous to G1426,G1455, G960 thaliana 55 G517 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G2053, G515, thaliana G516 56 G517 PRTArabidopsis Paralogous to G2053, G515, G516 thaliana 57 G559 DNAArabidopsis Predicted polypeptide sequence is paralogous to G631thaliana 58 G559 PRT Arabidopsis Paralogous to G631 thaliana 61 G594 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1496thaliana 62 G594 PRT Arabidopsis Paralogous to G1496 thaliana 65 G663DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1329,G2421, thaliana G2422 66 G663 PRT Arabidopsis Paralogous to G1329,G2421, G2422 thaliana 67 G668 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G256, G666, thaliana G932; orthologous toG3384, G3385, G3386, G3500, G3501, G3502, G3537, G3538, G3539, G3540,G3541 68 G668 PRT Arabidopsis Paralogous to G256, G666, G932;Orthologous to G3384, G3385, thaliana G3386, G3500, G3501, G3502, G3537,G3538, G3539, G3540, G3541 71 G680 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G214 thaliana 72 G680 PRT ArabidopsisParalogous to G214 thaliana 73 G729 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1040, G3034, thaliana G730 74G729 PRT Arabidopsis Paralogous to G1040, G3034, G730 thaliana 79 G812DNA Arabidopsis Predicted polypeptide sequence is paralogous to G2467thaliana 80 G812 PRT Arabidopsis Paralogous to G2467 thaliana 81 G860DNA Arabidopsis Predicted polypeptide sequence is paralogous to G152,G153, thaliana G1760; orthologous to G3479, G3480, G3481, G3482, G3483,G3484, G3485, G3487, G3488, G3489, G3980, G3981, G3982 82 G860 PRTArabidopsis Paralogous to G152, G153, G1760; Orthologous to G3479,thaliana G3480, G3481, G3482, G3483, G3484, G3485, G3487, G3488, G3489,G3980, G3981, G3982 85 G913 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G2514, G976, thaliana G1753 86 G913 PRTArabidopsis Paralogous to G2514, G976, G1753 thaliana 89 G940 DNAArabidopsis Predicted polypeptide sequence is paralogous to G938, G941thaliana 90 G940 PRT Arabidopsis Paralogous to G938, G941 thaliana 91G975 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1387, G2583; thaliana orthologous to G4294 92 G975 PRT ArabidopsisParalogous to G1387, G2583; Orthologous to G4294 thaliana 95 G1004 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1419, G43,thaliana G46, G29; orthologous to G3849 96 G1004 PRT ArabidopsisParalogous to G1419, G43, G46, G29; Orthologous to G3849 thaliana 97G1020 DNA Arabidopsis Predicted polypeptide sequence is paralogous to G6thaliana 98 G1020 PRT Arabidopsis Paralogous to G6 thaliana 101 G1047DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1808thaliana 102 G1047 PRT Arabidopsis Paralogous to G1808 thaliana 103G1063 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG2143 thaliana 104 G1063 PRT Arabidopsis Paralogous to G2143 thaliana105 G1070 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G2657; thaliana orthologous to G3404, G3405 106 G1070 PRT ArabidopsisParalogous to G2657; Orthologous to G3404, G3405 thaliana 107 G1075 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1076;thaliana orthologous to G3406, G3407, G3458, G3459, G3460, G3461 108G1075 PRT Arabidopsis Paralogous to G1076; Orthologous to G3406, G3407,G3458, thaliana G3459, G3460, G3461 109 G1082 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G576 thaliana 110 G1082 PRTArabidopsis Paralogous to G576 thaliana 117 G1108 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2394 thaliana 118 G1108PRT Arabidopsis Paralogous to G2394 thaliana 119 G1137 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1133 thaliana 120 G1137PRT Arabidopsis Paralogous to G1133 thaliana 121 G1145 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1056 thaliana 122 G1145PRT Arabidopsis Paralogous to G1056 thaliana 123 G1146 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1149, G1152 thaliana124 G1146 PRT Arabidopsis Paralogous to G1149, G1152 thaliana 125 G1197DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1959thaliana 126 G1197 PRT Arabidopsis Paralogous to G1959 thaliana 127G1198 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1806, G554, thaliana G555, G556, G558, G578, G629 128 G1198 PRTArabidopsis Paralogous to G1806, G554, G555, G556, G558, G578, G629thaliana 129 G1228 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1227 thaliana 130 G1228 PRT Arabidopsis Paralogous toG1227 thaliana 131 G1245 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1247 thaliana 132 G1245 PRT Arabidopsis Paralogous toG1247 thaliana 133 G1275 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1274; thaliana orthologous to G3722, G3723, G3724,G3731, G3732, G3803, G3719, G3720, G3721, G3725, G3726, G3727, G3728,G3729, G3730, G3733, G3795, G3797, G3802, G3804 134 G1275 PRTArabidopsis Paralogous to G1274; Orthologous to G3722, G3723, G3724,thaliana G3731, G3732, G3803, G3719, G3720, G3721, G3725, G3726, G3727,G3728, G3729, G3730, G3733, G3795, G3797, G3802, G3804 137 G1290 DNAArabidopsis Predicted polypeptide sequence is paralogous to G278thaliana 138 G1290 PRT Arabidopsis Paralogous to G278 thaliana 145 G1421DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1750,G440, thaliana G864; orthologous to G4079, G4080, G4283, G4284, G4285,G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 146 G1421 PRTArabidopsis Paralogous to G1750, G440, G864; Orthologous to G4079,thaliana G4080, G4283, G4284, G4285, G4286, G4287, G4288, G4289, G4290,G4291, G4292, G4293 147 G1463 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1461, G1462, thaliana G1464, G1465 148 G1463PRT Arabidopsis Paralogous to G1461, G1462, G1464, G1465 thaliana 149G1464 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1461, G1462, thaliana G1463, G1465 150 G1464 PRT Arabidopsis Paralogousto G1461, G1462, G1463, G1465 thaliana 153 G1482 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1888; thalianaorthologous to G5159 154 G1482 PRT Arabidopsis Paralogous to G1888;Orthologous to G5159 thaliana 155 G1492 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2742 thaliana 156 G1492 PRTArabidopsis Paralogous to G2742 thaliana 161 G1543 DNA ArabidopsisPredicted polypeptide sequence is orthologous to G3510, G3490, thalianaG3524, G4371 162 G1543 PRT Arabidopsis Orthologous to G3510, G3490,G3524, G4371 thaliana 169 G1594 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G428 thaliana 170 G1594 PRT ArabidopsisParalogous to G428 thaliana 179 G1747 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G251 thaliana 180 G1747 PRTArabidopsis Paralogous to G251 thaliana 181 G1753 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G913, G2514, thalianaG976 182 G1753 PRT Arabidopsis Paralogous to G913, G2514, G976 thaliana183 G1755 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1754 thaliana 184 G1755 PRT Arabidopsis Paralogous to G1754 thaliana187 G1757 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1847 thaliana 188 G1757 PRT Arabidopsis Paralogous to G1847 thaliana189 G1760 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G152, G153, thaliana G860; orthologous to G3479, G3480, G3481, G3482,G3483, G3484, G3485, G3487, G3488, G3489, G3980, G3981, G3982 190 G1760PRT Arabidopsis Paralogous to G152, G153, G860; Orthologous to G3479,G3480, thaliana G3481, G3482, G3483, G3484, G3485, G3487, G3488, G3489,G3980, G3981, G3982 191 G1795 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1791, G1792, thaliana G30; orthologous toG3380, G3381, G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735,G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 192 G1795 PRTArabidopsis Paralogous to G1791, G1792, G30; Orthologous to G3380,thaliana G3381, G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735,G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 193 G1798 DNAArabidopsis Predicted polypeptide sequence is paralogous to G149, G627,thaliana G1011, G154, G1797; orthologous to G4061, G4062, G4063, G4064,G4065, G4066, G4067 194 G1798 PRT Arabidopsis Paralogous to G149, G627,G1011, G154, G1797; Orthologous to thaliana G4061, G4062, G4063, G4064,G4065, G4066, G4067 195 G1809 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G557; thaliana orthologous to G4627, G4630,G4631, G4632, G5158 196 G1809 PRT Arabidopsis Paralogous to G557;Orthologous to G4627, G4630, G4631, thaliana G4632, G5158 199 G1817 DNAArabidopsis Predicted polypeptide sequence is paralogous to G2316thaliana 200 G1817 PRT Arabidopsis Paralogous to G2316 thaliana 201G1818 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1836 thaliana 202 G1818 PRT Arabidopsis Paralogous to G1836 thaliana207 G1836 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1818 thaliana 208 G1836 PRT Arabidopsis Paralogous to G1818 thaliana209 G1844 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G157, G1759, thaliana G1842, G1843, G859 210 G1844 PRT ArabidopsisParalogous to G157, G1759, G1842, G1843, G859 thaliana 211 G1883 DNAArabidopsis Predicted polypeptide sequence is paralogous to G648thaliana 212 G1883 PRT Arabidopsis Paralogous to G648 thaliana 213 G1895DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1903thaliana 214 G1895 PRT Arabidopsis Paralogous to G1903 thaliana 215G1902 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1901 thaliana 216 G1902 PRT Arabidopsis Paralogous to G1901 thaliana217 G1911 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1789, G2721, thaliana G997 218 G1911 PRT Arabidopsis Paralogous toG1789, G2721, G997 thaliana 219 G1930 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G867, G9, G993; thalianaorthologous to G3388, G3389, G3390, G3391, G3432, G3433, G3451, G3452,G3453, G3454, G3455 220 G1930 PRT Arabidopsis Paralogous to G867, G9,G993; Orthologous to G3388, G3389, thaliana G3390, G3391, G3432, G3433,G3451, G3452, G3453, G3454, G3455 221 G1935 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2058, G2578 thaliana 222 G1935PRT Arabidopsis Paralogous to G2058, G2578 thaliana 223 G1942 DNAArabidopsis Predicted polypeptide sequence is paralogous to G2144thaliana 224 G1942 PRT Arabidopsis Paralogous to G2144 thaliana 225G1944 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG605 thaliana 226 G1944 PRT Arabidopsis Paralogous to G605 thaliana 229G2052 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG506 thaliana 230 G2052 PRT Arabidopsis Paralogous to G506 thaliana 231G2128 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1491 thaliana 232 G2128 PRT Arabidopsis Paralogous to G1491 thaliana237 G2148 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G2145 thaliana 238 G2148 PRT Arabidopsis Paralogous to G2145 thaliana251 G2454 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G2456 thaliana 252 G2454 PRT Arabidopsis Paralogous to G2456 thaliana253 G2484 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1232 thaliana 254 G2484 PRT Arabidopsis Paralogous to G1232 thaliana255 G2514 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G913, G976, thaliana G1753 256 G2514 PRT Arabidopsis Paralogous toG913, G976, G1753 thaliana 261 G2574 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2110 thaliana 262 G2574 PRTArabidopsis Paralogous to G2110 thaliana 265 G2583 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1387, G975; thalianaorthologous to G4294 266 G2583 PRT Arabidopsis Paralogous to G1387,G975; Orthologous to G4294 thaliana 273 G2686 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2586, G2587 thaliana 274 G2686PRT Arabidopsis Paralogous to G2586, G2587 thaliana 275 G2719 DNAArabidopsis Predicted polypeptide sequence is paralogous to G216thaliana 276 G2719 PRT Arabidopsis Paralogous to G216 thaliana 277 G2741DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1435;thaliana orthologous to G4240, G4241, G4243, G4244, G4245 278 G2741 PRTArabidopsis Paralogous to G1435; Orthologous to G4240, G4241, G4243,thaliana G4244, G4245 279 G2742 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1492 thaliana 280 G2742 PRT ArabidopsisParalogous to G1492 thaliana 281 G2747 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1010 thaliana 282 G2747 PRTArabidopsis Paralogous to G1010 thaliana 285 G2831 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G903 thaliana 286 G2831PRT Arabidopsis Paralogous to G903 thaliana 289 G2859 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2779 thaliana 290 G2859PRT Arabidopsis Paralogous to G2779 thaliana 293 G2990 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2989; thalianaorthologous to G3680, G3681, G3691, G3859, G3860, G3861, G3934 294 G2990PRT Arabidopsis Paralogous to G2989; Orthologous to G3680, G3681, G3691,thaliana G3859, G3860, G3861, G3934 297 G3034 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1040, G729, thaliana G730 298G3034 PRT Arabidopsis Paralogous to G1040, G729, G730 thaliana 301 G3061DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1350thaliana 302 G3061 PRT Arabidopsis Paralogous to G1350 thaliana 305G3080 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG3079 thaliana 306 G3080 PRT Arabidopsis Paralogous to G3079 thaliana307 G10 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG3 thaliana 308 G10 PRT Arabidopsis Paralogous to G3 thaliana 309 G1010DNA Arabidopsis Predicted polypeptide sequence is paralogous to G2747thaliana 310 G1010 PRT Arabidopsis Paralogous to G2747 thaliana 311G1011 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG149, G627, thaliana G154, G1797, G1798; orthologous to G4061, G4062,G4063, G4064, G4065, G4066, G4067 312 G1011 PRT Arabidopsis Paralogousto G149, G627, G154, G1797, G1798; Orthologous to thaliana G4061, G4062,G4063, G4064, G4065, G4066, G4067 313 G1040 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G3034, G729, thaliana G730 314G1040 PRT Arabidopsis Paralogous to G3034, G729, G730 thaliana 315 G1056DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1145thaliana 316 G1056 PRT Arabidopsis Paralogous to G1145 thaliana 317G1076 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1075; thaliana orthologous to G3406, G3407, G3458, G3459, G3460, G3461318 G1076 PRT Arabidopsis Paralogous to G1075; Orthologous to G3406,G3407, G3458, thaliana G3459, G3460, G3461 319 G1133 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1137 thaliana 320 G1133PRT Arabidopsis Paralogous to G1137 thaliana 321 G1149 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1146, G1152 thaliana322 G1149 PRT Arabidopsis Paralogous to G1146, G1152 thaliana 323 G1152DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1146,G1149 thaliana 324 G1152 PRT Arabidopsis Paralogous to G1146, G1149thaliana 325 G1227 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1228 thaliana 326 G1227 PRT Arabidopsis Paralogous toG1228 thaliana 327 G1232 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G2484 thaliana 328 G1232 PRT Arabidopsis Paralogous toG2484 thaliana 329 G1247 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1245 thaliana 330 G1247 PRT Arabidopsis Paralogous toG1245 thaliana 331 G1274 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1275; thaliana orthologous to G3722, G3723, G3724,G3731, G3732, G3803, G3719, G3720, G3721, G3725, G3726, G3727, G3728,G3729, G3730, G3733, G3795, G3797, G3802, G3804 332 G1274 PRTArabidopsis Paralogous to G1275; Orthologous to G3722, G3723, G3724,thaliana G3731, G3732, G3803, G3719, G3720, G3721,63725, G3726, G3727,G3728, G3729, G3730, G3733, G3795, G3797, G3802, G3804 333 G1277 DNAArabidopsis Predicted polypeptide sequence is paralogous to G12, G1379,thaliana G24; orthologous to G3656 334 G1277 PRT Arabidopsis Paralogousto G12, G1379, G24; Orthologous to G3656 thaliana 335 G1329 DNAArabidopsis Predicted polypeptide sequence is paralogous to G2421,G2422, thaliana G663 336 G1329 PRT Arabidopsis Paralogous to G2421,G2422, G663 thaliana 337 G1350 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G3061 thaliana 338 G1350 PRT ArabidopsisParalogous to G3061 thaliana 339 G1364 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2345, G481, thaliana G482, G485;orthologous to G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 340G1364 PRT Arabidopsis Paralogous to G2345, G481, G482, G485; Orthologousto G3394, thaliana G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 341G1379 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG12, G1277, thaliana G24; orthologous to G3656 342 G1379 PRT ArabidopsisParalogous to G12, G1277, G24; Orthologous to G3656 thaliana 343 G1387DNA Arabidopsis Predicted polypeptide sequence is paralogous to G2583,G975; thaliana orthologous to G4294 344 G1387 PRT Arabidopsis Paralogousto G2583, G975; Orthologous to G4294 thaliana 345 G1416 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2 thaliana 346 G1416PRT Arabidopsis Paralogous to G2 thaliana 347 G1419 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G43, G46, thalianaG1004, G29; orthologous to G3849 348 G1419 PRT Arabidopsis Paralogous toG43, G46, G1004, G29; Orthologous to G3849 thaliana 349 G1425 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1454, G504;thaliana orthologous to G3809 350 G1425 PRT Arabidopsis Paralogous toG1454, G504; Orthologous to G3809 thaliana 351 G1426 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1455, G513, thalianaG960 352 G1426 PRT Arabidopsis Paralogous to G1455, G513, G960 thaliana353 G1435 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G2741; thaliana orthologous to G4240, G4241, G4243, G4244, G4245 354G1435 PRT Arabidopsis Paralogous to G2741; Orthologous to G4240, G4241,G4243, thaliana G4244, G4245 355 G1454 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1425, G504; thaliana orthologousto G3809 356 G1454 PRT Arabidopsis Paralogous to G1425, G504;Orthologous to G3809 thaliana 357 G1455 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1426, G513, thaliana G960 358G1455 PRT Arabidopsis Paralogous to G1426, G513, G960 thaliana 359 G1461DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1462,G1463, thaliana G1464, G1465 360 G1461 PRT Arabidopsis Paralogous toG1462, G1463, G1464, G1465 thaliana 361 G1462 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1461, G1463, thaliana G1464,G1465 362 G1462 PRT Arabidopsis Paralogous to G1461, G1463, G1464, G1465thaliana 363 G1465 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1461, G1462, thaliana G1463, G1464 364 G1465 PRTArabidopsis Paralogous to G1461, G1462, G1463, G1464 thaliana 365 G149DNA Arabidopsis Predicted polypeptide sequence is paralogous to G627,G1011, thaliana G154, G1797, G1798; orthologous to G4061, G4062, G4063,G4064, G4065, G4066, G4067 366 G149 PRT Arabidopsis Paralogous to G627,G1011, G154, G1797, G1798; Orthologous thaliana to G4061, G4062, G4063,G4064, G4065, G4066, G4067 367 G1491 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2128 thaliana 368 G1491 PRTArabidopsis Paralogous to G2128 thaliana 369 G1496 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G594 thaliana 370 G1496PRT Arabidopsis Paralogous to G594 thaliana 371 G152 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G153, G1760, thalianaG860; orthologous to G3479, G3480, G3481, G3482, G3483, G3484, G3485,G3487, G3488, G3489, G3980, G3981, G3982 372 G152 PRT ArabidopsisParalogous to G153, G1760, G860; Orthologous to G3479, thaliana G3480,G3481, G3482, G3483, G3484, G3485, G3487, G3488, G3489, G3980, G3981,G3982 373 G153 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G152, G1760, thaliana G860; orthologous to G3479, G3480,G3481, G3482, G3483, G3484, G3485, G3487, G3488, G3489, G3980, G3981,G3982 374 G153 PRT Arabidopsis Paralogous to G152, G1760, G860;Orthologous to G3479, thaliana G3480, G3481, G3482, G3483, G3484, G3485,G3487, G3488, G3489, G3980, G3981, G3982 375 G154 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G149, G627, thalianaG1011, G1797, G1798; orthologous to G4061, G4062, G4063, G4064, G4065,G4066, G4067 376 G154 PRT Arabidopsis Paralogous to G149, G627, G1011,G1797, G1798; Orthologous thaliana to G4061, G4062, G4063, G4064, G4065,G4066, G4067 377 G157 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1759, G1842, thaliana G1843, G1844, G859 378 G157 PRTArabidopsis Paralogous to G1759, G1842, G1843, G1844, G859 thaliana 379G1750 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1421, G440, thaliana G864; orthologous to G4079, G4080, G4283, G4284,G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 380 G1750PRT Arabidopsis Paralogous to G1421, G440, G864; Orthologous to G4079,thaliana G4080, G4283, G4284, G4285, G4286, G4287, G4288, G4289, G4290,G4291, G4292, G4293 381 G1754 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1755 thaliana 382 G1754 PRT ArabidopsisParalogous to G1755 thaliana 383 G1759 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G157, G1842, thaliana G1843,G1844, G859 384 G1759 PRT Arabidopsis Paralogous to G157, G1842, G1843,G1844, G859 thaliana 385 G1789 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1911, G2721, thaliana G997 386 G1789 PRTArabidopsis Paralogous to G1911, G2721, G997 thaliana 387 G1791 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1792,G1795, thaliana G30; orthologous to G3380, G3381, G3383, G3515, G3516,G3517, G3518, G3519, G3520, G3735, G3736, G3737, G3794, G3739, G3929,G4328, G4329, G4330 388 G1791 PRT Arabidopsis Paralogous to G1792,G1795, G30; Orthologous to G3380, thaliana G3381, G3383, G3515, G3516,G3517, G3518, G3519, G3520, G3735, G3736, G3737, G3794, G3739, G3929,G4328, G4329, G4330 389 G1792 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1791, G1795, thaliana G30; orthologous toG3380, G3381, G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735,G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 390 G1792 PRTArabidopsis Paralogous to G1791, G1795, G30; Orthologous to G3380,thaliana G3381, G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735,G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 391 G1797 DNAArabidopsis Predicted polypeptide sequence is paralogous to G149, G627,thaliana G1011, G154, G1798; orthologous to G4061, G4062, G4063, G4064,G4065, G4066, G4067 392 G1797 PRT Arabidopsis Paralogous to G149, G627,G1011, G154, G1798; Orthologous to thaliana G4061, G4062, G4063, G4064,G4065, G4066, G4067 393 G1806 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1198, G554, thaliana G555, G556, G558, G578,G629 394 G1806 PRT Arabidopsis Paralogous to G1198, G554, G555, G556,G558, G578, G629 thaliana 395 G1808 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1047 thaliana 396 G1808 PRTArabidopsis Paralogous to G1047 thaliana 397 G1842 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G157, G1759, thalianaG1843, G1844, G859 398 G1842 PRT Arabidopsis Paralogous to G157, G1759,G1843, G1844, G859 thaliana 399 G1843 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G157, G1759, thaliana G1842,G1844, G859 400 G1843 PRT Arabidopsis Paralogous to G157, G1759, G1842,G1844, G859 thaliana 401 G1847 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1757 thaliana 402 G1847 PRT ArabidopsisParalogous to G1757 thaliana 403 G1888 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1482; thaliana orthologous toG5159 404 G1888 PRT Arabidopsis Paralogous to G1482; Orthologous toG5159 thaliana 405 G1901 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1902 thaliana 406 G1901 PRT Arabidopsis Paralogous toG1902 thaliana 407 G1903 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1895 thaliana 408 G1903 PRT Arabidopsis Paralogous toG1895 thaliana 409 G1959 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G1197 thaliana 410 G1959 PRT Arabidopsis Paralogous toG1197 thaliana 411 G2053 DNA Arabidopsis Predicted polypeptide sequenceis paralogous to G515, G516, thaliana G517 412 G2053 PRT ArabidopsisParalogous to G515, G516, G517 thaliana 413 G2058 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1935, G2578 thaliana414 G2058 PRT Arabidopsis Paralogous to G1935, G2578 thaliana 415 G2110DNA Arabidopsis Predicted polypeptide sequence is paralogous to G2574thaliana 416 G2110 PRT Arabidopsis Paralogous to G2574 thaliana 417G2133 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG47; orthologous thaliana to G3643, G3644, G3645, G3646, G3647, G3649,G3650, G3651 418 G2133 PRT Arabidopsis Paralogous to G47; Orthologous toG3643, G3644, G3645, thaliana G3646, G3647, G3649, G3650, G3651 419G2138 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG35 thaliana 420 G2138 PRT Arabidopsis Paralogous to G35 thaliana 421G2143 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1063 thaliana 422 G2143 PRT Arabidopsis Paralogous to G1063 thaliana423 G2144 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1942 thaliana 424 G2144 PRT Arabidopsis Paralogous to G1942 thaliana425 G2145 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G2148 thaliana 426 G2145 PRT Arabidopsis Paralogous to G2148 thaliana427 G216 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG2719 thaliana 428 G216 PRT Arabidopsis Paralogous to G2719 thaliana 429G2316 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1817 thaliana 430 G2316 PRT Arabidopsis Paralogous to G1817 thaliana431 G2345 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1364, G481, thaliana G482, G485; orthologous to G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874,G3875, G3876, G3938, G4272, G4276 432 G2345 PRT Arabidopsis Paralogousto G1364, G481, G482, G485; Orthologous to G3394, thaliana G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874,G3875, G3876, G3938, G4272, G4276 433 G2394 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1108 thaliana 434 G2394 PRTArabidopsis Paralogous to G1108 thaliana 435 G24 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G12, G1277, thalianaG1379; orthologous to G3656 436 G24 PRT Arabidopsis Paralogous to G12,G1277, G1379; Orthologous to G3656 thaliana 437 G2421 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1329, G2422, thalianaG663 438 G2421 PRT Arabidopsis Paralogous to G1329, G2422, G663 thaliana439 G2422 DNA Arabidopsis Predicted polypeptide sequence is paralogousto G1329, G2421, thaliana G663 440 G2422 PRT Arabidopsis Paralogous toG1329, G2421, G663 thaliana 441 G243 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G201, G202 thaliana 442 G243 PRTArabidopsis Paralogous to G201, G202 thaliana 443 G2456 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2454 thaliana 444 G2456PRT Arabidopsis Paralogous to G2454 thaliana 445 G2467 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G812 thaliana 446 G2467PRT Arabidopsis Paralogous to G812 thaliana 447 G251 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1747 thaliana 448 G251PRT Arabidopsis Paralogous to G1747 thaliana 449 G256 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G666, G668, thalianaG932; orthologous to G3384, G3385, G3386, G3500, G3501, G3502, G3537,G3538, G3539, G3540, G3541 450 G256 PRT Arabidopsis Paralogous to G666,G668, G932; Orthologous to G3384, G3385, thaliana G3386, G3500, G3501,G3502, G3537, G3538, G3539, G3540, G3541 451 G2578 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1935, G2058 thaliana452 G2578 PRT Arabidopsis Paralogous to G1935, G2058 thaliana 453 G2586DNA Arabidopsis Predicted polypeptide sequence is paralogous to G2587,G2686 thaliana 454 G2586 PRT Arabidopsis Paralogous to G2587, G2686thaliana 455 G2587 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G2586, G2686 thaliana 456 G2587 PRT Arabidopsis Paralogousto G2586, G2686 thaliana 457 G265 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G261 thaliana 458 G265 PRT ArabidopsisParalogous to G261 thaliana 459 G2657 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1070; thaliana orthologous toG3404, G3405 460 G2657 PRT Arabidopsis Paralogous to G1070; Orthologousto G3404, G3405 thaliana 461 G2665 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G367 thaliana 462 G2665 PRT ArabidopsisParalogous to G367 thaliana 463 G2721 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1789, G1911, thaliana G997 464G2721 PRT Arabidopsis Paralogous to G1789, G1911, G997 thaliana 465G2779 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG2859 thaliana 466 G2779 PRT Arabidopsis Paralogous to G2859 thaliana467 G278 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1290 thaliana 468 G278 PRT Arabidopsis Paralogous to G1290 thaliana 469G29 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1419, G43, thaliana G46, G1004; orthologous to G3849 470 G29 PRTArabidopsis Paralogous to G1419, G43, G46, G1004; Orthologous to G3849thaliana 471 G2989 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G2990; thaliana orthologous to G3680, G3681, G3691, G3859,G3860, G3861, G3934 472 G2989 PRT Arabidopsis Paralogous to G2990;Orthologous to G3680, G3681, G3691, thaliana G3859, G3860, G3861, G3934473 G30 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1791, G1792, thaliana G1795; orthologous to G3380, G3381, G3383, G3515,G3516, G3517, G3518, G3519, G3520, G3735, G3736, G3737, G3794, G3739,G3929, G4328, G4329, G4330 474 G30 PRT Arabidopsis Paralogous to G1791,G1792, G1795; Orthologous to G3380, thaliana G3381, G3383, G3515, G3516,G3517, G3518, G3519, G3520, G3735, G3736, G3737, G3794, G3739, G3929,G4328, G4329, G4330 475 G3079 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G3080 thaliana 476 G3079 PRT ArabidopsisParalogous to G3080 thaliana 477 G3380 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3381, G3383, G3515, G3737;orthologous to G1791, G1792, G1795, G30, G3516, G3517, G3518, G3519,G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329, G4330 478 G3380PRT Oryza sativa Paralogous to G3381, G3383, G3515, G3737; Orthologousto G1791, G1792, G1795, G30, G3516, G3517, G3518, G3519, G3520, G3735,G3736, G3794, G3739, G3929, G4328, G4329, G4330 479 G3381 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3380, G3383,G3515, G3737; orthologous to G1791, G1792, G1795, G30, G3516, G3517,G3518, G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329,G4330 480 G3381 PRT Oryza sativa Paralogous to G3380, G3383, G3515,G3737; Orthologous to G1791, G1792, G1795, G30, G3516, G3517, G3518,G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329, G4330 481G3383 DNA Oryza sativa Predicted polypeptide sequence is paralogous toG3380, G3381, G3515, G3737; orthologous to G1791, G1792, G1795, G30,G3516, G3517, G3518, G3519, G3520, G3735, G3736, G3794, G3739, G3929,G4328, G4329, G4330 482 G3383 PRT Oryza sativa Paralogous to G3380,G3381, G3515, G3737; Orthologous to G1791, G1792, G1795, G30, G3516,G3517, G3518, G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328,G4329, G4330 483 G3384 DNA Oryza sativa Predicted polypeptide sequenceis paralogous to G3385, G3386, G3502; orthologous to G256, G666, G668,G932, G3500, G3501, G3537, G3538, G3539, G3540, G3541 484 G3384 PRTOryza sativa Paralogous to G3385, G3386, G3502; Orthologous to G256,G666, G668, G932, G3500, G3501, G3537, G3538, G3539, G3540, G3541 485G3385 DNA Oryza sativa Predicted polypeptide sequence is paralogous toG3384, G3386, G3502; orthologous to G256, G666, G668, G932, G3500,G3501, G3537, G3538, G3539, G3540, G3541 486 G3385 PRT Oryza sativaParalogous to G3384, G3386, G3502; Orthologous to G256, G666, G668,G932, G3500, G3501, G3537, G3538, G3539, G3540, G3541 487 G3386 DNAOryza sativa Predicted polypeptide sequence is paralogous to G3384,G3385, G3502; orthologous to G256, G666, G668, G932, G3500, G3501,G3537, G3538, G3539, G3540, G3541 488 G3386 PRT Oryza sativa Paralogousto G3384, G3385, G3502; Orthologous to G256, G666, G668, G932, G3500,G3501, G3537, G3538, G3539, G3540, G3541 489 G3388 DNA Oryza sativaPredicted polypeptide sequence is paralogous to G3389, G3390, G3391;orthologous to G1930, G867, G9, G993, G3432, G3433, G3451, G3452, G3453,G3454, G3455 490 G3388 PRT Oryza sativa Paralogous to G3389, G3390,G3391; Orthologous to G1930, G867, G9, G993, G3432, G3433, G3451, G3452,G3453, G3454, G3455 491 G3389 DNA Oryza sativa Predicted polypeptidesequence is paralogous to G3388, G3390, G3391; orthologous to G1930,G867, G9, G993, G3432, G3433, G3451, G3452, G3453, G3454, G3455 492G3389 PRT Oryza sativa Paralogous to G3388, G3390, G3391; Orthologous toG1930, G867, G9, G993, G3432, G3433, G3451, G3452, G3453, G3454, G3455493 G3390 DNA Oryza sativa Predicted polypeptide sequence is paralogousto G3388, G3389, G3391; orthologous to G1930, G867, G9, G993, G3432,G3433, G3451, G3452, G3453, G3454, G3455 494 G3390 PRT Oryza sativaParalogous to G3388, G3389, G3391; Orthologous to G1930, G867, G9, G993,G3432, G3433, G3451, G3452, G3453, G3454, G3455 495 G3391 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3388, G3389,G3390; orthologous to G1930, G867, G9, G993, G3432, G3433, G3451, G3452,G3453, G3454, G3455 496 G3391 PRT Oryza sativa Paralogous to G3388,G3389, G3390; Orthologous to G1930, G867, G9, G993, G3432, G3433, G3451,G3452, G3453, G3454, G3455 497 G3394 DNA Oryza sativa Predictedpolypeptide sequence is orthologous to G1364, G2345, G481, G482, G485,G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3470,G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870,G3873, G3874, G3875, G3876, G3938, G4272, G4276 498 G3394 PRT Oryzasativa Orthologous to G1364, G2345, G481, G482, G485, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874,G3875, G3876, G3938, G4272, G4276 499 G3395 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3396, G3397, G3398, G3429, G3938;orthologous to G1364, G2345, G481, G482, G485, G3394, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G4272, G4276 500 G3395PRT Oryza sativa Paralogous to G3396, G3397, G3398, G3429, G3938;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G4272, G4276 501 G3396DNA Oryza sativa Predicted polypeptide sequence is paralogous to G3395,G3397, G3398, G3429, G3938; orthologous to G1364, G2345, G481, G482,G485, G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875,G3876, G4272, G4276 502 G3396 PRT Oryza sativa Paralogous to G3395,G3397, G3398, G3429, G3938; Orthologous to G1364, G2345, G481, G482,G485, G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875,G3876, G4272, G4276 503 G3397 DNA Oryza sativa Predicted polypeptidesequence is paralogous to G3395, G3396, G3398, G3429, G3938; orthologousto G1364, G2345, G481, G482, G485, G3394, G3434, G3435, G3436, G3437,G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866, G3868,G3870, G3873, G3874, G3875, G3876, G4272, G4276 504 G3397 PRT Oryzasativa Paralogous to G3395, G3396, G3398, G3429, G3938; Orthologous toG1364, G2345, G481, G482, G485, G3394, G3434, G3435, G3436, G3437,G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866, G3868,G3870, G3873, G3874, G3875, G3876, G4272, G4276 505 G3398 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3395, G3396,G3397, G3429, G3938; orthologous to G1364, G2345, G481, G482, G485,G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473, G3474,G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875, G3876,G4272, G4276 506 G3398 PRT Oryza sativa Paralogous to G3395, G3396,G3397, G3429, G3938; Orthologous to G1364, G2345, G481, G482, G485,G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473, G3474,G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875, G3876,G4272, G4276 507 G3404 DNA Oryza sativa Predicted polypeptide sequenceis paralogous to G3405; orthologous to G1070, G2657 508 G3404 PRT Oryzasativa Paralogous to G3405; Orthologous to G1070, G2657 509 G3405 DNAOryza sativa Predicted polypeptide sequence is paralogous to G3404;orthologous to G1070, G2657 510 G3405 PRT Oryza sativa Paralogous toG3404; Orthologous to G1070, G2657 511 G3406 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3407; orthologous to G1075,G1076, G3458, G3459, G3460, G3461 512 G3406 PRT Oryza sativa Paralogousto G3407; Orthologous to G1075, G1076, G3458, G3459, G3460, G3461 513G3407 DNA Oryza sativa Predicted polypeptide sequence is paralogous toG3406; orthologous to G1075, G1076, G3458, G3459, G3460, G3461 514 G3407PRT Oryza sativa Paralogous to G3406; Orthologous to G1075, G1076,G3458, G3459, G3460, G3461 515 G3429 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3395, G3396, G3397, G3398, G3938;orthologous to G1364, G2345, G481, G482, G485, G3394, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G4272, G4276 516 G3429PRT Oryza sativa Paralogous to G3395, G3396, G3397, G3398, G3938;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G4272, G4276 517 G3432DNA Zea mays Predicted polypeptide sequence is paralogous to G3433;orthologous to G1930, G867, G9, G993, G3388, G3389, G3390, G3391, G3451,G3452, G3453, G3454, G3455 518 G3432 PRT Zea mays Paralogous to G3433;Orthologous to G1930, G867, G9, G993, G3388, G3389, G3390, G3391, G3451,G3452, G3453, G3454, G3455 519 G3433 DNA Zea mays Predicted polypeptidesequence is paralogous to G3432; orthologous to G1930, G867, G9, G993,G3388, G3389, G3390, G3391, G3451, G3452, G3453, G3454, G3455 520 G3433PRT Zea mays Paralogous to G3432; Orthologous to G1930, G867, G9, G993,G3388, G3389, G3390, G3391, G3451, G3452, G3453, G3454, G3455 521 G3434DNA Zea mays Predicted polypeptide sequence is paralogous to G3435,G3436, G3437, G3866, G3876, G4272, G4276; orthologous to G1364, G2345,G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470,G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873,G3874, G3875, G3938 522 G3434 PRT Zea mays Paralogous to G3435, G3436,G3437, G3866, G3876, G4272, G4276; Orthologous to G1364, G2345, G481,G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470, G3471,G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873, G3874,G3875, G3938 523 G3435 DNA Zea mays Predicted polypeptide sequence isparalogous to G3434, G3436, G3437, G3866, G3876, G4272, G4276;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 524 G3435 PRT Zea maysParalogous to G3434, G3436, G3437, G3866, G3876, G4272, G4276;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 525 G3436 DNA Zea maysPredicted polypeptide sequence is paralogous to G3434, G3435, G3437,G3866, G3876, G4272, G4276; orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873, G3874, G3875,G3938 526 G3436 PRT Zea mays Paralogous to G3434, G3435, G3437, G3866,G3876, G4272, G4276; Orthologous to G1364, G2345, G481, G482, G485,G3394, G3395, G3396, G3397, G3398, G3429, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3868, G3870, G3873, G3874, G3875, G3938 527G3437 DNA Zea mays Predicted polypeptide sequence is paralogous toG3434, G3435, G3436, G3866, G3876, G4272, G4276; orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870,G3873, G3874, G3875, G3938 528 G3437 PRT Zea mays Paralogous to G3434,G3435, G3436, G3866, G3876, G4272, G4276; Orthologous to G1364, G2345,G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470,G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873,G3874, G3875, G3938 529 G3451 DNA Glycine max Predicted polypeptidesequence is paralogous to G3452, G3453, G3454, G3455; orthologous toG1930, G867, G9, G993, G3388, G3389, G3390, G3391, G3432, G3433 530G3451 PRT Glycine max Paralogous to G3452, G3453, G3454, G3455;Orthologous to G1930, G867, G9, G993, G3388, G3389, G3390, G3391, G3432,G3433 531 G3452 DNA Glycine max Predicted polypeptide sequence isparalogous to G3451, G3453, G3454, G3455; orthologous to G1930, G867,G9, G993, G3388, G3389, G3390, G3391, G3432, G3433 532 G3452 PRT Glycinemax Paralogous to G3451, G3453, G3454, G3455; Orthologous to G1930,G867, G9, G993, G3388, G3389, G3390, G3391, G3432, G3433 533 G3453 DNAGlycine max Predicted polypeptide sequence is paralogous to G3451,G3452, G3454, G3455; orthologous to G1930, G867, G9, G993, G3388, G3389,G3390, G3391, G3432, G3433 534 G3453 PRT Glycine max Paralogous toG3451, G3452, G3454, G3455; Orthologous to G1930, G867, G9, G993, G3388,G3389, G3390, G3391, G3432, G3433 535 G3454 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3451, G3452, G3453, G3455;orthologous to G1930, G867, G9, G993, G3388, G3389, G3390, G3391, G3432,G3433 536 G3454 PRT Glycine max Paralogous to G3451, G3452, G3453,G3455; Orthologous to G1930, G867, G9, G993, G3388, G3389, G3390, G3391,G3432, G3433 537 G3455 DNA Glycine max Predicted polypeptide sequence isparalogous to G3451, G3452, G3453, G3454; orthologous to G1930, G867,G9, G993, G3388, G3389, G3390, G3391, G3432, G3433 538 G3455 PRT Glycinemax Paralogous to G3451, G3452, G3453, G3454; Orthologous to G1930,G867, G9, G993, G3388, G3389, G3390, G3391, G3432, G3433 539 G3458 DNAGlycine max Predicted polypeptide sequence is paralogous to G3459,G3460, G3461; orthologous to G1075, G1076, G3406, G3407 540 G3458 PRTGlycine max Paralogous to G3459, G3460, G3461; Orthologous to G1075,G1076, G3406, G3407 541 G3459 DNA Glycine max Predicted polypeptidesequence is paralogous to G3458, G3460, G3461; orthologous to G1075,G1076, G3406, G3407 542 G3459 PRT Glycine max Paralogous to G3458,G3460, G3461; Orthologous to G1075, G1076, G3406, G3407 543 G3460 DNAGlycine max Predicted polypeptide sequence is paralogous to G3458,G3459, G3461; orthologous to G1075, G1076, G3406, G3407 544 G3460 PRTGlycine max Paralogous to G3458, G3459, G3461; Orthologous to G1075,G1076, G3406, G3407 545 G3461 DNA Glycine max Predicted polypeptidesequence is paralogous to G3458, G3459, G3460; orthologous to G1075,G1076, G3406, G3407 546 G3461 PRT Glycine max Paralogous to G3458,G3459, G3460; Orthologous to G1075, G1076, G3406, G3407 547 G3470 DNAGlycine max Predicted polypeptide sequence is paralogous to G3471,G3472, G3473, G3474, G3475, G3476, G3478, G3873, G3874, G3875;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 548 G3470 PRT Glycine max Paralogous toG3471, G3472, G3473, G3474, G3475, G3476, G3478, G3873, G3874, G3875;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 549 G3471 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3470, G3472, G3473, G3474, G3475,G3476, G3478, G3873, G3874, G3875; orthologous to G1364, G2345, G481,G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 550 G3471PRT Glycine max Paralogous to G3470, G3472, G3473, G3474, G3475, G3476,G3478, G3873, G3874, G3875; Orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 551 G3472 DNAGlycine max Predicted polypeptide sequence is paralogous to G3470,G3471, G3473, G3474, G3475, G3476, G3478, G3873, G3874, G3875;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 552 G3472 PRT Glycine max Paralogous toG3470, G3471, G3473, G3474, G3475, G3476, G3478, G3873, G3874, G3875;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 553 G3473 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3470, G3471, G3472, G3474, G3475,G3476, G3478, G3873, G3874, G3875; orthologous to G1364, G2345, G481,G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 554 G3473PRT Glycine max Paralogous to G3470, G3471, G3472, G3474, G3475, G3476,G3478, G3873, G3874, G3875; Orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 555 G3474 DNAGlycine max Predicted polypeptide sequence is paralogous to G3470,G3471, G3472, G3473, G3475, G3476, G3478, G3873, G3874, G3875;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 556 G3474 PRT Glycine max Paralogous toG3470, G3471, G3472, G3473, G3475, G3476, G3478, G3873, G3874, G3875;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 557 G3475 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3470, G3471, G3472, G3473, G3474,G3476, G3478, G3873, G3874, G3875; orthologous to G1364, G2345, G481,G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 558 G3475PRT Glycine max Paralogous to G3470, G3471, G3472, G3473, G3474, G3476,G3478, G3873, G3874, G3875; Orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 559 G3476 DNAGlycine max Predicted polypeptide sequence is paralogous to G3470,G3471, G3472, G3473, G3474, G3475, G3478, G3873, G3874, G3875;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 560 G3476 PRT Glycine max Paralogous toG3470, G3471, G3472, G3473, G3474, G3475, G3478, G3873, G3874, G3875;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866, G3868, G3870,G3876, G3938, G4272, G4276 561 G3478 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3470, G3471, G3472, G3473, G3474,G3475, G3476, G3873, G3874, G3875; orthologous to G1364, G2345, G481,G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 562 G3478PRT Glycine max Paralogous to G3470, G3471, G3472, G3473, G3474, G3475,G3476, G3873, G3874, G3875; Orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3866, G3868, G3870, G3876, G3938, G4272, G4276 563 G3479 DNAOryza sativa Predicted polypeptide sequence is paralogous to G3480,G3481, G3482, G3483; orthologous to G152, G153, G1760, G860, G3484,G3485, G3487, G3488, G3489, G3980, G3981, G3982 564 G3479 PRT Oryzasativa Paralogous to G3480, G3481, G3482, G3483; Orthologous to G152,G153, G1760, G860, G3484, G3485, G3487, G3488, G3489, G3980, G3981,G3982 565 G3480 DNA Oryza sativa Predicted polypeptide sequence isparalogous to G3479, G3481, G3482, G3483; orthologous to G152, G153,G1760, G860, G3484, G3485, G3487, G3488, G3489, G3980, G3981, G3982 566G3480 PRT Oryza sativa Paralogous to G3479, G3481, G3482, G3483;Orthologous to G152, G153, G1760, G860, G3484, G3485, G3487, G3488,G3489, G3980, G3981, G3982 567 G3481 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3479, G3480, G3482, G3483;orthologous to G152, G153, G1760, G860, G3484, G3485, G3487, G3488,G3489, G3980, G3981, G3982 568 G3481 PRT Oryza sativa Paralogous toG3479, G3480, G3482, G3483; Orthologous to G152, G153, G1760, G860,G3484, G3485, G3487, G3488, G3489, G3980, G3981, G3982 569 G3482 DNAOryza sativa Predicted polypeptide sequence is paralogous to G3479,G3480, G3481, G3483; orthologous to G152, G153, G1760, G860, G3484,G3485, G3487, G3488, G3489, G3980, G3981, G3982 570 G3482 PRT Oryzasativa Paralogous to G3479, G3480, G3481, G3483; Orthologous to G152,G153, G1760, G860, G3484, G3485, G3487, G3488, G3489, G3980, G3981,G3982 571 G3483 DNA Oryza sativa Predicted polypeptide sequence isparalogous to G3479, G3480, G3481, G3482; orthologous to G152, G153,G1760, G860, G3484, G3485, G3487, G3488, G3489, G3980, G3981, G3982 572G3483 PRT Oryza sativa Paralogous to G3479, G3480, G3481, G3482;Orthologous to G152, G153, G1760, G860, G3484, G3485, G3487, G3488,G3489, G3980, G3981, G3982 573 G3484 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3485, G3980, G3981; orthologousto G152, G153, G1760, G860, G3479, G3480, G3481, G3482, G3483, G3487,G3488, G3489, G3982 574 G3484 PRT Glycine max Paralogous to G3485,G3980, G3981; Orthologous to G152, G153, G1760, G860, G3479, G3480,G3481, G3482, G3483, G3487, G3488, G3489, G3982 575 G3485 DNA Glycinemax Predicted polypeptide sequence is paralogous to G3484, G3980, G3981;orthologous to G152, G153, G1760, G860, G3479, G3480, G3481, G3482,G3483, G3487, G3488, G3489, G3982 576 G3485 PRT Glycine max Paralogousto G3484, G3980, G3981; Orthologous to G152, G153, G1760, G860, G3479,G3480, G3481, G3482, G3483, G3487, G3488, G3489, G3982 577 G3487 DNA Zeamays Predicted polypeptide sequence is paralogous to G3488, G3489;orthologous to G152, G153, G1760, G860, G3479, G3480, G3481, G3482,G3483, G3484, G3485, G3980, G3981, G3982 578 G3487 PRT Zea maysParalogous to G3488, G3489; Orthologous to G152, G153, G1760, G860,G3479, G3480, G3481, G3482, G3483, G3484, G3485, G3980, G3981, G3982 579G3488 DNA Zea mays Predicted polypeptide sequence is paralogous toG3487, G3489; orthologous to G152, G153, G1760, G860, G3479, G3480,G3481, G3482, G3483, G3484, G3485, G3980, G3981, G3982 580 G3488 PRT Zeamays Paralogous to G3487, G3489; Orthologous to G152, G153, G1760, G860,G3479, G3480, G3481, G3482, G3483, G3484, G3485, G3980, G3981, G3982 581G3489 DNA Zea mays Predicted polypeptide sequence is paralogous toG3487, G3488; orthologous to G152, G153, G1760, G860, G3479, G3480,G3481, G3482, G3483, G3484, G3485, G3980, G3981, G3982 582 G3489 PRT Zeamays Paralogous to G3487, G3488; Orthologous to G152, G153, G1760, G860,G3479, G3480, G3481, G3482, G3483, G3484, G3485, G3980, G3981, G3982 583G3490 DNA Zea mays Predicted polypeptide sequence is orthologous toG1543, G3510, G3524, G4371 584 G3490 PRT Zea mays Orthologous to G1543,G3510, G3524, G4371 585 G3500 DNA Solanum Predicted polypeptide sequenceis paralogous to G3501; lycopersicum orthologous to G256, G666, G668,G932, G3384, G3385, G3386, G3502, G3537, G3538, G3539, G3540, G3541 586G3500 PRT Solanum Paralogous to G3501; Orthologous to G256, G666, G668,G932, lycopersicum G3384, G3385, G3386, G3502, G3537, G3538, G3539,G3540, G3541 587 G3501 DNA Solanum Predicted polypeptide sequence isparalogous to G3500; lycopersicum orthologous to G256, G666, G668, G932,G3384, G3385, G3386, G3502, G3537, G3538, G3539, G3540, G3541 588 G3501PRT Solanum Paralogous to G3500; Orthologous to G256, G666, G668, G932,lycopersicum G3384, G3385, G3386, G3502, G3537, G3538, G3539, G3540,G3541 589 G3502 DNA Oryza sativa Predicted polypeptide sequence isparalogous to G3384, G3385, G3386; orthologous to G256, G666, G668,G932, G3500, G3501, G3537, G3538, G3539, G3540, G3541 590 G3502 PRTOryza sativa Paralogous to G3384, G3385, G3386; Orthologous to G256,G666, G668, G932, G3500, G3501, G3537, G3538, G3539, G3540, G3541 591G351 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG350, G545 thaliana 592 G351 PRT Arabidopsis Paralogous to G350, G545thaliana 593 G3510 DNA Oryza sativa Predicted polypeptide sequence isorthologous to G1543, G3490, G3524, G4371 594 G3510 PRT Oryza sativaOrthologous to G1543, G3490, G3524, G4371 595 G3515 DNA Oryza sativaPredicted polypeptide sequence is paralogous to G3380, G3381, G3383,G3737; orthologous to G1791, G1792, G1795, G30, G3516, G3517, G3518,G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329, G4330 596G3515 PRT Oryza sativa Paralogous to G3380, G3381, G3383, G3737;Orthologous to G1791, G1792, G1795, G30, G3516, G3517, G3518, G3519,G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329, G4330 597 G3516DNA Zea mays Predicted polypeptide sequence is paralogous to G3517,G3794, G3739, G3929; orthologous to G1791, G1792, G1795, G30, G3380,G3381, G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737, G4328,G4329, G4330 598 G3516 PRT Zea mays Paralogous to G3517, G3794, G3739,G3929; Orthologous to G1791, G1792, G1795, G30, G3380, G3381, G3383,G3515, G3518, G3519, G3520, G3735, G3736, G3737, G4328, G4329, G4330 599G3517 DNA Zea mays Predicted polypeptide sequence is paralogous toG3516, G3794, G3739, G3929; orthologous to G1791, G1792, G1795, G30,G3380, G3381, G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737,G4328, G4329, G4330 600 G3517 PRT Zea mays Paralogous to G3516, G3794,G3739, G3929; Orthologous to G1791, G1792, G1795, G30, G3380, G3381,G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737, G4328, G4329,G4330 601 G3518 DNA Glycine max Predicted polypeptide sequence isparalogous to G3519, G3520; orthologous to G1791, G1792, G1795, G30,G3380, G3381, G3383, G3515, G3516, G3517, G3735, G3736, G3737, G3794,G3739, G3929, G4328, G4329, G4330 602 G3518 PRT Glycine max Paralogousto G3519, G3520; Orthologous to G1791, G1792, G1795, G30, G3380, G3381,G3383, G3515, G3516, G3517, G3735, G3736, G3737, G3794, G3739, G3929,G4328, G4329, G4330 603 G3519 DNA Glycine max Predicted polypeptidesequence is paralogous to G3518, G3520; orthologous to G1791, G1792,G1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3735, G3736,G3737, G3794, G3739, G3929, G4328, G4329, G4330 604 G3519 PRT Glycinemax Paralogous to G3518, G3520; Orthologous to G1791, G1792, G1795, G30,G3380, G3381, G3383, G3515, G3516, G3517, G3735, G3736, G3737, G3794,G3739, G3929, G4328, G4329, G4330 605 G3520 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3518, G3519; orthologous toG1791, G1792, G1795, G30, G3380, G3381, G3383, G3515, G3516, G3517,G3735, G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 606 G3520PRT Glycine max Paralogous to G3518, G3519; Orthologous to G1791, G1792,G1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3735, G3736,G3737, G3794, G3739, G3929, G4328, G4329, G4330 607 G3524 DNA Glycinemax Predicted polypeptide sequence is paralogous to G4371; orthologousto G1543, G3510, G3490 608 G3524 PRT Glycine max Paralogous to G4371;Orthologous to G1543, G3510, G3490 609 G3537 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3538, G3539; orthologous to G256,G666, G668, G932, G3384, G3385, G3386, G3500, G3501, G3502, G3540, G3541610 G3537 PRT Glycine max Paralogous to G3538, G3539; Orthologous toG256, G666, G668, G932, G3384, G3385, G3386, G3500, G3501, G3502, G3540,G3541 611 G3538 DNA Glycine max Predicted polypeptide sequence isparalogous to G3537, G3539; orthologous to G256, G666, G668, G932,G3384, G3385, G3386, G3500, G3501, G3502, G3540, G3541 612 G3538 PRTGlycine max Paralogous to G3537, G3539; Orthologous to G256, G666, G668,G932, G3384, G3385, G3386, G3500, G3501, G3502, G3540, G3541 613 G3539DNA Glycine max Predicted polypeptide sequence is paralogous to G3537,G3538; orthologous to G256, G666, G668, G932, G3384, G3385, G3386,G3500, G3501, G3502, G3540, G3541 614 G3539 PRT Glycine max Paralogousto G3537, G3538; Orthologous to G256, G666, G668, G932, G3384, G3385,G3386, G3500, G3501, G3502, G3540, G3541 615 G3540 DNA Zea maysPredicted polypeptide sequence is paralogous to G3541; orthologous toG256, G666, G668, G932, G3384, G3385, G3386, G3500, G3501, G3502, G3537,G3538, G3539 616 G3540 PRT Zea mays Paralogous to G3541; Orthologous toG256, G666, G668, G932, G3384, G3385, G3386, G3500, G3501, G3502, G3537,G3538, G3539 617 G3541 DNA Zea mays Predicted polypeptide sequence isparalogous to G3540; orthologous to G256, G666, G668, G932, G3384,G3385, G3386, G3500, G3501, G3502, G3537, G3538, G3539 618 G3541 PRT Zeamays Paralogous to G3540; Orthologous to G256, G666, G668, G932, G3384,G3385, G3386, G3500, G3501, G3502, G3537, G3538, G3539 619 G3643 DNAGlycine max Predicted polypeptide sequence is orthologous to G2133, G47,G3644, G3645, G3646, G3647, G3649, G3650, G3651 620 G3643 PRT Glycinemax Orthologous to G2133, G47, G3644, G3645, G3646, G3647, G3649, G3650,G3651 621 G3644 DNA Oryza sativa Predicted polypeptide sequence isparalogous to G3649, G3651; orthologous to G2133, G47, G3643, G3645,G3646, G3647, G3650 622 G3644 PRT Oryza sativa Paralogous to G3649,G3651; Orthologous to G2133, G47, G3643, G3645, G3646, G3647, G3650 623G3645 DNA Brassica rapa Predicted polypeptide sequence is orthologous toG2133, G47, subsp. G3643, G3644, G3646, G3647, G3649, G3650, G3651Pekinensis 624 G3645 PRT Brassica rapa Orthologous to G2133, G47, G3643,G3644, G3646, G3647, subsp. G3649, G3650, G3651 Pekinensis 625 G3646 DNABrassica Predicted polypeptide sequence is orthologous to G2133, G47,oleracea G3643, G3644, G3645, G3647, G3649, G3650, G3651 626 G3646 PRTBrassica Orthologous to G2133, G47, G3643, G3644, G3645, G3647, oleraceaG3649, G3650, G3651 627 G3647 DNA Zinnia elegans Predicted polypeptidesequence is orthologous to G2133, G47, G3643, G3644, G3645, G3646,G3649, G3650, G3651 628 G3647 PRT Zinnia elegans Orthologous to G2133,G47, G3643, G3644, G3645, G3646, G3649, G3650, G3651 629 G3649 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3644, G3651;orthologous to G2133, G47, G3643, G3645, G3646, G3647, G3650 630 G3649PRT Oryza sativa Paralogous to G3644, G3651; Orthologous to G2133, G47,G3643, G3645, G3646, G3647, G3650 631 G3650 DNA Zea mays Predictedpolypeptide sequence is orthologous to G2133, G47, G3643, G3644, G3645,G3646, G3647, G3649, G3651 632 G3650 PRT Zea mays Orthologous to G2133,G47, G3643, G3644, G3645, G3646, G3647, G3649, G3651 633 G3651 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3644, G3649;orthologous to G2133, G47, G3643, G3645, G3646, G3647, G3650 634 G3651PRT Oryza sativa Paralogous to G3644, G3649; Orthologous to G2133, G47,G3643, G3645, G3646, G3647, G3650 635 G3656 DNA Zea mays Predictedpolypeptide sequence is orthologous to G12, G1277, G1379, G24 636 G3656PRT Zea mays Orthologous to G12, G1277, G1379, G24 637 G3680 DNA Zeamays Predicted polypeptide sequence is paralogous to G3681; orthologousto G2989, G2990, G3691, G3859, G3860, G3861, G3934 638 G3680 PRT Zeamays Paralogous to G3681; Orthologous to G2989, G2990, G3691, G3859,G3860, G3861, G3934 639 G3681 DNA Zea mays Predicted polypeptidesequence is paralogous to G3680; orthologous to G2989, G2990, G3691,G3859, G3860, G3861, G3934 640 G3681 PRT Zea mays Paralogous to G3680;Orthologous to G2989, G2990, G3691, G3859, G3860, G3861, G3934 641 G3691DNA Oryza sativa Predicted polypeptide sequence is orthologous to G2989,G2990, G3680, G3681, G3859, G3860, G3861, G3934 642 G3691 PRT Oryzasativa Orthologous to G2989, G2990, G3680, G3681, G3859, G3860, G3861,G3934 643 G3719 DNA Zea mays Predicted polypeptide sequence isparalogous to G3722, G3720, G3727, G3728, G3804; orthologous to G1274,G3723, G3724, G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729,G3730, G3733, G3795, G3797, G3802 644 G3719 PRT Zea mays Paralogous toG3722, G3720, G3727, G3728, G3804; Orthologous to G1274, G3723, G3724,G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729, G3730, G3733,G3795, G3797, G3802 645 G3720 DNA Zea mays Predicted polypeptidesequence is paralogous to G3722, G3719, G3727, G3728, G3804; orthologousto G1274, G3723, G3724, G3731, G3732, G3803, G1275, G3721, G3725, G3726,G3729, G3730, G3733, G3795, G3797, G3802 646 G3720 PRT Zea maysParalogous to G3722, G3719, G3727, G3728, G3804; Orthologous to G1274,G3723, G3724, G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729,G3730, G3733, G3795, G3797, G3802 647 G3721 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3725, G3726, G3729, G3730;orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275,G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802, G3804 648 G3721PRT Oryza sativa Paralogous to G3725, G3726, G3729, G3730; Orthologousto G1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275, G3719, G3720,G3727, G3728, G3733, G3795, G3797, G3802, G3804 649 G3722 DNA Zea maysPredicted polypeptide sequence is paralogous to G3719, G3720, G3727,G3728, G3804; orthologous to G1274, G3723, G3724, G3731, G3732, G3803,G1275, G3721, G3725, G3726, G3729, G3730, G3733, G3795, G3797, G3802 650G3722 PRT Zea mays Paralogous to G3719, G3720, G3727, G3728, G3804;Orthologous to G1274, G3723, G3724, G3731, G3732, G3803, G1275, G3721,G3725, G3726, G3729, G3730, G3733, G3795, G3797, G3802 651 G3723 DNAGlycine max Predicted polypeptide sequence is paralogous to G3724,G3803; orthologous to G1274, G3722, G3731, G3732, G1275, G3719, G3720,G3721, G3725, G3726, G3727, G3728, G3729, G3730, G3733, G3795, G3797,G3802, G3804 652 G3723 PRT Glycine max Paralogous to G3724, G3803;Orthologous to G1274, G3722, G3731, G3732, G1275, G3719, G3720, G3721,G3725, G3726, G3727, G3728, G3729, G3730, G3733, G3795, G3797, G3802,G3804 653 G3724 DNA Glycine max Predicted polypeptide sequence isparalogous to G3723, G3803; orthologous to G1274, G3722, G3731, G3732,G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728, G3729, G3730,G3733, G3795, G3797, G3802, G3804 654 G3724 PRT Glycine max Paralogousto G3723, G3803; Orthologous to G1274, G3722, G3731, G3732, G1275,G3719, G3720, G3721, G3725, G3726, G3727, G3728, G3729, G3730, G3733,G3795, G3797, G3802, G3804 655 G3725 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G3721, G3726, G3729, G3730;orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275,G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802, G3804 656 G3725PRT Oryza sativa Paralogous to G3721, G3726, G3729, G3730; Orthologousto G1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275, G3719, G3720,G3727, G3728, G3733, G3795, G3797, G3802, G3804 657 G3726 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3721, G3725,G3729, G3730; orthologous to G1274, G3722, G3723, G3724, G3731, G3732,G3803, G1275, G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802,G3804 658 G3726 PRT Oryza sativa Paralogous to G3721, G3725, G3729,G3730; Orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803,G1275, G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802, G3804 659G3727 DNA Zea mays Predicted polypeptide sequence is paralogous toG3722, G3719, G3720, G3728, G3804; orthologous to G1274, G3723, G3724,G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729, G3730, G3733,G3795, G3797, G3802 660 G3727 PRT Zea mays Paralogous to G3722, G3719,G3720, G3728, G3804; Orthologous to G1274, G3723, G3724, G3731, G3732,G3803, G1275, G3721, G3725, G3726, G3729, G3730, G3733, G3795, G3797,G3802 661 G3728 DNA Zea mays Predicted polypeptide sequence isparalogous to G3722, G3719, G3720, G3727, G3804; orthologous to G1274,G3723, G3724, G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729,G3730, G3733, G3795, G3797, G3802 662 G3728 PRT Zea mays Paralogous toG3722, G3719, G3720, G3727, G3804; Orthologous to G1274, G3723, G3724,G3731, G3732, G3803, G1275, G3721, G3725, G3726, G3729, G3730, G3733,G3795, G3797, G3802 663 G3729 DNA Oryza sativa Predicted polypeptidesequence is paralogous to G3721, G3725, G3726, G3730; orthologous toG1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275, G3719, G3720,G3727, G3728, G3733, G3795, G3797, G3802, G3804 664 G3729 PRT Oryzasativa Paralogous to G3721, G3725, G3726, G3730; Orthologous to G1274,G3722, G3723, G3724, G3731, G3732, G3803, G1275, G3719, G3720, G3727,G3728, G3733, G3795, G3797, G3802, G3804 665 G3730 DNA Oryza sativaPredicted polypeptide sequence is paralogous to G3721, G3725, G3726,G3729; orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803,G1275, G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802, G3804 666G3730 PRT Oryza sativa Paralogous to G3721, G3725, G3726, G3729;Orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803, G1275,G3719, G3720, G3727, G3728, G3733, G3795, G3797, G3802, G3804 667 G3731DNA Solanum Predicted polypeptide sequence is orthologous to G1274,G3722, lycopersicum G3723, G3724, G3732, G3803, G1275, G3719, G3720,G3721, G3725, G3726, G3727, G3728, G3729, G3730, G3733, G3795, G3797,G3802, G3804 668 G3731 PRT Solanum Orthologous to G1274, G3722, G3723,G3724, G3732, G3803, lycopersicum G1275, G3719, G3720, G3721, G3725,G3726, G3727, G3728, G3729, G3730, G3733, G3795, G3797, G3802, G3804 669G3732 DNA Solanum Predicted polypeptide sequence is orthologous toG1274, G3722, tuberosum G3723, G3724, G3731, G3803, G1275, G3719, G3720,G3721, G3725, G3726, G3727, G3728, G3729, G3730, G3733, G3795, G3797,G3802, G3804 670 G3732 PRT Solanum Orthologous to G1274, G3722, G3723,G3724, G3731, G3803, tuberosum G1275, G3719, G3720, G3721, G3725, G3726,G3727, G3728, G3729, G3730, G3733, G3795, G3797, G3802, G3804 671 G3733DNA Hordeum Predicted polypeptide sequence is orthologous to G1274,G3722, vulgare G3723, G3724, G3731, G3732, G3803, G1275, G3719, G3720,G3721, G3725, G3726, G3727, G3728, G3729, G3730, G3795, G3797, G3802,G3804 672 G3733 PRT Hordeum Orthologous to G1274, G3722, G3723, G3724,G3731, G3732, vulgare G3803, G1275, G3719, G3720, G3721, G3725, G3726,G3727, G3728, G3729, G3730, G3795, G3797, G3802, G3804 673 G3735 DNAMedicago Predicted polypeptide sequence is orthologous to G1791, G1792,truncatula G1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3518,G3519, G3520, G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 674G3735 PRT Medicago Orthologous to G1791, G1792, G1795, G30, G3380,G3381, truncatula G3383, G3515, G3516, G3517, G3518, G3519, G3520,G3736, G3737, G3794, G3739, G3929, G4328, G4329, G4330 675 G3736 DNATriticum Predicted polypeptide sequence is orthologous to G1791, G1792,aestivum G1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3518,G3519, G3520, G3735, G3737, G3794, G3739, G3929, G4328, G4329, G4330 676G3736 PRT Triticum Orthologous to G1791, G1792, G1795, G30, G3380,G3381, aestivum G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735,G3737, G3794, G3739, G3929, G4328, G4329, G4330 677 G3737 DNA Oryzasativa Predicted polypeptide sequence is paralogous to G3380, G3381,G3383, G3515; orthologous to G1791, G1792, G1795, G30, G3516, G3517,G3518, G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329,G4330 678 G3737 PRT Oryza sativa Paralogous to G3380, G3381, G3383,G3515; Orthologous to G1791, G1792, G1795, G30, G3516, G3517, G3518,G3519, G3520, G3735, G3736, G3794, G3739, G3929, G4328, G4329, G4330 679G3739 DNA Zea mays Predicted polypeptide sequence is paralogous toG3516, G3517, G3794, G3929; orthologous to G1791, G1792, G1795, G30,G3380, G3381, G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737,G4328, G4329, G4330 680 G3739 PRT Zea mays Paralogous to G3516, G3517,G3794, G3929; Orthologous to G1791, G1792, G1795, G30, G3380, G3381,G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737, G4328, G4329,G4330 681 G3794 DNA Zea mays Predicted polypeptide sequence isparalogous to G3516, G3517, G3739, G3929; orthologous to G1791, G1792,G1795, G30, G3380, G3381, G3383, G3515, G3518, G3519, G3520, G3735,G3736, G3737, G4328, G4329, G4330 682 G3794 PRT Zea mays Paralogous toG3516, G3517, G3739, G3929; Orthologous to G1791, G1792, G1795, G30,G3380, G3381, G3383, G3515, G3518, G3519, G3520, G3735, G3736, G3737,G4328, G4329, G4330 683 G3795 DNA Capsicum Predicted polypeptidesequence is orthologous to G1274, G3722, annuum G3723, G3724, G3731,G3732, G3803, G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728,G3729, G3730, G3733, G3797, G3802, G3804 684 G3795 PRT CapsicumOrthologous to G1274, G3722, G3723, G3724, G3731, G3732, annuum G3803,G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728, G3729, G3730,G3733, G3797, G3802, G3804 685 G3797 DNA Lactuca sativa Predictedpolypeptide sequence is orthologous to G1274, G3722, G3723, G3724,G3731, G3732, G3803, G1275, G3719, G3720, G3721, G3725, G3726, G3727,G3728, G3729, G3730, G3733, G3795, G3802, G3804 686 G3797 PRT Lactucasativa Orthologous to G1274, G3722, G3723, G3724, G3731, G3732, G3803,G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728, G3729, G3730,G3733, G3795, G3802, G3804 687 G3802 DNA Sorghum Predicted polypeptidesequence is orthologous to G1274, G3722, bicolor G3723, G3724, G3731,G3732, G3803, G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728,G3729, G3730, G3733, G3795, G3797, G3804 688 G3802 PRT SorghumOrthologous to G1274, G3722, G3723, G3724, G3731, G3732, bicolor G3803,G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728, G3729, G3730,G3733, G3795, G3797, G3804 689 G3803 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3723, G3724; orthologous toG1274, G3722, G3731, G3732, G1275, G3719, G3720, G3721, G3725, G3726,G3727, G3728, G3729, G3730, G3733, G3795, G3797, G3802, G3804 690 G3803PRT Glycine max Paralogous to G3723, G3724; Orthologous to G1274, G3722,G3731, G3732, G1275, G3719, G3720, G3721, G3725, G3726, G3727, G3728,G3729, G3730, G3733, G3795, G3797, G3802, G3804 691 G3804 DNA Zea maysPredicted polypeptide sequence is paralogous to G3722, G3719, G3720,G3727, G3728; orthologous to G1274, G3723, G3724, G3731, G3732, G3803,G1275, G3721, G3725, G3726, G3729, G3730, G3733, G3795, G3797, G3802 692G3804 PRT Zea mays Paralogous to G3722, G3719, G3720, G3727, G3728;Orthologous to G1274, G3723, G3724, G3731, G3732, G3803, G1275, G3721,G3725, G3726, G3729, G3730, G3733, G3795, G3797, G3802 693 G3809 DNAOryza sativa Predicted polypeptide sequence is orthologous to G1425,G1454, G504 694 G3809 PRT Oryza sativa Orthologous to G1425, G1454, G504695 G3849 DNA Solanum Predicted polypeptide sequence is orthologous toG1419, G43, lycopersicum G46, G1004, G29 696 G3849 PRT SolanumOrthologous to G1419, G43, G46, G1004, G29 lycopersicum 697 G3859 DNAFlaveria Predicted polypeptide sequence is orthologous to G2989, G2990,trinervia G3680, G3681, G3691, G3860, G3861, G3934 698 G3859 PRTFlaveria Orthologous to G2989, G2990, G3680, G3681, G3691, G3860,trinervia G3861, G3934 699 G3860 DNA Flaveria Predicted polypeptidesequence is paralogous to G3861; bidentis orthologous to G2989, G2990,G3680, G3681, G3691, G3859, G3934 700 G3860 PRT Flaveria Paralogous toG3861; Orthologous to G2989, G2990, G3680, bidentis G3681, G3691, G3859,G3934 701 G3861 DNA Flaveria Predicted polypeptide sequence isparalogous to G3860; bidentis orthologous to G2989, G2990, G3680, G3681,G3691, G3859, G3934 702 G3861 PRT Flaveria Paralogous to G3860;Orthologous to G2989, G2990, G3680, bidentis G3681, G3691, G3859, G3934703 G3866 DNA Zea mays Predicted polypeptide sequence is paralogous toG3434, G3435, G3436, G3437, G3876, G4272, G4276; orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870,G3873, G3874, G3875, G3938 704 G3866 PRT Zea mays Paralogous to G3434,G3435, G3436, G3437, G3876, G4272, G4276; Orthologous to G1364, G2345,G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470,G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873,G3874, G3875, G3938 705 G3868 DNA Physcomitrella Predicted polypeptidesequence is paralogous to G3870; patens orthologous to G1364, G2345,G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434,G3435, G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3866, G3873, G3874, G3875, G3876, G3938, G4272, G4276 706 G3868PRT Physcomitrella Paralogous to G3870; Orthologous to G1364, G2345,G481, patens G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475,G3476, G3478, G3866, G3873, G3874, G3875, G3876, G3938, G4272, G4276 707G3870 DNA Physcomitrella Predicted polypeptide sequence is paralogous toG3868; patens orthologous to G1364, G2345, G481, G482, G485, G3394,G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3470,G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866, G3873, G3874,G3875, G3876, G3938, G4272, G4276 708 G3870 PRT PhyscomitrellaParalogous to G3868; Orthologous to G1364, G2345, G481, patens G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436,G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478, G3866,G3873, G3874, G3875, G3876, G3938, G4272, G4276 709 G3873 DNA Glycinemax Predicted polypeptide sequence is paralogous to G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3874, G3875; orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3434, G3435, G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272,G4276 710 G3873 PRT Glycine max Paralogous to G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3874, G3875; Orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3434, G3435, G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272,G4276 711 G3874 DNA Glycine max Predicted polypeptide sequence isparalogous to G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3873, G3875; orthologous to G1364, G2345, G481, G482, G485, G3394,G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866,G3868, G3870, G3876, G3938, G4272, G4276 712 G3874 PRT Glycine maxParalogous to G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3873, G3875; Orthologous to G1364, G2345, G481, G482, G485, G3394,G3395, G3396, G3397, G3398, G3429, G3434, G3435, G3436, G3437, G3866,G3868, G3870, G3876, G3938, G4272, G4276 713 G3875 DNA Glycine maxPredicted polypeptide sequence is paralogous to G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3873, G3874; orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3434, G3435, G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272,G4276 714 G3875 PRT Glycine max Paralogous to G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3873, G3874; Orthologous to G1364,G2345, G481, G482, G485, G3394, G3395, G3396, G3397, G3398, G3429,G3434, G3435, G3436, G3437, G3866, G3868, G3870, G3876, G3938, G4272,G4276 715 G3876 DNA Zea mays Predicted polypeptide sequence isparalogous to G3434, G3435, G3436, G3437, G3866, G4272, G4276;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 716 G3876 PRT Zea maysParalogous to G3434, G3435, G3436, G3437, G3866, G4272, G4276;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 717 G3929 DNA Zea maysPredicted polypeptide sequence is paralogous to G3516, G3517, G3794,G3739; orthologous to G1791, G1792, G1795, G30, G3380, G3381, G3383,G3515, G3518, G3519, G3520, G3735, G3736, G3737, G4328, G4329, G4330 718G3929 PRT Zea mays Paralogous to G3516, G3517, G3794, G3739; Orthologousto G1791, G1792, G1795, G30, G3380, G3381, G3383, G3515, G3518, G3519,G3520, G3735, G3736, G3737, G4328, G4329, G4330 719 G3934 DNA Glycinemax Predicted polypeptide sequence is orthologous to G2989, G2990,G3680, G3681, G3691, G3859, G3860, G3861 720 G3934 PRT Glycine maxOrthologous to G2989, G2990, G3680, G3681, G3691, G3859, G3860, G3861721 G3938 DNA Oryza sativa Predicted polypeptide sequence is paralogousto G3395, G3396, G3397, G3398, G3429; orthologous to G1364, G2345, G481,G482, G485, G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874,G3875, G3876, G4272, G4276 722 G3938 PRT Oryza sativa Paralogous toG3395, G3396, G3397, G3398, G3429; Orthologous to G1364, G2345, G481,G482, G485, G3394, G3434, G3435, G3436, G3437, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874,G3875, G3876, G4272, G4276 723 G3980 DNA Glycine max Predictedpolypeptide sequence is paralogous to G3484, G3485, G3981; orthologousto G152, G153, G1760, G860, G3479, G3480, G3481, G3482, G3483, G3487,G3488, G3489, G3982 724 G3980 PRT Glycine max Paralogous to G3484,G3485, G3981; Orthologous to G152, G153, G1760, G860, G3479, G3480,G3481, G3482, G3483, G3487, G3488, G3489, G3982 725 G3981 DNA Glycinemax Predicted polypeptide sequence is paralogous to G3484, G3485, G3980;orthologous to G152, G153, G1760, G860, G3479, G3480, G3481, G3482,G3483, G3487, G3488, G3489, G3982 726 G3981 PRT Glycine max Paralogousto G3484, G3485, G3980; Orthologous to G152, G153, G1760, G860, G3479,G3480, G3481, G3482, G3483, G3487, G3488, G3489, G3982 727 G3982 DNAAntirrhinum Predicted polypeptide sequence is orthologous to G152, G153,majus G1760, G860, G3479, G3480, G3481, G3482, G3483, G3484, G3485,G3487, G3488, G3489, G3980, G3981 728 G3982 PRT Antirrhinum Orthologousto G152, G153, G1760, G860, G3479, G3480, majus G3481, G3482, G3483,G3484, G3485, G3487, G3488, G3489, G3980, G3981 729 G399 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G398, G964 thaliana 730G399 PRT Arabidopsis Paralogous to G398, G964 thaliana 731 G4061 DNASolanum Predicted polypeptide sequence is orthologous to G149, G627,lycopersicum G1011, G154, G1797, G1798, G4062, G4063, G4064, G4065,G4066, G4067 732 G4061 PRT Solanum Orthologous to G149, G627, G1011,G154, G1797, G1798, lycopersicum G4062, G4063, G4064, G4065, G4066,G4067 733 G4062 DNA Brassica rapa Predicted polypeptide sequence isorthologous to G149, G627, G1011, G154, G1797, G1798, G4061, G4063,G4064, G4065, G4066, G4067 734 G4062 PRT Brassica rapa Orthologous toG149, G627, G1011, G154, G1797, G1798, G4061, G4063, G4064, G4065,G4066, G4067 735 G4063 DNA Glycine max Predicted polypeptide sequence isparalogous to G4064; orthologous to G149, G627, G1011, G154, G1797,G1798, G4061, G4062, G4065, G4066, G4067 736 G4063 PRT Glycine maxParalogous to G4064; Orthologous to G149, G627, G1011, G154, G1797,G1798, G4061, G4062, G4065, G4066, G4067 737 G4064 DNA Glycine maxPredicted polypeptide sequence is paralogous to G4063; orthologous toG149, G627, G1011, G154, G1797, G1798, G4061, G4062, G4065, G4066, G4067738 G4064 PRT Glycine max Paralogous to G4063; Orthologous to G149,G627, G1011, G154, G1797, G1798, G4061, G4062, G4065, G4066, G4067 739G4065 DNA Zea mays Predicted polypeptide sequence is orthologous toG149, G627, G1011, G154, G1797, G1798, G4061, G4062, G4063, G4064,G4066, G4067 740 G4065 PRT Zea mays Orthologous to G149, G627, G1011,G154, G1797, G1798, G4061, G4062, G4063, G4064, G4066, G4067 741 G4066DNA Oryza sativa Predicted polypeptide sequence is paralogous to G4067;orthologous to G149, G627, G1011, G154, G1797, G1798, G4061, G4062,G4063, G4064, G4065 742 G4066 PRT Oryza sativa Paralogous to G4067;Orthologous to G149, G627, G1011, G154, G1797, G1798, G4061, G4062,G4063, G4064, G4065 743 G4067 DNA Oryza sativa Predicted polypeptidesequence is paralogous to G4066; orthologous to G149, G627, G1011, G154,G1797, G1798, G4061, G4062, G4063, G4064, G4065 744 G4067 PRT Oryzasativa Paralogous to G4066; Orthologous to G149, G627, G1011, G154,G1797, G1798, G4061, G4062, G4063, G4064, G4065 745 G4079 DNA SolanumPredicted polypeptide sequence is orthologous to G1750, G1421,lycopersicum G4080, G440, G864, G4283, G4284, G4285, G4286, G4287,G4288, G4289, G4290, G4291, G4292, G4293 746 G4079 PRT SolanumOrthologous to G1750, G1421, G4080, G440, G864, G4283, lycopersicumG4284, G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 747G4080 DNA Nicotiana Predicted polypeptide sequence is orthologous toG1750, G1421, tabacum G4079, G440, G864, G4283, G4284, G4285, G4286,G4287, G4288, G4289, G4290, G4291, G4292, G4293 748 G4080 PRT NicotianaOrthologous to G1750, G1421, G4079, G440, G864, G4283, tabacum G4284,G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 749 G4240DNA Zea mays Predicted polypeptide sequence is orthologous to G1435,G2741, G4241, G4243, G4244, G4245 750 G4240 PRT Zea mays Orthologous toG1435, G2741, G4241, G4243, G4244, G4245 751 G4241 DNA Oryza sativaPredicted polypeptide sequence is orthologous to G1435, G2741, G4240,G4243, G4244, G4245 752 G4241 PRT Oryza sativa Orthologous to G1435,G2741, G4240, G4243, G4244, G4245 753 G4243 DNA Glycine max Predictedpolypeptide sequence is paralogous to G4244; orthologous to G1435,G2741, G4240, G4241, G4245 754 G4243 PRT Glycine max Paralogous toG4244; Orthologous to G1435, G2741, G4240, G4241, G4245 755 G4244 DNAGlycine max Predicted polypeptide sequence is paralogous to G4243;orthologous to G1435, G2741, G4240, G4241, G4245 756 G4244 PRT Glycinemax Paralogous to G4243; Orthologous to G1435, G2741, G4240, G4241,G4245 757 G4245 DNA Solanum Predicted polypeptide sequence isorthologous to G1435, G2741, lycopersicum G4240, G4241, G4243, G4244 758G4245 PRT Solanum Orthologous to G1435, G2741, G4240, G4241, G4243,G4244 lycopersicum 759 G4272 DNA Zea mays Predicted polypeptide sequenceis paralogous to G3434, G3435, G3436, G3437, G3866, G3876, G4276;orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 760 G4272 PRT Zea maysParalogous to G3434, G3435, G3436, G3437, G3866, G3876, G4276;Orthologous to G1364, G2345, G481, G482, G485, G3394, G3395, G3396,G3397, G3398, G3429, G3470, G3471, G3472, G3473, G3474, G3475, G3476,G3478, G3868, G3870, G3873, G3874, G3875, G3938 761 G4276 DNA Zea maysPredicted polypeptide sequence is paralogous to G3434, G3435, G3436,G3437, G3866, G3876, G4272; orthologous to G1364, G2345, G481, G482,G485, G3394, G3395, G3396, G3397, G3398, G3429, G3470, G3471, G3472,G3473, G3474, G3475, G3476, G3478, G3868, G3870, G3873, G3874, G3875,G3938 762 G4276 PRT Zea mays Paralogous to G3434, G3435, G3436, G3437,G3866, G3876, G4272; Orthologous to G1364, G2345, G481, G482, G485,G3394, G3395, G3396, G3397, G3398, G3429, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3868, G3870, G3873, G3874, G3875, G3938 763G428 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1594 thaliana 764 G428 PRT Arabidopsis Paralogous to G1594 thaliana 765G4283 DNA Zea mays Predicted polypeptide sequence is paralogous toG4284; orthologous to G1750, G1421, G4079, G4080, G440, G864, G4285,G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 766 G4283 PRT Zeamays Paralogous to G4284; Orthologous to G1750, G1421, G4079, G4080,G440, G864, G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292,G4293 767 G4284 DNA Zea mays Predicted polypeptide sequence isparalogous to G4283; orthologous to G1750, G1421, G4079, G4080, G440,G864, G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 768G4284 PRT Zea mays Paralogous to G4283; Orthologous to G1750, G1421,G4079, G4080, G440, G864, G4285, G4286, G4287, G4288, G4289, G4290,G4291, G4292, G4293 769 G4285 DNA Glycine max Predicted polypeptidesequence is paralogous to G4286, G4287; orthologous to G1750, G1421,G4079, G4080, G440, G864, G4283, G4284, G4288, G4289, G4290, G4291,G4292, G4293 770 G4285 PRT Glycine max Paralogous to G4286, G4287;Orthologous to G1750, G1421, G4079, G4080, G440, G864, G4283, G4284,G4288, G4289, G4290, G4291, G4292, G4293 771 G4286 DNA Glycine maxPredicted polypeptide sequence is paralogous to G4285, G4287;orthologous to G1750, G1421, G4079, G4080, G440, G864, G4283, G4284,G4288, G4289, G4290, G4291, G4292, G4293 772 G4286 PRT Glycine maxParalogous to G4285, G4287; Orthologous to G1750, G1421, G4079, G4080,G440, G864, G4283, G4284, G4288, G4289, G4290, G4291, G4292, G4293 773G4287 DNA Glycine max Predicted polypeptide sequence is paralogous toG4285, G4286; orthologous to G1750, G1421, G4079, G4080, G440, G864,G4283, G4284, G4288, G4289, G4290, G4291, G4292, G4293 774 G4287 PRTGlycine max Paralogous to G4285, G4286; Orthologous to G1750, G1421,G4079, G4080, G440, G864, G4283, G4284, G4288, G4289, G4290, G4291,G4292, G4293 775 G4288 DNA Oryza sativa Predicted polypeptide sequenceis paralogous to G4289, G4290, G4291, G4292, G4293; orthologous toG1750, G1421, G4079, G4080, G440, G864, G4283, G4284, G4285, G4286,G4287 776 G4288 PRT Oryza sativa Paralogous to G4289, G4290, G4291,G4292, G4293; Orthologous to G1750, G1421, G4079, G4080, G440, G864,G4283, G4284, G4285, G4286, G4287 777 G4289 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G4288, G4290, G4291, G4292, G4293;orthologous to G1750, G1421, G4079, G4080, G440, G864, G4283, G4284,G4285, G4286, G4287 778 G4289 PRT Oryza sativa Paralogous to G4288,G4290, G4291, G4292, G4293; Orthologous to G1750, G1421, G4079, G4080,G440, G864, G4283, G4284, G4285, G4286, G4287 779 G4290 DNA Oryza sativaPredicted polypeptide sequence is paralogous to G4288, G4289, G4291,G4292, G4293; orthologous to G1750, G1421, G4079, G4080, G440, G864,G4283, G4284, G4285, G4286, G4287 780 G4290 PRT Oryza sativa Paralogousto G4288, G4289, G4291, G4292, G4293; Orthologous to G1750, G1421,G4079, G4080, G440, G864, G4283, G4284, G4285, G4286, G4287 781 G4291DNA Oryza sativa Predicted polypeptide sequence is paralogous to G4288,G4289, G4290, G4292, G4293; orthologous to G1750, G1421, G4079, G4080,G440, G864, G4283, G4284, G4285, G4286, G4287 782 G4291 PRT Oryza sativaParalogous to G4288, G4289, G4290, G4292, G4293; Orthologous to G1750,G1421, G4079, G4080, G440, G864, G4283, G4284, G4285, G4286, G4287 783G4292 DNA Oryza sativa Predicted polypeptide sequence is paralogous toG4288, G4289, G4290, G4291, G4293; orthologous to G1750, G1421, G4079,G4080, G440, G864, G4283, G4284, G4285, G4286, G4287 784 G4292 PRT Oryzasativa Paralogous to G4288, G4289, G4290, G4291, G4293; Orthologous toG1750, G1421, G4079, G4080, G440, G864, G4283, G4284, G4285, G4286,G4287 785 G4293 DNA Oryza sativa Predicted polypeptide sequence isparalogous to G4288, G4289, G4290, G4291, G4292; orthologous to G1750,G1421, G4079, G4080, G440, G864, G4283, G4284, G4285, G4286, G4287 786G4293 PRT Oryza sativa Paralogous to G4288, G4289, G4290, G4291, G4292;Orthologous to G1750, G1421, G4079, G4080, G440, G864, G4283, G4284,G4285, G4286, G4287 787 G4294 DNA Oryza sativa Predicted polypeptidesequence is orthologous to G1387, G2583, G975 788 G4294 PRT Oryza sativaOrthologous to G1387, G2583, G975 789 G43 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1419, G46, thaliana G1004, G29;orthologous to G3849 790 G43 PRT Arabidopsis Paralogous to G1419, G46,G1004, G29; Orthologous to G3849 thaliana 791 G4328 DNA SolanumPredicted polypeptide sequence is orthologous to G1791, G1792, tuberosumG1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3518, G3519,G3520, G3735, G3736, G3737, G3794, G3739, G3929, G4329, G4330 792 G4328PRT Solanum Orthologous to G1791, G1792, G1795, G30, G3380, G3381,tuberosum G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735, G3736,G3737, G3794, G3739, G3929, G4329, G4330 793 G4329 DNA Petunia xPredicted polypeptide sequence is orthologous to G1791, G1792, hybridaG1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, G3518, G3519,G3520, G3735, G3736, G3737, G3794, G3739, G3929, G4328, G4330 794 G4329PRT Pelunia x Orthologous to G1791, G1792, G1795, G30, G3380, G3381,hybrida G3383, G3515, G3516, G3517, G3518, G3519, G3520, G3735, G3736,G3737, G3794, G3739, G3929, G4328, G4330 795 G4330 DNA Populus Predictedpolypeptide sequence is orthologous to G1791, G1792, trichocarpa xG1795, G30, G3380, G3381, G3383, G3515, G3516, G3517, Populus nigraG3518, G3519, G3520, G3735, G3736, G3737, G3794, G3739, G3929, G4328,G4329 796 G4330 PRT Populus Orthologous to G1791, G1792, G1795, G30,G3380, G3381, trichocarpa x G3383, G3515, G3516, G3517, G3518, G3519,G3520, G3735, Populus nigra G3736, G3737, G3794, G3739, G3929, G4328,G4329 797 G4371 DNA Glycine max Predicted polypeptide sequence isparalogous to G3524; orthologous to G1543, G3510, G3490 798 G4371 PRTGlycine max Paralogous to G3524; Orthologous to G1543, G3510, G3490 799G440 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1750, G1421, thaliana G864; orthologous to G4079, G4080, G4283, G4284,G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292, G4293 800 G440PRT Arabidopsis Paralogous to G1750, G1421, G864; Orthologous to G4079,thaliana G4080, G4283, G4284, G4285, G4286, G4287, G4288, G4289, G4290,G4291, G4292, G4293 801 G450 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G448, G455, thaliana G456 802 G450 PRTArabidopsis Paralogous to G448, G455, G456 thaliana 803 G455 DNAArabidopsis Predicted polypeptide sequence is paralogous to G448, G450,thaliana G456 804 G455 PRT Arabidopsis Paralogous to G448, G450, G456thaliana 805 G456 DNA Arabidopsis Predicted polypeptide is paralogous toG448, G450, thaliana G455 806 G456 PRT Arabidopsis Paralogous to G448,G450, G455 thaliana 807 G46 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G1419, G43, thaliana G1004, G29; orthologousto G3849 808 G46 PRT Arabidopsis Paralogous to G1419, G43, G1004, G29;Orthologous to G3849 thaliana 809 G4627 DNA Oryza sativa Predictedpolypeptide sequence is paralogous to G4630, G5158; orthologous toG1809, G557, G4631, G4632 810 G4627 PRT Oryza sativa Paralogous toG4630, G5158; Orthologous to G1809, G557, G4631, G4632 811 G4630 DNAOryza sativa Predicted polypeptide sequence is paralogous to G4627,G5158; orthologous to G1809, G557, G4631, G4632 812 G4630 PRT Oryzasativa Paralogous to G4627, G5158; Orthologous to G1809, G557, G4631,G4632 813 G4631 DNA Glycine max Predicted polypeptide sequence isorthologous to G1809, G557, G4627, G4630, G4632, G5158 814 G4631 PRTGlycine max Orthologous to G1809, G557, G4627, G4630, G4632, G5158 815G4632 DNA Zea mays Predicted polypeptide sequence is orthologous toG1809, G557, G4627, G4630, G4631, G5158 816 G4632 PRT Zea maysOrthologous to G1809, G557, G4627, G4630, G4631, G5158 817 G482 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1364,G2345, thaliana G481, G485; orthologous to G3394, G3395, G3396, G3397,G3398, G3429, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875,G3876, G3938, G4272, G4276 818 G482 PRT Arabidopsis Paralogous to G1364,G2345, G481, G485; Orthologous to thaliana G3394, G3395, G3396, G3397,G3398, G3429, G3434, G3435, G3436, G3437, G3470, G3471, G3472, G3473,G3474, G3475, G3476, G3478, G3866, G3868, G3870, G3873, G3874, G3875,G3876, G3938, G4272, G4276 819 G485 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1364, G2345, thaliana G481, G482;orthologous to G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 820G485 PRT Arabidopsis Paralogous to G1364, G2345, G481, G482; Orthologousto thaliana G3394, G3395, G3396, G3397, G3398, G3429, G3434, G3435,G3436, G3437, G3470, G3471, G3472, G3473, G3474, G3475, G3476, G3478,G3866, G3868, G3870, G3873, G3874, G3875, G3876, G3938, G4272, G4276 821G502 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG501, G519, thaliana G767 822 G502 PRT Arabidopsis Paralogous to G501,G519, G767 thaliana 823 G506 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G2052 thaliana 824 G506 PRT ArabidopsisParalogous to G2052 thaliana 825 G515 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G2053, G516, thaliana G517 826G515 PRT Arabidopsis Paralogous to G2053, G516, G517 thaliana 827 G5158DNA Oryza sativa Predicted polypeptide sequence is paralogous to G4627,G4630; orthologous to G1809, G557, G4631, G4632 828 G5158 PRT Oryzasativa Paralogous to G4627, G4630; Orthologous to G1809, G557, G4631,G4632 829 G5159 DNA Oryza sativa Predicted polypeptide sequence isorthologous to G1482, G1888 830 G5159 PRT Oryza sativa Orthologous toG1482, G1888 831 G516 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G2053, G515, thaliana G517 832 G516 PRT ArabidopsisParalogous to G2053, G515, G517 thaliana 833 G519 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G501, G502, thalianaG767 834 G519 PRT Arabidopsis Paralogous to G501, G502, G767 thaliana835 G545 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG350, G351 thaliana 836 G545 PRT Arabidopsis Paralogous to G350, G351thaliana 837 G554 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1198, G1806, thaliana G555, G556, G558, G578, G629 838G554 PRT Arabidopsis Paralogous to G1198, G1806, G555, G556, G558, G578,G629 thaliana 839 G555 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1198, G1806, thaliana G554, G556, G558, G578, G629 840G555 PRT Arabidopsis Paralogous to G1198, G1806, G554, G556, G558, G578,G629 thaliana 841 G556 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1198, G1806, thaliana G554, G555, G558, G578, G629 842G556 PRT Arabidopsis Paralogous to G1198, G1806, G554, G555, G558, G578,G629 thaliana 843 G557 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1809; thaliana orthologous to G4627, G4630, G4631, G4632,G5158 844 G557 PRT Arabidopsis Paralogous to G1809; Orthologous toG4627, G4630, G4631, thaliana G4632, G5158 845 G558 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1198, G1806, thalianaG554, G555, G556, G578, G629 846 G558 PRT Arabidopsis Paralogous toG1198, G1806, G554, G555, G556, G578, G629 thaliana 847 G576 DNAArabidopsis Predicted polypeptide sequence is paralogous to G1082thaliana 848 G576 PRT Arabidopsis Paralogous to G1082 thaliana 849 G578DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1198,G1806, thaliana G554, G555, G556, G558, G629 850 G578 PRT ArabidopsisParalogous to G1198, G1806, G554, G555, G556, G558, G629 thaliana 851 G6DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1020thaliana 852 G6 PRT Arabidopsis Paralogous to G1020 thaliana 853 G605DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1944thaliana 854 G605 PRT Arabidopsis Paralogous to G1944 thaliana 855 G627DNA Arabidopsis Predicted polypeptide sequence is paralogous to G149,G1011, thaliana G154, G1797, G1798; orthologous to G4061, G4062, G4063,G4064, G4065, G4066, G4067 856 G627 PRT Arabidopsis Paralogous to G149,G1011, G154, G1797, G1798; Orthologous thaliana to G4061, G4062, G4063,G4064, G4065, G4066, G4067 857 G629 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G1198, G1806, thaliana G554, G555,G556, G558, G578 858 G629 PRT Arabidopsis Paralogous to G1198, G1806,G554, G555, G556, G558, G578 thaliana 859 G631 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G559 thaliana 860 G631 PRTArabidopsis Paralogous to G559 thaliana 861 G648 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1883 thaliana 862 G648PRT Arabidopsis Paralogous to G1883 thaliana 863 G666 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G256, G668, thalianaG932; orthologous to G3384, G3385, G3386, G3500, G3501, G3502, G3537,G3538, G3539, G3540, G3541 864 G666 PRT Arabidopsis Paralogous to G256,G668, G932; Orthologous to G3384, G3385, thaliana G3386, G3500, G3501,G3502, G3537, G3538, G3539, G3540, G3541 865 G730 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1040, G3034, thalianaG729 866 G730 PRT Arabidopsis Paralogous to G1040, G3034, G729 thaliana867 G767 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG501, G502, thaliana G519 868 G767 PRT Arabidopsis Paralogous to G501,G502, G519 thaliana 869 G859 DNA Arabidopsis Predicted polypeptidesequence is paralogous to G157, G1759, thaliana G1842, G1843, G1844 870G859 PRT Arabidopsis Paralogous to G157, G1759, G1842, G1843, G1844thaliana 871 G864 DNA Arabidopsis Predicted polypeptide sequence isparalogous to G1750, G1421, thaliana G440; orthologous to G4079, G4080,G4283, G4284, G4285, G4286, G4287, G4288, G4289, G4290, G4291, G4292,G4293 872 G864 PRT Arabidopsis Paralogous to G1750, G1421, G440;Orthologous to G4079, thaliana G4080, G4283, G4284, G4285, G4286, G4287,G4288, G4289, G4290, G4291, G4292, G4293 873 G867 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1930, G9, thalianaG993; orthologous to G3388, G3389, G3390, G3391, G3432, G3433, G3451,G3452, G3453, G3454, G3455 874 G867 PRT Arabidopsis Paralogous to G1930,G9, G993; Orthologous to G3388, G3389, thaliana G3390, G3391, G3432,G3433, G3451, G3452, G3453, G3454, G3455 875 G9 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G1930, G867, thalianaG993; orthologous to G3388, G3389, G3390, G3391, G3432, G3433, G3451,G3452, G3453, G3454, G3455 876 G9 PRT Arabidopsis Paralogous to G1930,G867, G993; Orthologous to G3388, thaliana G3389, G3390, G3391, G3432,G3433, G3451, G3452, G3453, G3454, G3455 877 G903 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G2831 thaliana 878 G903PRT Arabidopsis Paralogous to G2831 thaliana 879 G932 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G256, G666, thalianaG668; orthologous to G3384, G3385, G3386, G3500, G3501, G3502, G3537,G3538, G3539, G3540, G3541 880 G932 PRT Arabidopsis Paralogous to G256,G666, G668; Orthologous to G3384, G3385, thaliana G3386, G3500, G3501,G3502, G3537, G3538, G3539, G3540, G3541 881 G938 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G940, G941 thaliana 882G938 PRT Arabidopsis Paralogous to G940, G941 thaliana 883 G941 DNAArabidopsis Predicted polypeptide sequence is paralogous to G938, G940thaliana 884 G941 PRT Arabidopsis Paralogous to G938, G940 thaliana 885G960 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1426, G1455, thaliana G513 886 G960 PRT Arabidopsis Paralogous toG1426, G1455, G513 thaliana 887 G964 DNA Arabidopsis Predictedpolypeptide sequence is paralogous to G398, G399 thaliana 888 G964 PRTArabidopsis Paralogous to G398, G399 thaliana 889 G976 DNA ArabidopsisPredicted polypeptide sequence is paralogous to G913, G2514, thalianaG1753 890 G976 PRT Arabidopsis Paralogous to G913, G2514, G1753 thaliana891 G993 DNA Arabidopsis Predicted polypeptide sequence is paralogous toG1930, G867, thaliana G9; orthologous to G3388, G3389, G3390, G3391,G3432, G3433, G3451, G3452, G3453, G3454, G3455 892 G993 PRT ArabidopsisParalogous to G1930, G867, G9; Orthologous to G3388, G3389, thalianaG3390, G3391, G3432, G3433, G3451, G3452, G3453, G3454, G3455 893 G997DNA Arabidopsis Predicted polypeptide sequence is paralogous to G1789,G1911, thaliana G2721 894 G997 PRT Arabidopsis Paralogous to G1789,G1911, G2721 thaliana

Example IX Introduction of Polynucleotides into Dicotyledonous Plantsand Cereal Plants

Transcription factor sequences listed in the Sequence Listing recombinedinto expression vectors, such as pMEN20 or pMEN65, may be transformedinto a plant for the purpose of modifying plant traits. It is nowroutine to produce transgenic plants using most dicot plants (seeWeissbach and Weissbach, (1989); Gelvin et al. (1990); Herrera-Estrellaet al. (1983); Bevan (1984); and Klee (1985)). Methods for analysis oftraits are routine in the art and examples are disclosed above.

The cloning vectors of the invention may also be introduced into avariety of cereal plants. Cereal plants such as, but not limited to,corn, wheat, rice, sorghum, or barley, may also be transformed with thepresent polynucleotide sequences in pMEN20 or pMEN65 expression vectorsfor the purpose of modifying plant traits. For example, pMEN020 may bemodified to replace the NptII coding region with the BAR gene ofStreptomyces hygroscopicus that confers resistance to phosphinothricin.The KpnI and BglII sites of the Bar gene are removed by site-directedmutagenesis with silent codon changes.

The cloning vector may be introduced into a variety of cereal plants bymeans well known in the art such as, for example, direct DNA transfer orAgrobacterium tumefaciens-mediated transformation. It is now routine toproduce transgenic plants of most cereal crops (Vasil (1994)) such ascorn, wheat, rice, sorghum (Cassas et al. (1993)), and barley (Wan andLemeaux (1994)). DNA transfer methods such as the microprojectile can beused for corn (Fromm et al. (1990); Gordon-Kamm et al. (1990); Ishida(1990)), wheat (Vasil et al. (1992); Vasil et al. (1993b); Weeks et al.(1993)), and rice (Christou (1991); Hiei et al. (1994); Aldemita andHodges (1996); and Hiei et al. (1997)). For most cereal plants,embryogenic cells derived from immature scutellum tissues are thepreferred cellular targets for transformation (Hiei et al. (1997); Vasil(1994)).

Vectors according to the present invention may be transformed into cornembryogenic cells derived from immature scutellar tissue by usingmicroprojectile bombardment, with the A188XB73 genotype as the preferredgenotype (Fromm et al. (1990); Gordon-Kamm et al. (1990)). Aftermicroprojectile bombardment the tissues are selected on phosphinothricinto identify the transgenic embryogenic cells (Gordon-Kamm et al.(1990)). Transgenic plants are regenerated by standard corn regenerationtechniques (Fromm et al. (1990); Gordon-Kamm et al. (1990)).

The vectors prepared as described above can also be used to producetransgenic wheat and rice plants (Christou (1991); Hiei et al. (1994);Aldemita and Hodges (1996); and Hiei et al. (1997)) that coordinatelyexpress genes of interest by following standard transformation protocolsknown to those skilled in the art for rice and wheat (Vasil et al.(1992); Vasil et al. (1993); and Weeks et al. (1993)), where the bargene is used as the selectable marker.

Example X Genes that Confer Significant Improvements to Diverse PlantSpecies

The function of specific orthologs of the sequences of the invention maybe further characterized and incorporated into crop plants. The ectopicoverexpression of these orthologs may be regulated using constitutive,inducible, or tissue specific regulatory elements. Genes that have beenexamined and have been shown to modify plant traits (includingincreasing lycopene, soluble solids and disease tolerance) encodeorthologs of the transcription factor polypeptides found in the SequenceListing, Table 6 or Table 7. In addition to these sequences, it isexpected that related polynucleotide sequences encoding polypeptidesfound in the Sequence Listing can also induce altered traits, includingincreasing lycopene, soluble solids and disease tolerance, whentransformed into a considerable variety of plants of different species,and including dicots and monocots. The polynucleotide and polypeptidesequences derived from monocots (e.g., the rice sequences) may be usedto transform both monocot and dicot plants, and those derived fromdicots (e.g., the Arabidopsis and soy genes) may be used to transformeither group, although it is expected that some of these sequences willfunction best if the gene is transformed into a plant from the samegroup as that from which the sequence is derived.

Transgenic plants are subjected to assays to measure plant volume,lycopene, soluble solids, disease tolerance, and fruit set according tothe methods disclosed in the above Examples.

These experiments demonstrate that a significant number thetranscription factor polypeptide sequences of the invention can beidentified and shown to increased volume, lycopene, soluble solids anddisease tolerance. It is expected that the same methods may be appliedto identify and eventually make use of other members of the clades ofthe present transcription factor polypeptides, with the transcriptionfactor polypeptides deriving from a diverse range of species.

All publications and patent applications mentioned in this specificationare herein incorporated by reference to the same extent as if eachindividual publication or patent application was specifically andindividually indicated to be incorporated by reference.

The present invention is not limited by the specific embodimentsdescribed herein. The invention now being fully described, it will beapparent to one of ordinary skill in the art that many changes andmodifications can be made thereto without departing from the spirit orscope of the Claims. Modifications that become apparent from theforegoing description and accompanying figures fall within the scope ofthe following Claims.

REFERENCES CITED

-   Aldemita and Hodges (1996) Planta 199:612-617-   Ainley et al. (1993) Plant Mol. Biol. 22: 13-23-   Altschul et al. (1990) J. Mol. Biol. 215: 403-410-   Altschul (1993) J. Mol. Evol. 36: 290-300-   Ammirato et al., eds. (1984) Handbook of Plant Cell Culture-Crop    Species, Macmillan Publ. Co., NY, N. Y.-   An et al. (1988) Plant Physiol. 88: 547-552-   Anderson and Young (1985) “Quantitative Filter Hybridisation.” In:    Hames and Higgins, ed., Nucleic Acid Hybridisation, A Practical    Approach. Oxford, IRL Press, 73-111-   Angiosperm Phylogeny Group (1998) Ann. Missouri Bot. Gard. 84: 1-49-   Aoyama et al. (1995) Plant Cell 7: 1773-1785-   Ausubel et al. (1997) Short Protocols in Molecular Biology, John    Wiley & Sons, New York, N.Y., unit 7.7-   Ausubel et al., eds. (1998-2000) Current Protocols in Molecular    Biology, Greene Publishing Associates, Inc. and John Wiley & Sons,    Inc., (supplemented through 2000) (“Ausubel”)-   Baerson et al. (1993) Plant Mol. Biol. 22: 255-267-   Baerson et al. (1994) Plant Mol. Biol. 26: 1947-1959-   Bairoch et al. (1997) Nucleic Acids Res. 25: 217-221-   Baumann et al., (1999) Plant Cell 11: 323-334-   Beaucage et al. (1981) Tetrahedron Letters 22: 1859-1869-   Berger and Kimmel (1987) Guide to Molecular Cloning Techniques,    Methods in Enzymology, vol. 152 Academic Press, Inc., San Diego,    Calif. (“Berger and Kimmel”)-   Bevan (1984) Nucleic Acids Res. 12: 8711-8721-   Bhattacharjee et al. (2001) Proc Natl. Acad. Sci., USA, 98:    13790-13795-   Bird et al. (1988) Plant Mol. Biol. 11: 651-662-   Borevitz et al. (2000) Plant Cell 12: 2383-2394-   Boss and Thomas (2002) Nature, 416: 847-850-   Breen and Crouch (1992) Plant Mol. Biol. 19:1049-1055-   Bruce et al. (2000) Plant Cell, 12: 65-79-   Buchel et al. (1999) Plant Mol. Biol. 40: 387-396-   Bulyk et al. (1999) Nature Biotechnol. 17: 573-577-   Brummelkamp et al. (2002) Science 296:550-553-   Byrne et al (2000) Nature 408: 967-971-   Cassas et al. (1993) Proc. Natl. Acad. Sci. 90: 11212-11216-   Chase et al. (1993) Ann. Missouri Bot. Gard. 80: 528-580-   Cheng et al. (1994) Nature 369: 684-685-   Chien et al. (1991) Proc. Natl. Acad. Sci. 88: 9578-9582-   Chrispeels et al. (2000) Plant Mol. Biol. 42: 279-290-   Christou (1991) Bio/Technology 9: 957-962-   Constans (2002) The Scientist 16: 36-   Corona et al. (1996) Plant J. 9: 505-512-   Coupland (1995) Nature 377: 482-483-   Crowley et al. (1985) Cell 43: 633-641-   Daly et al. (2001) Plant Physiol. 127: 1328-1333-   Doolittle, ed., (1996) Methods Enzymol., vol. 266, “Computer Methods    for Macromolecular Sequence Analysis”, Academic Press, Inc., San    Diego, Calif., USA-   Eddy (1996) Curr. Opin. Str. Biol. 6: 361-365-   Eisen (1998) Genome Res. 8: 163-167-   Eyal et al. (1992) Plant Mol. Biol. 19: 589-599-   Feng and Doolittle (1987) J. Mol. Evol. 25: 351-360-   Fire et al. (1998) Nature 391: 806-811-   Fluhr et al (1986) EMBO J. 5: 2063-2071-   Fowler and Thomashow (2002) Plant Cell 14: 1675-1690-   Fraley et al. (1983) Proc. Natl. Acad. Sci. 80: 4803-4807-   Fromm et al. (1985) Proc. Natl. Acad. Sci. 82: 5824-5828-   Fromm et al. (1989) Plant Cell 1: 977-984-   Fromm et al. (1990) Bio/Technol. 8: 833-839-   Fu et al. (2001) Plant Cell 13: 1791-1802-   Gan and Amasino (1995) Science 270: 1986-1988)-   Gatz (1997) Annu. Rev. Plant Physiol. Plant Mol. Biol. 48: 89-108-   Gelvin et al. (1990) Plant Molecular Biology Manual, Kluwer Academic    Publishers-   Giniger and Ptashne (1987) Nature 330: 670-672-   Gilmour et al. (1998) Plant J. 16: 433-442-   Goodrich et al. (1993) Cell 75: 519-530-   Gordon-Kamm (1990) Plant Cell 2: 603-618-   Guevara-Garcia (1998) Plant Mol. Biol. 38: 743-753-   Guyer et al. (1998) Genetics 149: 633-639-   Hames and Higgins, eds. (1985) Nucleic Acid Hybridisation: A    Practical Approach, IRL Press, Oxford, U. K.-   Hammond et al. (2001) Nature Rev Gen 2: 110-119-   Harlow and Lane (1988), Antibodies: A Laboratory Manual, Cold Spring    Harbor Laboratory, New York-   He et al. (2000) Transgenic Res. 9: 223-227-   Hein (1990) Methods Enzymol. 183: 626-645-   Hempel et al. (1997) Development 124: 3845-3853-   Henikoff and Henikoff (1991) Nucleic Acids Res. 19: 6565-6572-   Henikoff and Henikoff (1992) Proc. Natl. Acad. Sci. 89: 10915-10919-   Herrera-Estrella et al. (1983) Nature 303: 209-   Hiei et al. (1994) Plant J. 6:271-282-   Hiei et al. (1997) Plant Mol. Biol. 35:205-218-   Higgins and Sharp (1988) Gene 73: 237-244-   Higgins et al. (1996) Methods Enzymol. 266: 383-402-   Hohn et al. (1982) Molecular Biology of Plant Tumors Academic Press,    New York, N.Y., pp. 549-560-   Horsch et al. (1984) Science 233: 496-498-   Ichikawa et al. (1997) Nature 390 698-701-   Isalan et al. (2001) Nature Biotechnol. 19: 656-660-   Ishida (1990) Nature Biotechnol. 14:745-750-   Ishida et al. (1996) Nature Biotechnol. 14: 745-750-   Izant and Weintraub (1985) Science 229: 345-352-   Jaglo et al. (2001) Plant Physiol. 127: 910-917-   Jones et al. (1992) Transgenic Res. 1: 285-297-   Kaiser et al. (1995) Plant Mol. Biol. 28: 231-243-   Kakimoto et al. (1996) Science 274: 982-985-   Karlin and Altschul (1993) Proc. Natl. Acad. Sci. 90: 5873-5787-   Kashima et al. (1985) Nature 313:402-404-   Kempin et al. (1997) Nature 389: 802-803-   Kim and Wold (1985) Cell 42: 129-138-   Kim et al. (2001) Plant J. 25: 247-259-   Kimmel (1987) Methods Enzymol. 152: 507-511-   Klee (1985) Bio/Technology 3: 637-642-   Klein et al. (1987) Nature 327: 70-73-   Koncz et al. (1992a) Methods in Arabidopsis Research, World    Scientific, River Edge, N.J.-   Koncz et al (1992b) Plant Molec. Biol. 20: 963-976-   Kop et al. (1999) Plant Mol. Biol. 39: 979-990-   Ku et al. (2000) Proc. Natl. Acad. Sci. 97: 9121-9126-   Kuhlemeier et al. (1989) Plant Cell 1: 471-478-   Kyozuka and Shimamoto (2002) Plant Cell Physiol. 43: 130-135-   Lehming et al (1987) EMBO J. 6: 3145-3153-   Lichtenstein and Nellen (1997) Antisense Technology: A Practical    Approach IRL Press at Oxford University Press, Oxford, U.K-   Lin et al. (1991) Nature 353: 569-571-   Liu et al. (2001) J. Biol. Chem. 276: 11323-11334-   Long and Barton (1998) Development 125: 3027-3035-   Long and Barton (2000) Dev. Biol. 218: 341-353-   Ma and Ptashne (1987) Cell 51: 113-119-   Mandel et al. (1992a) Nature 360: 273-277-   Mandel et al. (1992b) Cell 71: 133-143-   Manners et al. (1998) Plant Mol. Biol. 38: 1071-1080-   Matthes et al. (1984) EMBO J. 3: 801-805-   Melton (1985) Proc. Natl. Acad. Sci. 82: 144-148-   Meyers (1995) Molecular Biology and Biotechnology, Wiley VCH, New    York, N.Y., p 856-853-   Montgomery et al. (1993) Plant Cell 5: 1049-1062-   Moore et al. (1988) in Schaad, ed., Laboratory Guide for the    Identification of Plant Pathogenic Bacteria. APS Press, St. Paul,    Minn.-   Moore et al. (1998) Proc. Natl. Acad. Sci. 95: 376-381-   Mount (2001) in Bioinformatics: Sequence and Genome Analysis Cold    Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., page 543-   Müller et al. (2001) Plant J. 28: 169-179-   Mullis et al. (1990) PCR Protocols A Guide to Methods and    Applications (Innis et al. eds) Academic Press Inc. San Diego,    Calif.-   Murashige and Skoog (1962) Plant Physiol. 15: 473-497-   Nagel et al. (1990) FEMS Microbiol Letts. 67: 325-328-   Nandi et al. (2000) Curr. Biol. 10: 215-218-   Needleman and Wunsch (1970) J. Mol. Biol. 48: 443-453-   Nicholass et al. (1995) Plant Mol. Biol. 28: 423-435-   Odell et al. (1985) Nature 313: 810-812-   Odell et al. (1994) Plant Physiol. 106: 447-458-   Ohl et al. (1990) Plant Cell 2: 837-848-   Ori et al. (2000) Development 127: 5523-5532-   Paddison, et al. (2002) Genes & Dev. 16: 948-958-   Pearson and Lipman (1988) Proc. Natl. Acad. Sci. 85: 2444-2448-   Peng et al. (1997) Genes Development 11: 3194-3205-   Peng et al. (1999) Nature 400: 256-261-   Piazza et al. (2002) Plant Physiol. 128: 1077-1086-   Preiss et al. (1985) Nature 313: 27-32-   Ratcliffe et al. (2001) Plant Physiol. 126: 122-132-   Riechmann et al. (2000) Science 290: 2105-2110-   Rieger et al. (1976) Glossary of Genetics and Cytogenetics:    Classical and Molecular, 4th ed., Springer Verlag, Berlin-   Ringli and Keller (1998) Plant Mol. Biol. 37: 977-988-   Robson et al. (2001) Plant J. 28: 619-631-   Rosenberg et al. (1985) Nature 313: 703-706-   Sadowski et al. (1988) Nature 335: 563-564-   Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, 2nd    Ed., Vol. 1-3, Cold Spring Harbor Laboratory, Cold Spring Harbor,    N.Y. (“Sambrook”)-   Schaffner and Sheen (1991) Plant Cell 3: 997-1012-   Sharp (1999) Genes and Development 13: 139-141-   Shi et al. (1998) Plant Mol. Biol. 38: 1053-1060-   Shimamoto et al. (1989) Nature 338: 274-276-   Shpaer (1997) Methods Mol. Biol. 70: 173-187-   Siebertz et al. (1989) Plant Cell 1: 961-968-   Sjodahl et al. (1995) Planta 197: 264-271-   Smith and Waterman (1981) Adv. Appl. Math. 2: 482-489-   Smith et al. (1988) Nature, 334: 724-726-   Smith et al. (1990) Plant Mol. Biol. 14: 369-379-   Smith et al. (1992) Protein Engineering 5: 35-51-   Sonnhammer et al. (1997) Proteins 28: 405-420-   Stemmer (1994a) Nature 370: 389-391-   Stemmer (1994b) Proc. Natl. Acad. Sci. 91: 10747-10751-   Suzuki et al. (2001) Plant J. 28: 409-418-   Taylor and Scheuring (1994) Mol. Gen. Genet. 243: 148-157-   Thoma et al. (1994) Plant Physiol. 105: 35-45-   Thompson et al. (1994) Nucleic Acids Res. 22: 4673-4680-   Timmons and Fire (1998) Nature 395: 854-   Tudge (2000) in The Variety of Life, Oxford University Press, New    York, N.Y., pp. 547-606-   Vasil et al. (1990) Bio/Technol. 8: 429-434-   Vasil et al. (1992) Bio/Technol. 10:667-674-   Vasil (1993a) Bio/Technology 10: 667-674-   Vasil et al. (1993 b) Bio/Technol. 11:1553-1558-   Vasil (1994) Plant Mol. Biol. 25: 925-937-   Wahl and Berger (1987) Methods Enzymol. 152: 399-407-   Wan and Lemeaux (1994) Plant Physiol. 104: 37-48-   Wanner and Gruissem (1991) Plant Cell 3: 1289-1303-   Weeks et al. (1993) Plant Physiol. 102: 1077-1084-   Weigel and Nilsson (1995) Nature 377: 482-500-   Weissbach and Weissbach (1989) Methods for Plant Molecular Biology,    Academic Press-   Willmott et al. (1998) Plant Molec. Biol. 38: 817-825-   Winans (1992) Microbiol. Rev. 56: 12-31-   Wu, ed. (1993) Methods Enzymol. (vol. 217, Academic Press, San    Diego)-   Xu et al. (2001) Proc. Natl. Acad. Sci., USA, 98: 15089-15094-   Zamore (2001) Nature Struct. Biol., 8: 746-750-   Zhang et al. (2000) J. Biol. Chem. 275: 33850-33860

1. A transformed plant having greater seedling vigor or increased plant size than a control plant, wherein the transformed plant is transformed with a recombinant polynucleotide encoding a polypeptide that has at least 95% amino acid identity to the amino acid sequence set forth in SEQ ID NO: 230, and wherein said greater seedling vigor or increased plant size results from expression of the polypeptide in the transformed plant.
 2. The transformed plant of claim 1, wherein the polypeptide has at least 98% amino acid identity to the amino acid sequence set forth in SEQ ID NO:
 230. 3. The transformed plant of claim 1, wherein the recombinant polynucleotide comprises a constitutive, inducible, or tissue-specific promoter that regulates expression of the polypeptide.
 4. A transgenic seed produced by the transformed plant of claim 1, wherein the transgenic seed comprises the recombinant polynucleotide.
 5. A transformed plant cell obtained from the transgenic plant of claim 1, wherein the transformed plant cell comprises the recombinant polynucleotide.
 6. The transformed plant of claim 1, wherein the polypeptide is SEQ ID NO:
 230. 7. A transgenic seed produced by the transformed plant of claim 2, wherein the transgenic seed comprises the recombinant polynucleotide.
 8. A transformed plant cell obtained from the transgenic plant of claim 2, wherein the transformed plant cell comprises the recombinant polynucleotide.
 9. A transgenic seed produced by the transformed plant of claim 6, wherein the transgenic seed comprises the recombinant polynucleotide.
 10. A transformed plant cell obtained from the transgenic plant of claim 6, wherein the transformed plant cell comprises the recombinant polynucleotide. 